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Abstract
Exogenous retroviruses (i.e. horizontally transmitted) must integrate their pro viral DNA 
into the host’s genome as part o f the retroviral cycle. Therefore, infections o f the germ 
line can give rise to vertically transmitted endogenous retroviruses (ERVs). ERVs are 
present in all vertebrates. During evolution, most ERVs have accumulated mutations 
and/or deletions that hampered their ability to replicate and hence to harm the host. 
However, some ERVs have retained at least some of their open reading frames intact 
even after several million years. One possible reason for the selection o f ERVs is that 
they protected the host against incoming pathogenic exogenous retroviruses. The fact 
that the vast majority o f ERVs do not possess circulating exogenous counterparts 
supports this view.
Ovine pulmonary adenocarcinoma (OPA) is a transmissible lung cancer of sheep caused 
by a Betaretrovirus known as Jaagsiekte sheep retrovirus (JSRV). Notably, the sheep 
genome possesses approximately 30 ERVs highly related to JSRV (and hence referred 
to as enJSRVs). A specific en JSRV provirus, termed enJS56Al, acts as a transdominant 
restriction factor that blocks the exogenous JSRV at late stages of the replication cycle. 
The main determinant o f this block (termed JLR for JSRV /ate restriction) has been 
mapped to the N-terminal region o f the Gag polyprotein, more precisely to residue 21 of 
the matrix protein. In this study, the molecular basis of JLR was investigated by 
functionally characterizing the JSRV and enJS56Al Gag polyproteins. Putative Gag 
trafficking signals, such as membrane binding (M) and late domains (L) were identified, 
although it was determined that these domains lack any involvement in JLR. enJS56Al~ 
expression constructs bearing truncated Gags were unable to block JSRV, indicating 
that an intact Gag polyprotein is required for JLR. Moreover, intracellular colocalization 
and protein-protein interaction between JSRV and enJS56Al Gag molecules was 
determined by confocal microscopy and co-immunoprecipitation, respectively. 
Complementation assays suggest that JSRV and enJS56Al Gag likely co-assemble. 
These data are supported by the fact that deletion of the major homology region of 
enJS56Al Gag allows JSRV to escape JLR. Confocal microscopy experiments indicate 
that JSRV must reach the pericentriolar region as part o f its normal cell cycle and that 
JLR takes place before this stage.
This work unveils basic aspects of JSRV biology that were previously unknown. It also 
provides insight on the molecular basis o f JLR, highlighting the dynamic evolutionary 
interplay between viruses and host.
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Chapter 1 
General Introduction
Summary
This chapter will provide the theoretical framework to the studies detailed in this thesis. 
It starts with a concise history o f retroviroiogy followed by an overview on the biology 
o f this family o f viruses with specific emphasis on endogenous retroviruses. Since a 
whole book could be written about the history o f retroviruses, only seminal works and 
landmark papers will be referenced. Along the same line, 1 will briefly describe the 
taxonomy, viral structure and life cycle o f retroviruses. The second part o f the chapter 
will focus on Jaagsiekte sheep retrovirus (JSRV) and the related endogenous sheep 
Betaretroviruses. Finally, since the primary focus o f this thesis is the interaction 
between two Betaretroviruses, the reader should be aware that whenever possible 1 will 
use members of this genus as examples.
Brief history of retroviroiogy
It may sound presumptuous to say that we owe what we are today to retroviruses. 
However, since approximately 8% o f our genome is constituted by retroviral DNA 
(Gifford and Tristem 2003; Weiss 2006), that statement is not far from the truth. 
Retroviruses have evolved with us for millions of years, and in doing so they co-shaped 
our genome, modified our phenotype and in recent times they have even changed our 
customs and practices. However, from a human perspective, the history o f this family of 
viruses started only around a hundred years ago and can be divided in three periods that 
reflect the dynamics o f the evolving paradigms in the field. During the first or 
“oncogenic period”, the driving force for researchers was the study o f viruses as 
causative agents o f cancer. It was followed by the “reverse-transcriptase and AIDS 
period”, characterized by the discovery o f the reverse-transcriptase that challenged the 
central dogma of molecular biology, and the AIDS epidemics that preceded the 
discovery of HIV. Finally, our current time or “post-genomic period” in which
Pablo R Murcia, 2007 Chapter 1, 18
systematic sequencing o f diverse genomes has unveiled the fossil imprints o f past 
retroviral infections, allowing us to study viral and host coevolution, as well as the 
dynamics o f their interaction.
The earliest report on the infectious nature of retroviral diseases dates back to 1904, 
with studies on equine infectious anemia (EIAV) by Henri Vallée and Henri Carré 
(Vallée and Carré 1904). However, what is here regarded as the initial period of 
retroviroiogy started with the experimental transmission o f the first oncogenic 
retroviruses. In 1908 two Danish veterinary surgeons, Vilhelm Ellerman and Olaf Bang, 
who were studying erythroleukaemia in chickens, succeeded in transmitting the disease 
from one chick to another by means o f cell-free filtrates (Ellerman and Bang 1908). 
Three years later, Peyton Rous published his seminal work on the propagation o f a solid 
tumour (sarcoma) o f the chicken using a similar approach (Rous 1911). Because in 
those days leukaemia was not regarded as cancer and chickens were not considered a 
relevant animal model for the study of human diseases, none o f those landmark studies 
had the impact they deserved. With time and subsequent discoveries those studies 
received the importance they should have initially had and we now regard the group o f 
agents discovered by Ellerman and Bang as avian leukosis virus (ALV) (Vogt 1997). 
Peyton Rous on the other hand was awarded a Nobel Prize in 1966 and the avian 
sarcoma virus bears his name (Rous sarcoma virus, RSV). Until the discovery o f HIV, 
RSV had arguably been the most informative retrovirus, based on the number of 
research articles published on it.
A new impetus was brought to the field with the development of inbred strains of mice 
that displayed a high incidence of cancer. As the occurrence of the tumours could not be 
explained solely by genetic factors, an “extra-chromosomal influence” was claimed to 
be involved. In 1936, John Bittner performed foster nursing experiments with suckling 
mice and showed that the “extra-chromosomal influence“-w hich we now know as 
Mouse Mammary Tumour Virus (MMTV) - was transmitted from mothers with high- 
incidence of mammary tumours to litters with low incidence o f tumours by maternal 
milk. Quoting his cautious statement in the original article “the incidence of mammary 
gland tumours in mice may be affected by nursing” (Bittner 1936).
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It took fifteen more years to provide convincing evidence on the viral aetiology of 
mouse tumours. Ludwig Gross, working on leukaemia o f inbred mice at the Bronx 
Veterans Hospital, showed in 1951 that mice from a low-incidence strain developed 
tumours when inoculated within the first 12 hours o f life with supernatants prepared 
from leukaemia tissues o f AKR mice (Gross 1951). Discovery o f other strains o f murine 
leukaemia virus soon followed, as well as several other tumour viruses that affected 
different species. At the same time, the development of cell culture techniques together 
with the invention of the electron microscope resulted in significant advances in 
virology, from which retroviroiogy also benefited.
The decade from 1960 was a particularly troublesome period for those researchers 
working on retroviruses. Diverse lines o f investigation gave rise to theories that did not 
fit with the current paradigms of the time, or were simply against them. For example, 
the observation that progeny cells derived from infected cultures displayed an 
“infected” phenotype in the absence of infection was puzzling, as was the occurrence of 
endogenous viral genomes in healthy animals, and/or the presence o f intermediate DNA 
forms of RNA tumour viruses.
Howard Temin, who was working on RSV replication, postulated the DNA provirus 
hypothesis, which followed the same line o f reasoning o f André L w off s prophage 
theory. The latter claimed that the bacteriophage - a  DNA virus that infects bacteria- 
inserts its genome within the host’s genome. This integration leads to a non-infectious 
form called the “prophage” that can be later reactivated back to its original lytic form. 
Analogously, Temin (as well as other researchers working on Simian Virus 40 in 
Renato Dulbecco’s laboratory) coined the term “provirus” when referring to the 
integrated state o f RSV during the early stages of infection. When Temin and Rubin 
first proposed the term “provirus”, which was a suitable hypothesis for a DNA virus, the 
nature o f the RSV genome was at the time unknown (Marcum 2002). Therefore, the 
publication o f a paper where the genome of RSV was shown to be RNA (Crawford 
1960) brought a scientific crisis to the field, because Temin’s hypothesis implicated the 
synthesis of DNA using RNA as a template, something simply unacceptable at that 
time. However, he unequivocally proved the requirement o f DNA synthesis for the 
replication of RSV by showing that this virus was sensitive to Actinomycin D (an
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inhibitor o f DNA synthesis) while Newcastle disease virus, an RNA virus which does 
not display a DNA intermediate, was unaffected by the same drug (Temin 1963).
At the same time, endogenous retroviruses were showing traces o f their existence: while 
studying ALV infection in chickens, Dougherty and Di Stefano were puzzled by the 
observation o f positive serology for “group-specific antigen” (this is where the term 
Gag comes from) o f uninfected animals (Dougheity and Di Stefano 1966). A further 
study by Payne and Chubb showed that this “chick antigen” was identical to the RSV 
group-specific antigen and moreover, it was inherited in a Mendelian fashion (Payne 
and Chubb 1968). But again the current paradigms of the time were against the 
existence o f endogenous RNA tumour genomes in healthy animals. In a review about 
the discovery of endogenous retroviruses, Robin Weiss describes the rejection o f a 
manuscript where he postulated the presence o f a novel endogenous envelope that 
complemented the defective Bryan strain of RSV in normal chicken embryo cells 
(Weiss 2006). However, he was later vindicated by the subsequent acceptance of his 
work and the publication o f Hanafusa’s paper showing a cell-associated factor, coined 
“chick-associated helper factor” (Hanafusa, Miyamoto et al. 1970), which was in 
agreement with W eiss’ results. Moreover, other investigators strengthened that concept 
describing the hereditary nature of MMTV in mice (Bentvelzen, Daams et al. 1970).
In June of 1970, the most important discovery of retroviroiogy was achieved: two 
papers from different laboratories published side by side in Nature announced the 
isolation of an RNA-dependent DNA polymerase, called reverse transcriptase (RT) 
from MLV and RSV (Baltimore 1970; Temin and Mizutani 1970). The consequences o f 
this discovery are hard to summarize. First, reverse transcription provided the 
theoretical framework that allowed researchers to answer the riddles that had been 
puzzling them in the previous decade. Second, it successfully challenged the central 
dogma of molecular biology without contradicting it. And third, it marked the origin of 
a biotechnological tool that boosted incredibly the advancement o f science.
Studies on RSV again in 1976 proved formative to the scientific community when 
Harold Varmus’ laboratoiy showed by hybridisation techniques that the viral genomic 
sequence responsible for neoplastic transformation (later characterized as the src gene)
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was present in normal chicken genomic DNA and in the genome o f other avian species 
such as quail, turkey, duck and the more evolutionarily distant emu (Stehelin, Varmus et 
al. 1976). Thus, the genetic nature o f cancer was revealed and the term “oncogene” was 
coined. Src was the first oncogene and the first tyrosine kinase discovered.
The discovery o f a vast number o f animal retroviruses encouraged researchers to look 
for human retroviruses associated with high-incidence neoplasias such as leukaemia, 
breast cancer, prostate and lung tumours. American president Richard Nixon promoted 
cancer research through the National Cancer Act, which was known as the “War on 
cancer” . However, until the mid-seventies efforts had been fruitless and plagued with 
cross-contaminations with animal retroviruses. Work in Robert Gallo’s laboratory 
paved the way with the discovery o f interleukin-2 (IL-2), a T-cell growth factor that 
allowed the long-term culture o f primary T-lymphocytes (reviewed in Gallo, 2005). 
This technology, together with sensitive RT assays made it possible to identify a 
retrovirus associated with a T-ceil malignancy: human T-cell leukaemia virus 1 (HTLV- 
1) (Poiesz, Ruscetti et al. 1980). HTLV-1 was found to be the causative agent o f adult 
T-cell leukaemia, and tropical spastic paraparesis (TSP).
By the time HTLV-1 and -2 were being discovered, an outbreak o f an unknown illness 
was detected in the US. The disease was mainly observed among gay men from 
California and New York City, and common symptoms were the presence o f Kaposi’s 
sarcoma and opportunistic infections due to a severe immunosuppression. The “AIDS 
era” had started and nothing was going to be the same. Despite the immense 
controversy about the actual discoverers o f HIV, it was Luc Montaigner’s group in Paris 
who were the first to isolate the virus (Barre-Sinoussi, Chermann et al. 1983; Gallo 
2005), and Robert Gallo’s laboratory who linked HIV with AIDS (Gallo, Salahuddin et 
al. 1984; Popovic, Sarngadharan et al. 1984; Sarngadharan, Popovic et al. 1984; 
Schupbach, Popovic et al. 1984). A detailed account about the discovery o f HIV 
including original transcripts, memos, pictures, and recordings is freely accessible at the 
following NIH website; http://aidshistory.nih.gov/home.html. Since its discovery, HIV 
has probably been the most studied virus in science history and despite the efforts of 
some of the brightest minds in the scientific community, neither a protective vaccine 
nor a curative treatment have been developed yet. Current therapies with antiretroviral
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drugs have kept AIDS patients alive for a number o f years now, but undesired side 
effects are common. Moreover, the emergence o f HIV/AIDS unveiled the limitations of 
our society: antiretroviral drugs do not reach underdeveloped countries due to their high 
cost and preventions campaigns have proved inefficient. Therefore, 65% of infected 
people live in sub-Saharan Africa (an updated incidence rate can be obtained at the 
World Health Organization HIV/AIDS website: http://www.who.int/hiv/en/).
The inherent ability o f retroviruses to integrate into the host’s genome has been used to 
develop retroviral vectors capable o f expressing specific proteins in transduced cells 
(Miller 1997). The development o f this technology started in the early eighties when the 
first packaging cell lines were created and retroviral-mediated gene transfer was 
achieved in somatic stem cells (Baum, Schambach et al. 2006). Commercial retroviral 
vectors are nowadays widely available and used in the laboratory. The RSV-derived 
RCAS system constitutes an example that has been extensively applied for in vitro, ex- 
vivo and in vivo studies (Orsulic 2002). Furthermore, germ line stem cells can be 
transduced to generate transgenic animals (Nagano, Brinster et al. 2001) and intense 
research is currently being carried out to develop retroviral vectors for human gene 
therapy (Baum, Schambach et al. 2006). Although promising, this approach has recently 
suffered a serious drawback when two out o f ten patients that received a therapeutic 
MLV-based retroviral vector in a clinical trial to correct an X-linked severe combined 
immunodeficiency developed leukaemia, most likely caused by insertional mutagenesis 
in proximity o f the LM 02 proto-oncogene promoter (Hacein-Bey-Abina, Von Kalle et 
al. 2003). Recent studies on integration patterns by different retroviruses suggest that 
the use of lentiviral vectors could achieve better results (see below).
The post-genomic era started at the beginning o f the twenty-first century with the 
publication of the first integrated draft sequence of the human genome (Lander, Linton 
et al. 2001; Venter, Adams et al. 2001), although smaller genomes had been sequenced 
before. Since then, rapid progress followed, and genomes from diverse organisms such 
as fruit flies, dogs, chimps and yeast have been sequenced, ft is obvious that the benefits 
obtained from the generation o f such a vast amount o f data boosted the advance of all 
areas of science, not just retrovirology. We can now look for genes that provide 
susceptibility or resistance for viral infections in a given species, determine their
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distribution in different populations or breeds, and address their evolutionary 
importance in related species. The same applies for endogenous retroviruses and 
transposable elements: although we have known o f their existence for many years, we 
are currently able to easily identify in silico previously uncharacterized loci. Such 
approach can be used as a starting point for further in vitro and in vivo studies by means 
o f the vast variety o f molecular biology techniques that are presently available.
Throughout millions of years, germ line infections by exogenous retroviruses led to 
further accumulation o f endogenous retroviral sequences within the genome o f every 
species where they have been sought. Therefore, although it may sound presumptuous 
to say that we owe what we are to retroviruses, it may actually be true,
Viral taxonomy
Retroviruses are enveloped viruses with a diameter of 80-120 nm. The viral genome 
within the particle consists o f two copies o f linear, single-stranded RNA of positive 
polarity with a size o f 7-12 Kb (Vogt 1997). Retroviruses are classified as “simple” 
when they encode the minimum canonical genes gag, po l and env (see below), or 
“complex” if they bear other genes, which are regarded as “accessory”. Retroviruses 
display a unique replication strategy: after entering their target cell, they reverse- 
transcribe their RNA genome into DNA and further integrate into the genome o f the 
host cell. The integrated viral DNA genome, termed provirus, is transcribed by the 
cellular RNA polymerases and the resulting messenger RNAs (mRNAs) will in turn be 
translated into viral proteins and also provide the viral genomes that will be assembled 
within progeny virions (Vogt 1997). The family Retroviridae has been recently 
reclassified by the International Committee on Taxonomy of Viruses (ICTV) and is 
currently divided in two subfamilies, orthoretrovirinae and spuniaretrovirinae, and 
further divided in seven genera that are listed in Table 1.1 (ICTVdB 2006).
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Subfamily Genera Example
Genomic
organization
Orthoretrovirinae
Alpharetrovirus Rous sarcoma virus Simple
Betaretrovirus Jaagsiekte sheep retrovirus Simple
Gammaretrovirus Murine leukaemia viruses Simple
Deltaretrovirus Bovine leukaemia virus Complex
Epsilonretrovirus Walleye dermal sarcoma virus Complex
Lenti virus Human immunodeficiency virus type 1 Complex
Spumavirinae Spumavirus Human foamy virus Complex
Table 1. Taxonomy of retroviruses.
The Alpharetrovirus genus comprises a group o f viruses whose members have been 
identified only in birds and were previously regarded as avian type-C retroviruses 
(ICTVdB 2006). Avian leukosis virus (ALV) is the prototype o f the genus, and distinct 
isolates are classified according to envelope specificities (Vogt 1997). Betaretrovirmes 
comprise the former mammalian type-B and type-D viruses (see below). Well studied 
members o f this genus are Mason-Pfizer monkey virus (M-PMV), Mouse mammary 
tumour virus (MMTV) and Jaagsiekte sheep retrovirus (JSRV). Gammaretroviruses are 
simple retroviruses that infect more than one vertebrate class (Gifford and Tristem 
2003). Some examples are feline leukaemia virus (FeLV), murine leukaemia virus 
(MLV), gibbon ape leukaemia virus (GaLV), and bird reticuloendotheliosis viruses that 
affect ducks, chickens, turkeys, geese and pheasants. Epsilonretroviruses are complex 
retroviruses described in fish that include Walleye dermal sarcoma virus (WDSV). 
Spumaretroviruses also bear a complex genome and despite their broad distribution
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amongst mammals, no disease has been associated with them. Members o f the genus 
include feline, bovine, and chimpanzee foamy viruses (Gifford and Tristem 2003). 
Finally, Deltaretroviruses and Lentiviruses comprise two different genera with common 
features: they bear a complex genome encoding /ram-acting regulatory proteins and 
produce slow chronic diseases. Remarkably, no endogenous counterparts o f the former 
genera have been identified yet (Gifford and Tristem 2003), whereas the discovery o f  
the first endogenous Lentivirus has recently been reported (Katzourakis, Tristem et al. 
2007).
Figure 1. Electron micrographs of retroviral particles.
Extracellular (left) or intracellular (right) JSRV viral particles, where phenotypical differences 
between mature and immature virions can be observed (see text). Pictures are courtesy of 
Massimo Palmarini, Alan Rein and Kunio Nagashima.
Originally, retroviruses were classified according to the morphology they displayed by 
electron microscopy. This gave rise to A, B, C, or D-type viruses. For example, A-type 
particles possess an electron-lucent centre surrounded by one or two electron-dense 
rings. The translucence o f the core is typical o f immature particles, while mature 
retroviruses display a compact opaque core due to rearrangements in the structural 
proteins that will be described later. Both type-B and type-D viruses assemble in the 
cytoplasm (Figure I), but while the former displays an eccentrically positioned round
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core, the latter possesses a  cylindrical core. Type-C retroviruses assem ble at the plasm a 
m em brane and have a round core located in central position. Spum aviruses on the other 
hand, have a unique m orphology, w ith conspicuous spikes protruding from  the surface 
and an uncondensed core located in the centre o f  the viral particle. A lthough the new  
classification has been adopted for a num ber o f  years now, the old one is still broadly 
used, in particular w hen describing the site o f  assembly.
Genomic organization of retroviruses
Retroviruses are functionally diploids as the viral genome com prises in general two 
identical copies o f  linear single-stranded RN A o f  positive polarity. The dim er linkage 
structure (DLS) is a self-com plem entary region located at the 5 ’ end o f  the RNAs that 
holds the two m olecules together form ing a kissing loop. The viral genom e shares m any 
com m on features w ith cellular m essenger RNAs since they are both  synthesized using 
the same cellular transcriptional m achinery (i.e. they are capped at the 5’ end and 
polyadenylated at the 3 ’ end). V iral genes are flanked by non-coding sequences that 
play specific roles in reverse transcription and will constitute the prom oter that drives 
the expression o f  the proviral DNA. A  schem atic organization o f  the retroviral RN A  
genome is depicted in Figure 2.
A t both ends o f  the RNA m olecule; dow nstream  o f  the cap at the 5’ end and upstream  
o f  the poly(A) signal at the 3 ’ end, lie two short repeated regions term ed R. There are 
also two unique sequences: U5, located after the R  sequence at the 5 ’ extreme, and U3, 
at the 3 ’ end ju s t upstream  o f  the R  region. Both unique regions bear the att sites that 
are required for integration. A n 18-nucleotide sequence term ed prim er binding site (pbs) 
is located downstream  o f  U5. The pbs anneals with a host transfer RNA (tRNA) to 
prim e the synthesis o f  viral D N A  during reverse transcription (see below). Signals for 
encapsidation o f the viral RN A into the viral particles lie after the pbs and com prise the 
Psi elem ent Q¥). The genom ic organization o f  the RNA genom e is slightly different to 
that o f  the proviral DNA, w hich w ill be described later. The subtle changes that take 
place during reverse transcription have functional im plications for the expression o f  the 
viral genome, w hich is then part o f  the host genome.
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^  US ^  gag pro pol env U3 ^
5’ CAP AAA 3’
PBS SD SA PPT PA
Figure 2. Schematic organization of a prototypical retroviral RNA genome.
The RNA molecule is shown as a straight line, displaying a 5’ cap followed by the first repetitive 
sequence (R); a unique sequence U5; the primer binding site (PBS); the packaging signal T; 
the splice donor (SD) and acceptor (SA); the viral genes gag, pol and env; the polypurine tract 
(PPT); the unique sequence U3, is followed by the second repetitive sequence R and a 
polyadenylation signal (PA). Genomic sequences are not drawn to scale.
All replication-com petent retroviruses bear a m inim um  o f  four genes. These open 
reading fram es (ORPs), term ed gag, p ro , p o l  and env, take up m ost o f  the space o f  the 
genome and follow  that invariable order. Simple retroviruses (like JSRV) possess only 
these canonical genes. The gag  gene eneodes a structural polyprotein that after 
assem bly is cleaved into at least thi'ee polypeptides: m atrix (M A), capsid (CA) and 
nucleocapsid (NC). This cleavage is perform ed during m aturation by the viral protease 
encoded by pro . The ehanges produced by this cleavage are reflected in  the 
phenotypical differences observed by electron m icroscopy betw een im m ature and 
m ature viral particles (see Figure 1). The gene products o f  p o l  are the viral polym erase 
(an RN A -dependent D N A  polym erase w ith associated RN A se FI activity) and the 
integrase (IN), which m ediate the replication o f  the viral genome. Finally, env  encodes 
the envelope glycoprotein, w hich derives from  the synthesis o f  a spliced sub-genom ic 
mRNA. The envelope is com posed by the surface (SU) dom ain that interacts w ith the 
cellular receptor and by the transm em brane (TM ) dom ain that fixes the Env to the cell 
m em brane. In the case o f  JSRV, env possesses also oncogenic properties, as w ill be 
discussed later.
Retroviruses that possess a  small array o f  accessory genes in addition to the canonical 
gag, pro , p o l  and env  are regarded as “com plex” (Figure 3). These regulatory genes
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coordinate viral gene expression or have other roles during the replication cycle. 
Examples o f  complex retroviruses are human immunodeficiency virus-1 (HIV-1), 
bovine leukaemia virus (BLV) and human T-cell leukaemia virus (HTLV) (G off 2001). 
Other retroviruses carry host-derived genes whose expression leads to cell 
transformation, and hence they are referred to as oncogenes. In general they are 
defective because o f  deletions on genes required for viral replication, and hence require 
the presence o f  a non-defective or ‘helper’ virus to replicate. Some examples are 
Moloney murine sarcoma virus (Mo M SV), and simian sarcoma virus (SSV). It should 
be noted that some strains o f  Rous sarcoma virus (RSV) are replication competent 
despite bearing oncogenes (Vogt 1997).
I—
1 gag pro] Z9ag}
ALV □ -------------------------------- □  HTLV n ------------------------------------ n
tax
Figure 3. Genetic organization of a simple (left) and a complex (right) retrovirus (see 
text).
ALV; avian leukaemia virus, HTLV; human T-cell leukaemia virus. Rectangles represent the 
open reading frame for the gene indicated. Horizontal line linking two segments in ALV env 
represents splicing out of the indicated segment. Adapted from Vogt (1997).
Viral proteins and virion structure
Throughout the years, different studies on the structure o f  retroviruses have produced a 
vast body o f  information that allows us to know important aspects o f  the retroviral 
virion such as size, density, and the approximate proportion o f  lipids, proteins, and 
nucleic acids (Vogt 1997). Moreover, electron microscopy studies played a fundamental 
role in the early days o f  retrovirology, when retroviruses were classified according to 
their morphological features. However, the tridimensional arrangement that all the viral 
components adopt to constitute a retroviral particle is currently ignored. We must 
therefore rely on models for retroviral structure. Several proteins that form the virion
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have been solved either by crystallography and/or nuclear m agnetic resonance (NM R) 
(Vogt 1997; Am arasinghe, De G uzm an et al. 2000; Klein, Johnson et al. 2000; 
Sarafianos, Das et al. 2001) and the resulting structures provided a great support in 
building up such models.
The structural basis o f  the retroviral particle is provided by the Gag polyprotein and the 
polypeptides derived from  it. The im ierm ost part o f  the particle is constituted by the 
genom ic RN A  tightly associated w ith the nucleocapsid protein (Figure 4). This com plex 
is surrounded by the capsid protein, w hich in turn is encircled by another Gag-derived 
protein, the matrix. The viral envelope originates from  the cellular m em brane, 
surrounds the m atrix and contains the viral glycoproteins. These are believed to form  
trim ers with a single-spaiming transm em brane dom ain (TM ) bound to an extra-virion 
surface dom ain (SU) by m eans o f  non-covalent interactions, or in some cases, by 
disulfide bonds (Vogt 1997; G off 2001). Together w ith the structural proteins, the viral 
enzym es such as reverse-transcriptase, integrase, and protease are also co-packaged 
w ithin the virion. Some accessory proteins are found in high am ounts within the viral 
particle whereas others are either absent or found in small quantities. In the case o f 
HIV-1, while V pr and V pu are incorporated into virions at high levels, V px seem s to be 
absent, and V if  and N e f  can only be detected in small am ounts (Freed and M artin 2001). 
Finally, cellular proteins are also incorporated into virions, giving the host a chance to 
introduce restriction factors that can act at the early stages o f  the following round o f  
infection. The APO BEC fam ily o f  m am m alian polynucleotide cytidine deam inases 
constitutes an excellent exam ple (M angeat, Turelli et al. 2003; Okeom a, Lovsin et al. 
2007) that will be described later in this chapter.
A ll the different building blocks that constitute a viral particle m ust be synthesized in a 
coordinate fashion and targeted to a specific site w ithin the cell in order to assem ble into 
viral particles. By synthesizing polyproteins, retroviruses sim plify this issue because 
they can m ake m ultiple proteins from  a single ORF sim ultaneously, transport them  to a 
specific cellular com partm ent using one trafficking signal (therefore requiring less 
transporters), and m ore im portantly, they are delivered at the required ratio. In addition, 
since viruses are arguably living (or at least dynamic) entities, the function o f  the 
polyprotein as a whole, or o f  its individual components, can be regulated by proteolysis
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(i.e. exposing or hiding specific domains). As was mentioned above, all the structural 
proteins are derived from Gag, which is indeed synthesized as a polyprotein, always 
following the same invariable order: NH 2 -MA-CA-NC-COOH (Figure 5). This constant 
order matches the spatial distribution o f  the constituting polypeptides within the viral 
particle. Several retroviruses bear other proteins derived from Gag, usually located 
between MA and CA, or after NC (Figure 5). As will be shown further, this is also the
case for JSRV.
f  Env o  MA °  NC °  CA
Figure 4. Schematic representation of a generic retroviral particle.
Structural features of a given retrovirus are indicated: Surface envelope protein (SU), 
transmembrane envelope protein (TM), capsid (CA), matrix (MA), nucleocapsid (NC), 
polymerase (Pol), protease (Pro), integrase (IN), and viral RNA. (Courtesy of Mariana Varela. 
Adapted from Retroviruses, Cold Spring Harbor Laboratory Press).
The presence o f  short spacer peptides has also been described (Henderson, Bowers et al. 
1992; Tobin, Sowder et al. 1994).
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The MA is the most external o f  the Gag polypeptides, as faces and associates with the 
lipid envelope. In several (but not all) retroviruses, addition o f  a myristate together with 
the presence o f  a basic stretch o f  amino acids constitutes the membrane (M) domain that 
targets Gag to the plasma membrane and provides the chemical requirements for this 
association (Henderson, Krutzsch et al. 1983; Swanstrom and Wills 1997). The 
importance o f  this interaction is underscored by the fact that assembly is prevented in 
certain retroviruses, such as MLV, when myristoylation is abrogated (Rein, McClure et 
al. 1986). In some retroviruses such as MLV, Gag can be subject to glycosylation 
(Edwards and Fan 1979), and this post-translational modification seems to play an 
important role in viral infectivity, as well as in budding and release (Low, Datta et al. 
2007). Moreover, because the MA associates with the envelope glycoproteins in a 
seemingly non-specific fashion, a well known feature o f  retroviruses is their ability to 
form pseudotypes (Vogt 1997).
Myr MA CA NC
“Minimum” Gag
Myr MA p12 CA NC
MLV Gag
Figure 5. Schematic representation of the Gag polyprotein
Above; Cartoon of a minimal Gag polyprotein. Below: cartoon of MLV Gag. MLV Gag is 
depicted to show an example of a Gag polyprotein bearing other polypeptides besides MA-CA- 
NC). Adapted from Vogt (1997).
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W ithin the viral particle, the capsid protein  lim its inward w ith M A  and outw ard w ith the 
N C -R N A  complex. In a given Gag polyprotein, CA determ ines the size and 
m orphology o f the virion, as well as the other Gag m olecules that w ill coassem ble w ith 
that particular Gag (Ako-Adjei, Johnson et al. 2005). Furtherm ore, CA possesses a 
highly conserved sequence term ed the “m ajor hom ology region” (M HR) (V ogt 1997). 
D eletion o f  this 20 residue-long sequence can abrogate assem bly o f  M -PM V, RSV, and 
HIV-1 (Stram bio-de-Castillia and H unter 1992; Craven, Leure-duPree et al. 1995; 
Provitera, G off et al. 2001).
The nucleocapsid protein is coinplexed w ith the viral genom ic RN A  within the virion 
constituting the inner core o f  the retroviral particle. To associate w ith the viral genom e, 
N C  m ust have an intrinsic affinity for R N A  and this is achieved by the presence o f  basic 
residues and one or two Cys-His m otifs bearing the consensus sequence CX2CX 4HX 4C. 
A s m entioned above, the viral RN A  displays a packaging signal Y  that is recognized by 
the N C  protein (Berkowitz, O hagen et al. 1995) and thus helps to discrim inate betw een 
m olecules o f  viral and cellular origin, w hich is o f  great aid since the latter are m ore 
abundant. W ithin the nucleocapsid there is also a dom ain responsible for the interaction 
betw een Gag m olecules, term ed the interaction dom ain (1). This dom ain is im portant 
during assem bly and does not display a  characteristic sequence, although basic residues 
have been im plicated as its prim ary com ponents (Swanstrom  and W ills 1997; Bowzard, 
Bennett et al. 1998). Furtherm ore, R N A  has been proposed as a structural com ponent o f 
the virion, acting as a scaffold for Gag-G ag interactions (M uriaux, M irro et al. 2001). 
This role can be perform ed either by viral or cellular RNA, and it has been supported by 
the observation that HlV-1 M A  can also bind RNA, featuring a redundant role w ith NC 
(Ott, Coren et al. 2005). Consequently, M A-RN A binding is required for particle 
production in the absence o f  N C , (Ott, Coren et al. 2005).
The presence o f other dom ains besides M A, CA, and N C in som e retroviral Gags 
reflects its variable m olecular organization. These dom ains are usually located betw een 
M A  and CA or betw een CA  and NC, and in certain cases at the C-term inus o f  NC. In 
M -PM V , Gag processing releases two proteins that lie betw een M A  and CA: pp24/16 
and p i 2, and a short polypeptide dow nstream  from  NC, p4. pp24/16 displays two short 
am ino acid sequences required for viral budding know n as late (L) dom ains (Gottw ein,
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Bodem  et al. 2003). p l2  in turn, seem s to constitute an “internal scaffold dom ain” (ISD) 
that m odulates assem bly efficiency (Sakalian and Rapp 2006). p 6 , a short polypeptide 
present in HIV-1 Gag, represents a further example: it lies dow nstream  o f  NC and bears 
the late dom ains required for viral budding (Henderson, Bow ers et al. 1992; M aitin- 
Serrano and B ieniasz 2003).
Besides the structural proteins, all retroviruses possess thi'ee enzym es derived from  p o l  
and pro: reverse transcriptase (RT), integrase (IN), and protease (PR). They also 
originate from polyprotein precursors such as Gag-Pro or Gag-Pro-Pol, but the num ber 
incorporated w ithin viral particles is m uch sm aller than Gag alone. O ther non-structural 
proteins incorporated in virions are som e products o f  accessory genes and host derived 
proteins, both o f w hich have been m entioned before.
The m ost external layer o f  the viral particle is the envelope, a lipid bilayer derived from  
the cellular plasm a m em brane adorned w ith a variable num ber o f  protruding 
glycoproteins (Vogt 1997). The obvious function o f  the envelope is to interact w ith 
cellular receptors to prom ote viral entry (W yatt and Sodroski 1998). How ever, other 
less conspicuous and very interesting roles have been described both in vitro  and in 
vivo, such as intercellular fusion, syncytium  form ation in placental developm ent (M i, 
Lee et al. 2000; Rote, Chakrabarti et al. 2004; Dunlap, Palm arini et al. 2006) and cell 
transform ation (M aeda, Palm arini et al. 2001; Caporale, Consens et al. 2006).
Overview of the retroviral cycle
The replication cycle o f  retroviruses can be sum m arized as follows: free extracellular 
virions attach to the host target cells, b ind to their cognate receptor (and in some cases 
coreceptor), and fuse their m em branes w ith the plasm a m em brane. Internalized particles 
uncoat and reverse transcription o f  the RN A genome rapidly starts. D ouble stranded 
viral DNA is transported to the nucleus for further integration into the host’s genome, 
and once the provirus is established, precursor polyproteins are synthesized using the 
cellular transcriptional and translational m achinery. Viral RN A  that w ill constitute the 
genom e o f  the progeny virions is then packaged into assem bling particles, w hich in turn 
w ill either bud out o f  the productively infected cell and release new  progeny o f  free
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extracellular viral particles, or infect target cells through a virological synapsis (Figure 
6).
Figure 6. Schematic representation of a simplified retroviral cycle.
Each stage of the cycle is numbered. 1: viral attachment and entry, 2: uncoating and reverse 
transcription, 3: entry of the pre-integration complex into the nucleus and integration, 4; 
transcription of the provirus, 5: synthesis of viral proteins, 6; assembly, 7: targeting of immature 
progeny virions to the plasma membrane, 8: viral budding and maturation. See text for further 
details. Figure kindly provided by Mariana Varela.
Viral attachment and entry
The first step o f  the retroviral cycle comprises a complex series o f  events that result in 
the entry o f  the viral particle into a target cell. The earliest stage is viral attachment, 
which is characterized by the specific binding o f  the envelope glycoproteins to 
membrane receptors and defines the first order o f  tropism (Figure 6, step 1). To date, 
many receptors and coreceptors for retroviral entry have been identified, such as 
HYAL2 for JSRV (Rai, Duh et al. 2001) and CD 134 for feline immunodeficiency virus 
(FIV) (Shimojima, Miyazawa et al. 2004). It is thought that the SU protein recognizes 
the cell receptor and TM mediates membrane fusion (G off 2001). Based on receptor 
specificity, retroviruses can be classified in four categories: ecotropic, xenotropic.
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am photropic, and polytropic. This classification criterion was originally applied to 
endogenous M L V s (Stoye and Coffin 1987) but it is used by som e authors also for other 
retroviruses. The so-called ecotropic viruses can infect only cells o f  the species where 
they originate. N on-ecotropic endogenous M LVs are classified as xenotropic and 
polytropic. The form er can not infect cells o f  laboratory mice but can infect a wide 
range o f  cells from  different species (Levy 1973); whereas the latter can replicate in 
both m urine and non-m urine cells. A m photropyc M LVs are exogenous M LVs that can 
infect m ouse and non-m ouse cells (Boeke and Stoye 1997; H unter 1997). A m photropic 
and polytropic M LVs use different cell receptors (Rein and Schultz 1984). After 
infection, the envelope proteins expressed by the provirus bind to their cognate 
receptors intracellulaiiy, dim inishing the num ber o f  available m olecules at the plasm a 
m em brane, and consequently blocking the entry o f  any virus that requires such receptor.
Reverse transcription
After internalization, the incom ing virus uncoats (Figure 6 , step 2). M ature Gag is 
required for this step (G off 2001), as w ell as host factors, an exam ple being Cyclophilin 
A  (GypA), a cellular protein  incorporated in HlV-1 virions that is necessary to allow  
replication in non-hum an prim ate cells (Sokolskaja and Luban 2006). A  m ore detailed 
description on the function o f  CypA will be given below  where restriction factors w ill 
be covered. Reverse transcription, the hallm ark o f  the retroviral cycle, is a highly 
com plex reaction and has been thoroughly studied. In m em bers o f  the subfam ily 
O rthoretrovirinae, reverse transcription starts after uncoating and requires at least RT, 
IN, NC, and o f  course, the viral RNA. For foam y viruses {Spumavirinae), reverse 
transcription is a  late event during the viral replication cycle (M oebes, Enssle et al. 
1997). Briefly, a tRN A  anneals w ith the prim er binding sequence located near U5, and 
the polym erase synthesizes the m inus-strand strong-stop sequence using the viral RN A  
as a tem plate. This step is follow ed by the first “jum p” : as the RN A  o f  the form ed 
heteroduplex is degraded by the RN Ase H activity o f  Pol, the m inus-strand strong-stop 
sequence can now  anneal w ith the 3 ’ R o f  the (rem aining) viral RN A, to further proceed 
w ith the com pletion o f  the long m inus-strand sequence that ends close to the pbs. 
Synthesis o f  this D N A  strand is coupled w ith the degradation o f  the RN A  tem plate, w ith 
the exception o f  the polypurine tract (PPT), a  short RN A  sequence w hich in som e
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retroviruses (i.e. spum aviruses) is duplicated (Kupiec, Tobaly-Tapiero et al. 1988). The 
PPT will prim e the initiation o f  the plus-strand DNA sequence. A t this stage, RT will 
use DNA as a tem plate, extending the nascent com plem entary chain towards the 5’ end 
o f  the m inus-strand DNA, and stopping at the level o f  the pbs o f  the tRNA that prim ed 
the first step o f  the reaction and is still bound to the m inus-strand DNA. A fter rem oval 
o f  the tRNA, the second jum p  occurs, and now  the two exposed pbs regions o f  both 
chains amieal form ing a circular structui'e that allows the com pletion o f  the synthesis o f  
both strands. A t the end o f  this final elongation step, a linear double-stranded DNA 
m olecule, nam ed pro virus, is form ed (G off 2001). As a consequence o f  reverse 
transcription, the proviral D N A  displays two long term inal repeats (LTRs) that arose 
after duplication o f  U3 and U5. The w hole process o f  reverse transcription is depicted in 
Figure 7.
Integration
The following step o f  the retroviral cycle after reverse transcription is the integration o f  
the provirus into the host’s genom e (Figure 6 , step 3). This process, w hich puzzled 
researchers for m any years, has profound im plications in retroviral biology. First, a cell 
is infected by a retrovirus it is persistently  infected and hence becom es a perm anent 
source o f  virus. Second, infection is heritable since the viral genom e is transm itted 
during m itosis from  infected cells to daughter cells like a  host gene following 
M endelian rules. Third, integration is m utagenic p er  se and this characteristic accounts 
for the oncogenic nature o f  some retroviruses. Fourth, endogenous retroviruses can 
originate from  geim line infections, w ith potential evolutionary consequences for the 
host, and/or the exogenous virus from  w hich they derive.
Follow ing reverse transcription, the viral DNA that is contained in a nucleoprotein 
com plex term ed the preintegration com plex (PIC) m ust gain access to the nucleus to 
further integrate into the host’s genome. To achieve this, sim ple retroviruses ju st w ait 
until the nuclear m em brane breaks dow n during m itosis, hence they can only infect 
dividing cells. In contrast, Lentiviruses have m eans to pass thi'ough the intact nuclear 
m em brane as they successfully infect non-dividing cells (G off 2001). Foam y viruses 
instead rem ain as assem bled capsids in the vicinity o f  the m icrotubule-organizing centre
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Figure 7. Scheme of reverse transcription.
RNA is represented as a black line, minus-strand DNA as a light line, and plus-strand DNA as a 
dark line. Process is described in the text. From Retroviruses (Cold Spring Harbor Laboratory 
Press, with permission).
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(M TOC) until the infected cell is stim ulated to divide. U pon cell activation, viral 
disassem bly takes place and infection proceeds (Lehm ann-Che, Renault et al. 2007).
The viral integrase has a  preponderant role in the whole integration process (Lewinsld 
and Bushm an 2005). Integration starts w ith the rem oval o f  the two term inal nucleotides 
located at the 3 ’ end o f  the linear DN A (3 ’ end processing). The resulting 3 ’ OH ends 
attack the phosphodiester bonds o f  the host DNA, form ing a new  linlcage betw een the 
extrem es o f  the viral D N A  and the host DNA, and originating gaps at the sites o f  this 
bond. Filling in these gaps gives rise to short duplications that flank the proviral D N A  
that now  lies neatly integrated w ithin the host genome (Brow n 1997). The m echanism  
that actually determ ines the sites o f  integration is currently unlcnown, but genom e-wide 
studies suggest that active clu'omatin is m ainly targeted (Lewinsld and Bushm an 2005). 
For M LV, a G am m aretrovirus adapted to use as gene delivery vector in  the 
aforem entioned gene therapy trials, regions near transcription start sites and associated 
CpG islands are preferred targets for integration (W u, Li et al. 2003; Lewinski, 
Y am ashita et al. 2006). In contrast, Lentiviruses show  an increased frequency o f  
integration within transcription units (Schroder, Shimi et al. 2002). Recent w ork 
indicates that the m ain viral determ inant in the selection o f  the integration site is IN, 
although Gag seems to play an auxiliary role (Lewinski, Y am ashita et al. 2006). It has 
recently been suggested that integration profiles can be predicted based on phylogenetic 
analysis o f  the integrase protein (Derse, Crise et al. 2007). U nderstanding the m olecular 
basis o f  this targeting is essential for the developm ent o f  safe gene delivery therapies 
with retroviral vectors.
From  a ‘retroviral point o f  v iew ’ integration is a  m assive achievem ent, as viral genes 
w ill share the same status as host genes, and w ill therefore be expressed by the cellular 
m achinery (Brow n 1997; G off 2001).
Expression of viral genes
The cellular polym erase II system  synthesizes the viral RNA as a long prim ary 
transcript that is further processed (Figure 6 , step 4), and in some cases spliced before 
nuclear export. V iral RN A s are subject to capping and polyadenylation and the signals
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for such processes have been described above. Both LTRs possess the necessary 
inform ation to function as prom oters in order to drive the expression o f  viral genes, but 
in general the 5’ LTR is dom inant. The efficiency o f  transcription initiation is 
influenced by the presence or absence o f  cellular transcription factors (determ ined by 
the cell lineage), the physiological state o f  the cell, and the positional location o f  the 
provirus (Rabson and Graves 1997; G off 2001). Unspliced RNAs serve as genom es o f 
progeny virus or to synthesize Gag and Gag-Pol proteins, whereas spliced m olecules ai'e 
either translated into envelope glycoproteins or, for com plex retroviruses, accessory 
proteins (Figure 8 ). Some retroviruses such as M LV display two distinct populations o f  
unspliced viral RN A  that are either translated or packaged into virions (Butsch and 
Boris-Lawrie 2002). Furtherm ore, a recent study suggests that the Gag polyprotein o f  
HIV-1 can m odulate its own translation in a bim odal fashion by binding to its own 
packaging signal and thus obstructing the translation initiation com plex (Anderson and 
Lever 2006).
LTRs possess core transcriptional elem ents such as TA TA and CCAT boxes that are 
recognized by transcription factors such as TFIIB and CEBP (Ryden and Beem on 1989; 
M cG ee-Estrada and Fan 2006). Besides, positive and negative regulatory factors can 
bind regulatory elem ents located in the LTR. For example, the glucocorticoid receptor 
binds to the horm one responsive elem ent located in the U3 o f  M M TV (Payvar, 
Firestone et al. 1982) and enhances its expression, in opposition to the CCAA T 
displacem ent protein (CDP) that binds to the negative regulatory elem ent (NRE) and 
repress transcription (Zhu, Gregg et al. 2000). For com plex retroviruses, accessory 
proteins activate transcription in trans, as the Tax protein encoded by HTLV-1 does. 
Since transcription term ination apparently cannot be controlled by retrovirases, the 
exact end o f  the viral transcript is set at a posttranscriptional stage. The long prim ary 
transcript is cleaved and polyadenylated, giving rise to an RN A  m olecule that ends at 
the 3 ’ LTR, precisely at the boundary betw een R  and U5 (Rabson and Graves 1997). 
However, a small proportion o f  m RNA s can be read-through and thus incorporate 
cellular sequences, this being a feasible m echanism  for the acquisition o f  proto­
oncogenes (Herm an and Coffin 1987).
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Because in normal cells only fully processed mRNAs can be exported from the nucleus, 
the unspliced, full-length viral transcripts that will be either packaged within newly 
formed virions or serve for synthesis o f  Gag and/or Gag-Pol, must find a way to get out 
o f  the nucleus and into the cytoplasm. Simple retroviruses achieve this by means o f  e x ­
acting elements that bind to cellular proteins responsible for mediating nuclear export, 
as is the case o f  the constitutive export element (CTE) found near the 3 ’ end o f  M-PMV  
(Bray, Prasad et al. 1994; Ernst, Bray et al. 1997). In complex retroviruses, RNA export 
relies on accessory genes encoding /raw.s'-acting proteins that interact with cX-acting 
sequences. For examples HlV-1 and -2, encode the Rev protein that facilitates RNA  
export by binding the Rev responsive element (RRE), a highly structured segment o f  
RNA located at the 3 ’ end o f  the viral genome (Freed and Martin 2001).
Host DNA _________________________________________________  Host DNA
gag pro
S' CAP -  I   AAA 3’
5’ CAP ■  ^  AAA 3'
Figure 8. Transcription of retroviral genes.
Top: proviral structure of a simple retrovirus. Middle: Full length genomic RNA that can be either 
incorporated in newly formed viral particles or serve as mRNA for the synthesis of Gag and/or 
Gag-Pol. Bottom; subgenomic transcript from which the envelope glycoprotein is translated.
Synthesis o f  viral proteins and viral assembly are highly dynamic processes in which 
the Gag polyprotein has a central role as all the structural proteins derive from it (Figure 
6, step 5). Moreover, the viral enzymes (Pro, RT, and IN) are synthesized as fusion 
proteins with Gag when the stop codon o f  the latter is strategically by-passed. Gag and 
Gag-Pro-Pol are all translated by free ribosomes and directed to the site o f  assembly 
through trafficking signals located in Gag. In contrast, the envelope glycoprotein is
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translated tlirough the rough endoplasm ic reticulum  (RER) and transported v ia  the 
Golgi apparatus towards the plasm a m em brane (Swanstrom  and W ills 1997).
Some retroviruses such as JSRV, M -PM V and M M TV assem ble w ithin the cytoplasm  
o f  the infected cell, w hereas others (the so-called C-type viruses) assem ble at the 
plasm a m em brane. D espite the existence o f  these tw o m orphogenetic pathw ays, the 
m echanistic nature o f  the assem bly process itse lf m ust not be very different since a 
single amino acid substitution w ithin Gag transform s M -PM V to a type-C retrovirus 
(Rhee and Hunter 1990). A fter assem bly and upon budding, the viral protease cleaves 
Gag into its constituent polypeptides, and this m aturation process accounts for the 
dram atic phenotypic changes observed betw een im m ature and m ature viral particles by 
electron m icroscopy.
A lthough viral RN As are capped, ribosom e scanning m ust be an arduous task  due to  the 
high degree o f  secondary structure observed in the leader o f  retroviral RNA. Therefore, 
cap-dependent and independent m echanism s for translation initiation have been 
proposed (Yilm az, B olinger et al. 2006). The latter strategy is supported by reports on 
the presence o f  internal ribosom e entry sites (1RES) in some m urine (Berlioz and D arlix 
1995; Berlioz, Torrent et al. 1995) and avian (Balvay, Lastra et al. 2007) retroviruses.
Since a viral particle needs m any m ore structural (M A, CA, and N C) than catalytic 
m olecules (Pro and Pol) it is not suiprising that the num ber o f  Gag m olecules is larger 
than those o f  Gag-Pro-Pol. The w ay retroviruses arrange this ratio is another exam ple o f  
their resourcefulness: to bypass the term ination codon that determ ines the end o f  Gag, 
some retroviruses such as M oM LV, m isread it as a sense codon and incorporate 
Glutam ine instead (Yoshinaka, Katoh et al. 1985). This m echanism  is regulated by ex­
acting sequences w ith defined secondary structure dow nstream  from  the stop codon 
(Swanstrom  and W ills 1997). A nother w ay to bypass the term ination codon is by 
fram eshift suppression, a  strategy em ployed by HIV-1, bovine leukaem ia virus (BLV) 
and other retroviruses (Jacks, M adhani et al. 1988) where gag  and p o l, or gag  and pro  
overlap in the -1 direction. Therefore, the translational m achinery slips backw ards one 
base to continue adding residues in the alternative frame. This fram eshift is also 
regulated by a heptanucleotide sequence that acts in concert w ith a pseudoknot form ed
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by the RN A  secondary structure dow nstream  from the term ination codon (Balvay, 
Lastra et al. 2007). In Betaretroviruses, gag, p ro , and p o l  are all in different fram es and 
thus consecutive fram eshifts are required to make Gag-Pro and Gag-Pro-Pol. 
Spum aviruses synthesize Pro-Pol from  a sub-genom ic m RN A  that is separated from  
Gag (Yu, Baldw in et al. 1996). Post and co-translational m odifications are com m on 
am ong retroviral Gag proteins. Exam ples include m yristoylation, acétylation, 
ubiquitination, glycosylation, phosphorylation and proteolytical cleavage and will be 
described below  in m ore detail. The envelope glycoproteins are expressed from  a 
spliced RN A m olecule, different from  the long viral transcript that gives rise to Gag 
and/or Gag-Pro-Pol. SU and TM  are also derived from a polyprotein, but in contrast 
w ith Gag, they are synthesized at the RER since Env bears a hydrophobic signal 
peptide. The Env protein is glycosylated in specific Asparagine residues located w ithin 
canonical sequences. Further, the protein is folded and oligom erized before being 
exported to the Golgi apparatus, where cellular furin proteases cleave it into SU and TM  
(Swanstrom  and W ills 1997).
Viral assembly
A fter the synthesis o f  viral proteins, all the com ponents that w ill constitute the virion 
have to come together to a  specific location w ithin the cell to assem ble into viral 
particles that w ill subsequently bud out o f  the infected eell (Figure 6 , step 6 ). A ssem bly 
is a trem endous task, as requires the direction o f  all the virion com ponents to the site o f 
assem bly, where they have to reeognize each other and m ake specific contacts to give 
rise to a highly-ordered structure o f  a certain size and shape. Further, the newly 
assem bled -y e t  im m ature-particle has to pass thi'ough and pinch o ff the cellular 
m em brane. Finally, the virion m ust undergo m aturation to be fully infectious; this 
exquisite process being finely regulated. Strikingly, m ost o f  these functions are earned  
out by a single m olecule; Gag. Despite the lack o f  sequence sim ilaiities am ong Gag 
proteins from  different genera o f  retroviruses, they all share functional dom ains that 
play key roles during assem bly. Three o f  them  have been hitherto well characterized: a 
m em brane-binding dom ain (M), an interaction dom ain (I), and a late assem bly (L) 
dom ain (Swanstrom  and W ills 1997; G off 2001; Dem irov and Freed 2004).
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M  dom ains are bipartite m otifs responsible for directing and binding Gag to the plasm a 
mem brane. In general, they include a m yristate group covalently linlced to the N- 
term inal Gag plus a  group o f  basic residues located in the M A  protein, both o f  which 
provide a m arked affinity for the negatively charged cytosolic face o f  the lipid bilayer 
(Swanstrom  and W ills 1997). Studies on HIV-1 have shown that the com position o f  the 
lipid bilayer plays an im portant role in m em brane targeting, although the m olecular 
m echanism s underlying this process are poorly understood (Ono, A blan et al. 2004; 
Ono, W aheed et al. 2006). B locking m yristoylation o f  M LV Gag abrogates viral 
assem bly (Rein, M cClure et al. 1986) whereas in M -PM V viral particles can still 
assem ble but are unable to reach the m em brane for further release (Rhee and Hunter 
1987). A  “m yristoyl sw itch” m odel, in w hich the m yristate group displays either an 
exposed or a  buried form  to allow  reversible binding o f  Gag to the plasm a m em brane 
has been proposed and further supported by structural biology studies (Paillart and 
Gottlinger 1999; Tang, Loeliger et al. 2004).
Viral assem bly requires Gag m ultim erization to form  the structural skeleton o f  the 
virion, and these tight interactions have been proposed to take place tlirough I dom ains. 
They have been m apped to the NC protein in m any retroviruses such as RSV, HIV, 
M LV and hum an foam y virus (HFV) (Swanstrom  and W ills 1997; Bowzard, Bennett et 
al. 1998). Unlike L dom ains (see below), I dom ains lack conserved m otifs that allow 
their identification. How ever, since I-m utants display lower densities they can be 
identified by m utational analysis follow ed by isopycnic gradient centrifugation. 
Although located in NC, zinc fingers are not related to I dom ain activity. M oreover, two 
independent studies on RSV using different approaches showed that addition or deletion 
o f  basic residues w ithin N C  can substitute or abrogate Gag-Gag interactions, 
respectively (Bowzard, Bem iett et al. 1998; Lee and Linial 2004).
As m entioned above, RN A  is a  structural elem ent o f  the virion. To be packaged, the 
viral RN A  has to interact w ith Gag, where Cys-His (CH) boxes present in NC, as well 
as basic residues located w ithin N C and M A  likely play different roles in RNA binding 
(Lee and Linial 2004; M uriaux, Costes et al. 2004; Ott, Coren et al. 2005). V iral RN A is 
recognized for packaging thi’ough the T  sequence located near the 5’ end o f  the RN A 
m olecule (G off 2001; M uriaux, M irro et al. 2001). Deletion o f  leads to the
Pablo R Murcia, 2007 Chapter 1, 44
incorporation o f  cellular RNA, predom inantly ribosom al RNA (M uriaux, Miri'o et al. 
2001; M uriaux, MiiTO et al. 2002). A nother RN A  species incorporated w ithin the virion 
is tRNA, w hich will serve to prim e reverse transeription.
Viral budding
Retroviruses are enveloped viruses. The viral envelope is acquired from  the plasm a 
m em brane during budding in a process that resem bles m em brane fission during 
cytokinesis (Carlton and M artin-Senuno 2007). Late dom ains are short, linear m odular 
m otifs that are required for virus-cell separation (Swanstrom  and W ills 1997; Dem irov 
and Freed 2004). Typically, L dom ain m utants are unable to pinch o ff  the cell, and 
rem ain tethered to the plasm a m em brane (Swanstrom  and W ills 1997). L dom ains have 
been identified not only in retroviruses but also in non-related viruses such as Ebola 
virus and vesicular stom atitis virus (Dem irov and Freed 2004). Three L dom ain 
consensus sequences have been identified so far: P(T/S)AP, PPxY , and YPxL. There is 
no preferential use o f  speeific late dom ains by different genera, as HIV-1 (Lentivirus), 
M -PM V  (Betaretrovirus), and HTLV-1 (D eltaretrovirus) all possess a P(T/S)AP motif. 
M oreover, in several cases there are tw o tandem  L dom ains separated by a couple o f  
amino acid residues within the same Gag (i.e., HTLV-1, M -PM V) (Gottw ein, Bodem  et 
al. 2003; H eidecker, Lloyd et al. 2004). Electron m icroscopy studies using single and 
double M -PM V L-m utants showed that L dom ains are not redundant, but play different 
and cooperative roles during viral release (Gottwein, Bodem  et al. 2003). The location 
o f  the L dom ain is variable: they can lie w ithin the M A (HTLV-1), betw een the M A  and 
CA (RSV, M -PM V, and M LV), or w ithin the short peptides that lie a t the C-term inus o f 
NC (HIV-1, and EIAV) (Dem irov and Freed 2004). This “geographical” diversity 
displayed by L dom ains allowed Lesley Parent and co-w orkers to predict and show that 
L dom ains could act in a position-independent fashion, suggestive o f  a  docking site 
function for host proteins (see below). They also showed the rem arkable feature that L 
dom ains can be functionally exchanged betw een distantly related vim ses like RSV and 
HIV, or RSV and EIA V  (Parent, B ennett et al. 1995). H ow ever, some L dom ains 
display functional context-dependence w hen inserted in different viruses (Dem irov and 
Freed 2004).
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Interestingly, ubiquitination o f  Gag proteins is essential for retroviral budding since 
ubiquitin-depleted cells exhibited accum ulation o f  RSV viral particles at the plasm a 
m em brane (Patnaik, Chau et al. 2000). U biquitin (Ub) is a 76 residue-long protein  that 
can be covalently linked to the side chain o f  lysine residues in a  three-step reaction 
m ediated by the ubiquitin-activating enzym es E l ,  E2, and E3. The fate o f  the tagged 
protein depends on the num ber o f  Ub m olecules added to it: w hile polyubiquitination 
m arks a protein for proteasom al degradation, m onoubiquitination o f a  m em brane cargo 
protein prom otes receptor-m ediated endocytosis into endosom es (Lodish, B erk et al. 
2003). Because retroviral budding has a  topology that resem bles that o f  vesicles 
budding into the interior o f  endosom es. Gag ubiquitination m ay serve as a m echanism  
that allows retroviruses to recruit host proteins used in endosom al budding for their ow n 
advantage. In agreem ent with this hypothesis, it has been show n that both processes 
require a com m on set o f  proteins, and m oreover, each late dom ain m otif binds to a 
distinct protein that recruits endosom al sorting com plexes required for transport 
(ESCRT): P(T/S)AP binds to TsglO l (Tum our susceptibility gene 101) (Garrus, von 
Schwedler et al. 2001; VerPlanlc, B ouam r et al. 2001), PPxY  binds a N edd4-related E3 
ubiquitin  Ugase (Neuronal precursor cell-expressed developm entally dow nregulated 4) 
(K ikonyogo, Bouam r et al. 2001; Yasuda, Hunter et al. 2002), and the Y PxL m otif 
interacts with A lix (ALG-2 interacting protein  X) (M artin-Sen'ano, Yarovoy et al. 2003; 
Strack, Calistri et al. 2003). The access o f  a  com m on m ultivesicular endosom al pathw ay 
is supported by the observation that a  dom inant negative V PS4 (required at the last 
steps o f  this pathway) inhibits viral budding regardless o f  the L dom ain used (M artin- 
Serrano, Zang et al. 2003).
The viral envelope derives from cellular m em branes and the presence o f  Env 
glycoproteins is crucial to form  an infectious particle. For a type-C  virus like HIV-1, 
lipid rafts act as a platform  for assem bly and budding (Ono and Freed 2001; 
Bukrinskaya 2004), and th is has also been described for other enveloped viruses 
(Bukrinskaya 2004). Since type-B/D  retroviruses assem ble in the cytoplasm , they likely 
obtain their envelopes in a different way, as has been shown for M -PM V, where its Gag 
protein interacts w ith Env in the pericentriolar region o f  the cell (Sfakianos and Hunter 
2003). Foam y viruses also assem ble in the pericentriolar region. How ever, Gag-Env
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interactions have been observed at the trans-Go\g\ network, suggesting that this is the 
intracellular com partm ent where envelopm ent takes place (Yu, Eastm an et al. 2006).
Maturation
A nother critical late event in the retroviral cycle is viral m aturation, a step required for 
further infectivity o f  progeny virions (Figui'e 6 , step 8 ). A lthough im m ature particles 
can be com petent for budding, a cleaved Gag is necessary to initiate reverse 
transcription in a subsequent infection (G off 2001). The central p layer o f  this process is 
the viral protease, an aspartyl pro tease that functions as a  dim er (G off 2001; 
B ukrinskaya 2004). A ctivation o f  the protease, as well as the sites and sequential order 
o f  cleavages is strictly regulated (B ulainskaya 2004). This proteolytic processing is 
responsible for the m orphological changes observed betw een im m ature and m ature 
virions by electron m icroscopy. M oreover, cleavage o f  the TM  glycoprotein by the viral 
protease has been shown to enliance the fusion activity o f  this protein in M uLVs (G off 
2001) and M -PM V (Brody, Rliee et al. 1994).
Endogenous retroviruses
Biology of endogenous retroviruses
Endogenous retroviruses (ERVs) can originate from  germ  line proviral insertions or 
retrotransposition. From  the host’s perspective, ERVs can be regarded as m obile 
sequences o f  DNA w ithin the genom e, or, in other words, transposable elem ents (TEs). 
TEs are sequences o f  D N A  that m ove around cellular genomes, contributing to genetic 
diversity in  different organism s (B iem ont and V ieira 2006). They are divided in two 
classes (Figure 9): class I, also regarded as retrotransposons, w hich display an RNA 
interm ediate, and class II or D N A  transposons, which m obilize through a DNA 
interm ediate. The latter include the ubiquitously distributed m iniature inverted-repeat 
transposable elem ents (M ITEs). Retrotransposons on the other hand, can be further 
subclassified in LTR  and non-LTR  retrotransposons depending on the presence or 
absence o f  long teim inal repeats (Dewannieux and H eidm ann 2005). Endogenous 
retroviruses fall into the form er category together w ith m em bers o f  the M etaviridae  and
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the Pseudoviridae. Among the non-LTR retroelements we can find the long and short 
interspersed elements (LINEs and SINEs, respectively) (Biemont and Vieira 2006).
DNA transposons
Trp
Class II elements
Non-LTR retrotransposons
LTR retrotransposons
Retroviruses
Class I elements
Figure 9. Nomenclature and structure of transposable elements (see text).
ITR: Inverted terminal repeats; Trp: transposase; PR: protease; RT: reverse transcriptase; RH: 
ribonuclease H; IN I: integrase. Adapted from Biemont and Vieira (2006).
Integration is an obligatory step in the life cycle o f  retroviruses, therefore the progeny o f  
the infected cell inherits the proviral genome and can produce virus in the absence o f  
further rounds o f  infection. When this process occurs in a germ cell, the provirus will be 
passed on to the progeny derived from it and the offspring o f  the infected individual will 
inherit an endogenous virus. Like any other gene, endogenous retroviruses can become 
fixed in a species as a whole if  they succeed in the evolutionary game played by the 
strict rules o f  natural selection.
Since endogenous retroviruses are vertically transmitted they are subject to different 
selective pressures than their exogenous counterparts. While a provirus that severely 
affects its host will be condemned to extinction, a ‘beneficial’ endogenous virus will 
likely be positively selected. However, the relationship between an endogenous 
retrovirus and its host is not a black and white situation where good proviruses persist
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and pathogenic ones becom e extinct. There are grey areas in w hich deleterious effects 
and benefits achieve a long-lasting balance. A  further possible outcom e for ERVs is the 
accum ulation o f  irreversible m utations that affect the replication capacity o f  the 
provirus and lead to an um 'ecognizable sequence o f  junlc DNA as a consequence o f  a 
long decay process (G ifford and Tristem  2003). Beneficial endogenous proviruses can 
confer resistance to exogenous retroviruses and the studies described in this thesis 
support this view. A n exam ple o f  this kind is the presence o f  a g ag  ORE encoded by the 
F v l  provirus in m ice that will be described below  (Best, Le T issier et al. 1996). 
M oreover, there are exam ples o f  endogenous pro viruses that have becom e 
“dom esticated” to the extent o f  regulating placental m orphogenesis in sheep and 
hum ans (Gifford and Tristem  2003; Dunlap, Palm arini et al. 2006), or the tissue-specific 
expression o f  amylase in prim ates, including hum ans (Sam uelson, Phillips et al. 1996). 
In contrast w ith the exam ples described above, ERVs have also been associated w ith 
disease. A ctivation o f  endogenous retroviruses can lead to virally-induced tum ours, as 
has been shown w ith certain inbred strains o f  m ice that were developed and selected for 
having a high incidence o f  m am m ary tum ours. For example, the proviral loci M ty l and  
M tv2  have been im plicated in the developm ent o f  m am m ary adenocarcinom a o f  G R and 
C3H m ice (M ichalides, van N ie et al. 1981; M ichalides, V erstraeten et al. 1985; 
Callahan and Sm ith 2000).
Endogenous retroviruses constitute a significant portion o f  our genom e and have been 
found in every vertebrate species w here they have been sought (Stoye 2001; W eiss 
2006), even in extinct species such as the woolly m am m oth (Gifford and Tristem  2003). 
ERVs were initially identified by m eans o f  Southern blot hybridization and later by 
specific polym erase chain reaction (PGR) assays. N ow adays the search for endogenous 
retroviruses has been greatly facilitated by the availability o f  com plete genome 
sequence data com bined w ith pow erful com puter-based program s. Proviral expression 
is controlled in an LTR-dependent fashion, but other factors such as its position w ithin 
the chrom osom e, or DN A m éthylation are likely to play a role in this process (Boeke 
and Stoye 1997). W ith some exceptions, ERVs are usually replication-defective and 
non-pathogenic, even though they can retain a certain level o f  activity if  their essential 
regulatory sequences are preserved and the proteins necessary for replication are 
provided in trans, either by other ERV s or by exogenous retroviruses (Boeke and Stoye
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1997; G ifford and Tristem  2003). M oreover, i f  this com plem entation m echanism  is 
followed by recom bination, it can lead to full restoration o f  the replication ability o f  the 
provirus, as m ay have happened w ith the baboon endogenous retrovirus (BaEV), a 
G am m aretrovirus that bears a betaretroviral env  gene (G ifford and Tristem  2003). 
Cui'iously, it seems that BaEV w as subsequently transm itted to cats horizontally, and 
gave rise to R D I 14, an endogenous virus o f  cats (W eiss 2006).
Endogenous retroviruses are also used as m arkers to perform  phylogenetic studies based 
on the ERVs distribution in m odern hosts (Gifford and Tristem  2003; Coffin 2004; 
W eiss 2006). Because the chance for an independent integration event to occur at the 
exact same site w ithin a genome is negligible (Coffin 2004), species who share an 
integration site m ust have a com m on ancestor (Boeke and Stoye 1997). M oreover, since 
the sequence o f  the LTRs is identical at the tim e o f integration, the age o f  a pro virus 
w ithin a certain lineage can be calculated ju st by com paring the m utations accum ulated 
betw een the two LTRs (Coffin 2004).
ERVs distribution
Endogenous retroviruses related to m ost retroviral genera have been identified (Gifford 
and Tristem  2003). Rem arkably, and w ith the controversial exception o f  spumaviruses, 
all but one (an endogenous Lentivirus) o f  the ERVs described so far derive from  sim ple 
retroviruses (W eiss 2006; Katzourakis, Tristem  et al. 2007), although this perception 
m ay change in the near future as m ore genom es o f  different animal species are 
sequenced. ERVs can be divided in two categories: ancient and recent^ depending on 
whether integration took place before or after spéciation, respectively (Coffin 2004). 
Therefore, while ancient ERVs can be found in all vertebrates, recent pro viruses are 
only present in few species. Germ line infection w ith subsequent generation o f  ERVs is 
an ongoing and dynam ic process. At the present tim e, koalas are undergoing 
endogenization o f  the koala retrovirus (KoRV) (Tarlinton, M eers et al. 2006), and the 
sheep genome is seem ingly being invaded by a Betaretrovirus highly related to JSRV 
(Arnaud, Caporale et al. 2007).
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A lpharetroviruses-related ERVs have been found in the genom e o f  birds. For example, 
the genom e o f  the dom estic chicken {Gallus gallus) exhibits various fam ilies o f  ERVs 
related to ALV (Boyce-Jacino, O 'Donoghue et al. 1992). They can act as “helper 
viruses” o f  replication-defective exogenous ALVs by providing essential functions in 
trans. The ALVE fam ily, closely related to exogenous ALV sequences, can originate 
RAV-0, a replication com petent retrovirus (Vogt and Friis 1971). Betareti'oviruses 
display a w ide distribution o f  ERVs in m am m als, some o f  which possess exogenous 
counterparts like JSRV  (Hecht, Stedm an et al. 1996). Exam ples o f  endogenous 
Betaretroviruses that lack exogenous counterparts are sim ian endogenous retrovirus 
(SERV) in baboons (van der Kuyl, M ang et al. 1997), and Trichosurus vulpecula  
endogenous retrovirus type D (TvERV [D j) in possum s (Baillie and W ilkins 2001). 
W ithin this category, hum an endogenous retrovirus K  (FIERV-K) is a particularly 
interesting example. A lthough thought to be replication-deficient, HERV -K  m ay have 
replicated no longer than 1 m illion years ago (Hughes and Coffin 2004; Lee and 
Bieniasz 2007). Recently, two independent laboratories reconstructed HERV -K  
(Dewannieux, H arper et al. 2006; Lee and B ieniasz 2007) using in silico  data to build a 
consensus sequence. N otably, one o f these studies showed in vitro that hum an 
infectious retroviruses could arise from  recom bination events among different HERV -K  
loci (Dewannieux, H arper et al. 2006).
Gam m aretrovirus-related ERVs have been thoroughly studied, in particular M LV- 
related ERVs in inbred m ice (Boeke and Stoye 1997). As stated above, they were 
classified according to their host-range, and one singular class w as that o f  xenotropic 
M L Vs that cannot infect m urine cells since they do not bear the appropriate receptor. 
But to becom e endogenous, these xenotropic M L Vs m ust have once been able to find a 
cognate receptor. A  post-endogenization m utation in the genes that encode either the 
receptor or the envelope is a  possible explanation. R D I 14, a  feline endogenous 
retrovirus, constitutes an interesting exam ple o f  a “xenotropic” virus: R D I 14 is 
generally non-infectious in feline cells (Fischinger, Peebles et al. 1973; L ivingston and 
Todaro 1973) and it was hence regarded as a xenotropic vim s (Livingston and Todaro 
1973). However, this view  has proved w rong as cat cells possess a  functional receptor 
for R D I 14 (Fischinger, N om ura et al. 1975), and it has been shown that R D I 14 can 
replicate in a feline em bryonic glial cell line w ith high titres (Haapala, Robey et al.
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1985). Subsequent studies indicated that non-perm issive cat cells support one cycle o f 
infection w ithout further spread o f  the virus (Dunn, Y uan et al. 1993). Endogenous 
Gam m aretroviruses have been also found in pigs (Patience, Sw itzer et al. 2001), a 
potential organ donor species for hum an xenotransplants. Because pig endogenous 
retroviruses (PERVs) can infect hum an cells in vitro (Patience, Takeuchi et al. 1997), 
there is a great concern about the pathogenic potential o f such ERVs (Patience, Switzer 
et al. 2001; Gifford and Tristem  2003; W eiss 2006). A nother im portant issue 
concerning ERVs and hum an therapies regards the use o f  retroviral vectors for gene 
delivery, because endogenous proviral genom es present in  packaging cell lines can 
contam inate therapeutic vectors. M oreover, replication-com petent viruses can arise as a 
product o f  recom bination betw een host-derived ERVs and gene-delivery retroviral 
vectors.
Interactions between exogenous and endogenous retroviruses
Coding regions derived from  ERVs have been kept within our genom es for m illions o f  
years, therefore one w ould be tem pted to think that, as a whole, they m ust provide (or 
have provided at one point during evolution) a beneficial effect to their host. This seems 
to be the case since ERVs have been conclusively associated w ith disease only in a  few  
cases. Expression o f  endogenous retroviruses can m odify the outcom e o f  exogenous 
retroviral infections in either positive or detrim ental ways. For instance, endogenous 
envelopes can block the receptors needed by exogenous retroviruses to enter the cell, a 
phenom enon regarded as receptor interference (depicted in step 1 o f  Figure 14). This is 
the case o f  Fv4, an endogenous pro virus expressing a m utated env that provides 
resistance to Friend leukaem ia virus (FV) in m ice (Gardner, Rasheed et al. 1980; 
O'Brien, Berm an et al. 1983). Sim ilar exam ples have been described in chicken and cats 
(Boeke and Stoye 1997).
But receptor blockade is not the only m echanism  by which endogenous retroviruses can 
protect the host against viral infection. A nother retrovirus-derived gene product, F v l,  
which is present in different allelic forms in Balb/c (Fvl"^) and N IH /sw iss {F V F )  m ice, 
determ ines susceptibility to particular m urine leukaem ia viruses (Lilly 1970). W hile the 
so-called N -tropic viruses can infect NIH/swiss but not Balb/c m ice, B-tropic viruses
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display the exact opposite host range o f  infection. Crosses carrying the two alleles are 
resistant to both virus variants. However, there are M LV viruses referred to as NB~ 
tropic, which are not restricted by either F v l  allele. A lthough the underpinning 
m echanism s involved in -m ediated block are not yet understood, it is clear that the 
viral determ inants for this restriction lie in CA, m ore precisely in residue 110 
(DesGroseillers and Jolicoeur 1983; Ou, Boone et al. 1983; K ozak and Chakraboiti 
1996). M oreover, the blockade is dom inant in cell fusion experim ents, satui'able, and 
takes place after reverse transcription and before integration (see Figure 14) (Boeke and 
Stoye 1997; G off 2004). Isolation and cloning o f  F v l  (Best, Le T issier et al, 1996) 
showed that its gene product is a  Gag-like protein that shares sim ilarities w ith other 
endogenous retroviruses such as HERV-L and M uERV -L (murine endogenous 
retrovirus-like gene) (G off 2004).
Endogenous retroviruses can m odulate the immune response to either related or 
unrelated viruses and other infectious agents such as bacteria (Bhadra, Lozano et al. 
2006). As aforem entioned, M M TV displays both endogenous and exogenous 
counterparts. Exogenous M M TV is transm itted through m ilk to new born pups, where 
antigen-presenting cells (AFC), like B-lym phocytes and dendritic cells are the prim ary 
target o f  infection (Held, Shaldiov et al. 1993; Held, W aanders et al. 1993). Infected 
AFCs express sag  (superantigen), a  viral encoded gene responsible for unleashing a T- 
cell response whose end result is the proliferation o f M M TV susceptible cells, rendering 
circulating lym phocytes as reservoirs o f  infection (Held, W aanders et al. 1993; 
W aanders, Shaldiov et al. 1993). By the tim e infected cells transm it M M TV to dividing 
m am mary cells. Sag-reactive T-cells have undergone gradual deletion or anergy (Boeke 
and Stoye 1997; Bhadra, Lozano et al. 2006). Laboratory m ice possess betw een 2 and 8 
endogenous replication-defective M M TV s referred to as M tvs  (Kozak, Feters et al. 
1987), m ost o f  which encode functional sag  genes. Transgenic expression o f  M M TV 
sag  prevents exogenous M M TV infection in mice (Golovkina, Chervonsky et al. 1992; 
Golovkina, Frescott et al. 1993; Boeke and Stoye 1997). How ever, the notion that 
endogenous M M TVs have beneficial effects (Boeke and Stoye 1997) has recently been 
challenged: Balb/M fv-null m ice (mice lacking M tv  genes) are resistant to m am m ary 
tum our developm ent and leukaem ia by two different M M TV strains. M oreover, these 
knock-out m ice display an increased resistance to lethal doses o f  Vibrio cholearae
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(Bhadra, Lozano et ah 2006). In chickens, expression o f  ER V s correlates w ith reduction 
in neutralizing antibodies titre upon challenge w ith A LV , likely as a result o f  
im m unotolérance induced by shared antigens betw een endogenous and exogenous 
viruses. On the other hand, birds expressing ERVs are less likely to be affected by 
wasting syndrom e (Boeke and Stoye 1997), a  m ajor econom ic disease in the poultry 
industry associated w ith ALVs and REV  (Rosenberg and Jolicoeur 1997), characterized 
by anemia, poor growth, and im m unosupression (M ussm an and Tw iehaus 1971).
Alternatively, ERVs constitute a genetic source for recom bination w ith exogenous 
viruses. I f  cells expressing ERVs are infected by an exogenous retrovirus, RN A  from  
the endogenous provirus could be co-packaged within the progeny virion, possibly 
leading to further recom bination and generation o f  viruses w ith  m odified biological 
characteristics, as described above w ith regard to BaEV (Benveniste, Lieber et al. 1974; 
Benveniste and Todaro 1974). Besides, co-packaging and further recom bination pose a 
practical tlneat w ith regard to the cell lines used to develop retroviral vectors.
Endogenous retroviruses and disease
As m entioned above, ERVs generally do not cause disease (otherwise they w ould be 
counterselected during evolution). How ever, studies on inbred m ouse strains selected 
for their high incidence o f  tum ours have show n that ERVs expression can lead to 
disease even in the absence o f  exogenous viruses. This has been well docum ented in 
spontaneous lym phom a and m am m aiy adenocarcinom a o f  A K R  m ice, which display a 
high incidence o f  thym ic lym phom a likely resulting from  viral insertional activation o f 
proto-oncogenes. Rem arkably, the oncogenic agent is not ju s t an activated ERV, but 
rather recom binant viruses term ed minlc cell focus foim ing viruses (MCE). M CE viruses 
aie the end product o f  a consistent series o f  recom bination events involving at least 
th iee different ERV s (Stoye, M oroni et al. 1991). M oreover, the proviral loci M tv l  and 
M tv2  have been im plicated in developm ent o f  m am m ary tum ours in the GR strain o f  
mice in the absence o f  exogenous M M TV. Apparently, these pro viruses release 
infectious virus w hen expressed in the lactating glands, causing m am m ary cancer in  a 
sim ilar fashion to their exogenous counterparts, as novel insertions near the same genes 
have been observed in both type o f  tum ours (Boeke and Stoye 1997).
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Biological roles played by endogenous retroviruses
There is m ounting evidence supporting the view  that som e ERVs have been m aintained 
tlmoughout evolution not ju s t because they protect the host against exogenous viral 
infections, but also, because they provided a different kind o f  selective advantage. As 
aforem entioned, these genetically dom esticated endogenous retroviruses have been 
shown to participate in  placental m orphogenesis o f hum ans and sheep, as w ell as in 
tissue-specific expression o f  am ylase in the salivary gland o f  certain prim ates (Ting, 
Rosenberg et al. 1992).
Fusion o f  the cytotrophoblast cells gives rise to the syncytiotrophoblast layer o f  the 
hum an placenta (M idgley, Pierce et al. 1963). This layer is located betw een the foetal 
and m aternal com partm ents, and is o f  literally vital im portance for the developm ent o f 
the foetus (Aplin 1991). Curiously, the highly fusogenic envelope glycoprotein derived 
from FIERV-W, term ed syncytin, is highly expressed in the placenta (Mi, Lee et al. 
2000). M oreover, blockade o f  envW  expression in prim ary cultures o f  hum an villous 
cytotrophoblast results in  decrease o f  cell fusion and differentiation (de Parseval and 
H eidm ann 2005) suggesting that these m olecules are involved in placental developm ent. 
U nfortunately, due to the im possibility o f  experim entally testing this hypothesis in vivo, 
the actual role o f  syncytin in gestation rem ains obscure. How ever, recent studies in 
sheep underscore the im portance o f  endogenous Envs in placental m orphogenesis (see 
below), but these results should be cautiously interpreted due to cross-species 
physiological differences, Syncytin has also been suggested to play som e role on 
m aternal im m unotolérance to the foetus, but this rem ains speculative (Knerr, H uppertz 
et al. 2004).
In hum ans, the am ylase gene fam ily com prises a cluster o f  five genes located on 
chrom osom e 1. Expression o f  two o f  these genes takes place in  the pancreas (pancreatic 
amylase), while the other tluee genes are expressed in the salivary gland (salivary 
amylase). All five hum an amylase genes are associated w ith insertions o f  two TEs; a  y- 
actin pseudogene and an endogenous virus. Studies using transgenic m ice have show n 
that the am ylase-associated provirus bears transcriptional control elem ents specifically 
active in the parotid gland, suggesting that salivary specificity is due to the retroviral
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insertion. However, further studies w ith N ew  and Old W orld m onkeys (which lack the 
provirus) disputed this result since these species display a high level o f  am ylase in  the 
saliva (Ting, Rosenberg et al. 1992; Sam uelson, Phillips et al. 1996).
Jaagsiekte sheep retrovirus
History
Jaagsiekte sheep retrovirus is the causative agent o f  ovine pulm onary adenocarcinom a 
(OPA) (Palm arini, Sharp et al. 1999), a  transm issible lung tum our o f  sheep that is 
w idely distributed around the w orld (York and Querat 2003). Because o f  the 
developm ent o f  pulm onary tum ours, affected anim als display signs o f  respiratory 
distress that include nasal discharge that becom es evident w hen the rear lim bs are lifted 
(Garcia-Goti, Gonzalez et al. 2000; De las Heras, Gonzalez et al. 2003). This is w hy in 
the earliest descriptions o f  the disease (dating from  the nineteenth century in South 
Africa) farm ers coined the term  Jaagsiekte  to point out that their sheep appeared as if  
they had been chased (in A frikaans ja g  m eans chase and ziekte  sickness)(Tustin 1969). 
Transm issibility o f  the disease to in-contact sheep was shown in the late 1920s (DE 
Kock 1929), and suspicions o f  a  retroviral aetiology arose in the seventies w ith the 
observation o f  retrovirus-like particles by EM  from  adenom atous lung samples (Perk, 
M ichalides et al. 1974). Soon after that, OP A  w as experim entally transm itted to sheep 
inoculated w ith particles bearing reverse transcriptase activity (M artin, Scott et al. 1976; 
Verwoerd, W illiam son et al. 1980), and the incubation period was observed to be 
inversely proportional to the RT activity o f  the inoculum  (Verwoerd, W illiam son et al. 
1980). D espite these prom ising results, isolation o f a  virus associated w ith the disease 
proved to be a form idable challenge. The first problem  encountered was (and still is) the 
im possibility o f  growing the virus in cell culture. Second, because the m ain source o f  
virus was lung fluid from  affected sheep, purification protocols were tedious and 
yielded a highly contam inated “purified” sample. Such contam inants m ade the 
developm ent o f  useful reagents (i.e. antibodies) extrem ely difficult (York and Querat 
2003). Adding m ore confusion to the picture was the fact that m any affected anim als 
were also infected w ith M aedi-V isna virus ( M W ) , a Lentivirus that also causes a 
respiratory disease. JSRV  and M W  could finally be discrim inated by using antisera
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directed against the capsid proteins o f  M PM V  and M M TV, w hich cross-react w ith 
JSRV  but not w ith M W  (Sharp and H erring 1983). The presence o f  endogenous 
JSRV s (enJSRVs) in norm al and tum our tissues made it difficult to associate JSRV  w ith 
O PA  as capsid proteins were im m unodetected not only in affected tissues but also in 
norm al ones (York and Q uerat 2003). M olecular studies on JSRV started in 1991 w hen 
Y ork and co w orkers identified its genom e from virus present in lung fluid fi'om an 
OPA-affected sheep in South Afi:ica (York, V igne et al. 1991). A  year later these 
workers published the com plete genom e sequence o f  what w e now  know  as JSRV -SA  
(South Africa), and also provided evidence for the presence o f  endogenous JSRV s 
(enJSRVs) in genom ic DN A from  norm al sheep and goats (York, Vigne et al. 1992). 
The finding o f  enJSRV s in the sheep genom e raised doubts about the exogenous virus 
as the cause o f  OPA. There was a possibility  that oncogenesis was caused by activation 
o f  enJSRVs, or alternatively, tum origenesis could lead to activation o f  enJSRVs. A  hint 
on this issue was given by the developm ent o f  reagents and techniques to discrim inate 
betw een endogenous and exogenous JSRV  (Bai, Zhu et al. 1996; Palm arini, Consens et 
al. 1996) together with the finding that the exogenous form was detected consistently 
only in tum our tissue (Palm arini, Consens et al. 1996). Conclusive evidence o f  JSRV  as 
the etiological agent o f  OPA was provided w hen an infectious m olecular clone term ed 
JSRV 21 was developed, and virus produced in vitro  was sufficient to reproduce the 
disease in inoculated anim als (Palm arini, Sharp et al. 1999).
Ovine pulmonary adenocarcinoma (OPA)
A s aforem entioned, anim als affected w ith  OPA display signs o f  respiratory distress due 
to the developm ent o f  lung tum ours. A lthough it is assum ed that OPA tm nours originate 
from  type II pneum ocytes and Clara cells (Nisbet, M ackay et al. 1971; Perk, H od et al. 
1971; Hod, Herz et al. 1977; Payne and V erw oerd 1984), the cell type from  w hich the 
tum ours derive has not been unequivocally determined. It is possible that a  com m on 
precursor o f  type II pneum ocytes and C lara cells is the origin o f  the neoplasm  
(Caporale, Centoram e et al. 2005). O PA  is endemic in m any countries including the 
UK. However, only a few  anim als show clinical signs o f  disease during their 
com m ercial lifespan in naturally infected flocks. This is likely because infection o f 
target cells is not a  com m on event in  infected anim als (Caporale, Centoram e et al.
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2005). Rem arkably, OPA  affected anim als do not display circulating antibodies against 
JSRV (Ortin, M inguijon et al. 1998). M acroscopically, OPA lungs display neoplastic 
lesions that range from  small nodules to m assive tum ours involving vast pulm onary 
areas (Tustin 1969; W andera 1971). H istologically, the disease is characterized by the 
presence o f several papillary foci o f  epithelial proliferation in alveolar and bronchiolar 
regions (Figure 10 B). U sually, the architecture o f  the alveoli is not disrupted although 
colum nar cells replace the nonually  flat pneum ocytes (W andera 1971; G onzalez 1989). 
JSRV structural proteins can be readily detected in tum our cells by 
im m unohistochem ical techniques using antibodies raised against either the m atrix, the 
capsid, or the surface antigen (Figure 10 C and D) (Palm arini, Dew ar et al. 1995; 
Salvatori, Gonzalez et al. 2004; Caporale, Centoram e et al. 2005).
OPA has been proposed as an anim al m odel for the study o f  hum an bronchioloalveolar 
carcinom a (BAC) as both diseases share m any clinical and histological features 
(Palm arini and Fan 2001; M ornex, Thivolet et al. 2003). Furtherm ore, and based on 
these sim ilarities, a linlc betw een JSRV (or a  JSRV -related Betaretrovirus/es) and 
hum an BAC has been sought using either PCR-based or im m unohistochem ical 
m ethods, w ithout conclusive results (De las Heras, Barsky et al. 2000; M orozov, 
Lagaye et al. 2004).
JSRV genomic organization and molecular pathogenesis
JSRV belongs to the Betaretro virus genus and is phylogenetically related to M -PM V  
and M M TV. JSRV was originally classified as a type-B/D  retrovirus, because the gag, 
pro , and p o l  genes were closely related to M -PM V, whereas the env  gene was related to 
M M TV (York, Vigne et al. 1992; York and Querat 2003). A  schem atic diagram  o f  the 
JSRV genetic structure is shown in Figure 11. In recent years, a  third JSRV isolate, 
JSRVjs?, was cloned from  a cell line developed from  a tum our o f  an OPA-affected
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Figure 10. Histological features of normal and OPA-affected lungs (see text).
A: section of sheep lung stained with haematoxylin and eosin (H/E). RB: Respiratory bronchiole; 
Alv: alveoli. B: Section of an OPA-affected lung. Arrows indicate neoplastic alveoli. C: 
Immunolabeling of an OPA affected lung section with anti-SU. Tumour cells exhibit positive 
brown staining. Slides were counterstained with haematoxylin. D; Immunolabeling of an OPA  
affected lung section with anti-MA. Tumour cells exhibit positive brown staining. Slides were 
counterstained with haematoxylin. Pictures are courtesy of Marcelo de Las Heras.
sheep (DeMartini, Bishop et al. 2001). O f the three JSRV isolates studied so far 
(JSRV2 1 , JSRV-SA and JSRVjs?), JSRV21 (the first molecular clone) is probably the 
most thoroughly studied. However, it should be noted that the sequence homology 
among them is remarkably high, over 93% identical (Palmarini and Fan 2003). The 
genome o f  JSRV is 7.5 Kb long and bears the classical retroviral genes gag, pro , p o l  
and env plus an additional open reading frame o f  unidentified function known as orf-x, 
which overlaps p o l  (Palmarini, Sharp et al. 1999). The U3 o f  JSRV21 is 266 base pairs 
(bp) long, possesses a TATA box, putative enhancer motifs, and a poly A signal.
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whereas the R and U5 regions are 13 bp and 115 bp long, respectively (Palmarini and 
Fan 2003). Whether orf-x represents an accessory gene has been the subject o f  debate, 
since its level o f  conservation in all three isolates contrasts with the fact that JSRV21 
orf-x mutants are not affected in their ability to infect and transform cells, as well as to 
induce tumours in vivo (Palmarini and Fan 2003; Consens, Maeda et al. 2007). 
However, transcripts bearing an in-frame spliced orf-x have been detected in either 
transfected or infected cells, as well as tumour cells (Palmarini, Murgia et al. 2002).
LTR
gag
LTRenv
orf-x
Figure 11. Genetic structure of Jaagsiekte sheep retrovirus.
JSRV is represented using standard retroviral notation. The names of the open reading frames 
and the regulatory sequences are indicated.
A detailed characterization o f  JSRV Gag has been lacking and will be provided in this 
thesis. As described for other Betaretroviruses, pro  and p o l  are encoded in different 
ORFs (Palmarini, Sharp et al. 1999). The pro  gene likely encodes a deoxyuridine 
triphosphatase (dUTPase) and a protease, and p o l  expresses the reverse transcriptase 
and the integrase. The envelope glycoproteins are derived from a single-spliced, 2.4 Kb- 
long transcript (Palmarini, Murgia et al. 2002). The JSRV envelope mediates viral entry 
into the target cells and constitutes the main determinant o f  viral transformation in vitro 
(Figure 12) and in vivo  (Maeda, Palmarini et al. 2001; Caporale, Consens et al. 2006). 
While the SU fragment is responsible for the interaction with Hyal2, the cellular 
receptor o f  JSRV (Rai, Duh et al. 2001), the TM subunit anchors the envelope 
glycoproteins to the lipid bilayer through its membrane-spanning domain. The 
cytoplasmic tail o f  the TM is the main determinant o f  the envelope oncogenicity 
apparently through the activation o f  the Ras/MEK/MAPK and the P1-3K/Akt-dependent
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pathways (Palmarini, Maeda et al. 2001; Chow, Alberti et al. 2003; Maeda, Fu et al. 
2005; Varela, Chow et al. 2006).
JSRV is able to enter and integrate within a variety o f  cell types. Proof o f  this is the 
detection o f  its genomic DNA in lymphoid tissues from experimentally infected animals 
(Palmarini, Holland et al. 1996) and sheep cell lines (Palmarini, Sharp et al. 1999). 
However, viral expression is limited in vivo to the transformed lung epithelium  
(Palmarini, Dewar et al. 1995). This selective tropism is likely due to a high tissue- 
specificity o f  the LTRs, which have been found to be active only in differentiated lung 
epithelial cell lines (Palmarini, Datta et al. 2000). These cell types express a 
transcription factor termed hepatocyte nuclear factor-3 (HNF-3) because it is also 
present in hepatocytes. NIH3T3 cells do not display LTR activity and do not express 
any isoform o f  HNF-3. However, they show a remarkable dose-dependent LTR 
activation when transiently expressing HNF-3, further supporting that view (Palmarini, 
Datta et al. 2000).
Figure 12. Transformation of rodent fibroblasts by JSRV Env.
1: Focus of transformed 208F cells transfected with plasmid DNA expressing JSRV Env. 2: 
Monolayer of mock-transfected cells. Pictures are courtesy of Mariana Varela.
Enzootic nasal tumour virus (ENTV) is another exogenous Betaretrovirus that causes a 
naturally occurring neoplasm in the respiratory tract o f  sheep and goats (De las Heras, 
Garcia de Jalon et al. 1991; De las Heras, Sharp et al. 1991; De las Heras, Garcia de 
Jalon et al. 1995). ENTV displays high sequence homology with JSRV, with more than
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95%  sim ilarity at the amino acid level (Consens, M inguijon et al. 1999). N ot 
surprisingly, the m ain differences observed betw een JSRV and ENTV lie w ithin the U3 
LTR and the 3 ’ env region (Consens, M inguijon et al. 1999). M oreover, the envelope 
protein o f  ENTV induces transform ation and can also use Hyal2 as a  cellular receptor in 
vitro  (Alberti, M urgia et al. 2002).
Endogenous JSRVs
The existence o f  endogenous sequences in sheep and goats was realized as soon as the 
viral genom e o f  JSRV w as isolated (York, Vigne et al. 1992). Based on Southern blot 
analysis o f  sheep genom ic D N A  using probes derived from  JSRV gag, p o l  and env, it 
w as estim ated that 15-20 copies o f  enJSRVs ai’e present in the sheep genom e 
(DeM artini, Carlson et al. 2003), although this num ber is likely to be larger (Arnaud, 
Caporale et al. 2007). U sing probes derived from  JSRV CA  and SU, H echt and 
coworkers studied the distribution o f  endogenous sequences not only within m em bers o f 
the order A rtyodactyla but also other orders within M am m alia  (Hecht, Stedman et al. 
1996). They concluded that dom estic sheep share several endogenous pro viruses at 
sim ilar integration sites regardless o f  the breed studied, and m oreover, they displayed 
sim ilarities in some proviral integration patterns w ith w ild sheep. Because the probes 
used hybridized at highly stringent conditions w ith genom ic D N A  o f  other m em ber o f 
the genus Capra, endogenous retroviruses o f  sheep and goats seem  to be closely related. 
However, they m ust have been am plified after goats and sheep diverged. A lthough this 
kind o f  w ork provides useful inform ation to draw  a general picture on the distribution o f 
endogenous Betaretroviruses am ong m am m als, they are ju st the starting point o f  a  long 
series o f  studies since they pose new  questions (i.e. are these ERVs still active? I f  they 
are, w hat tissues are they expressed in? W hat is the sequence o f  these ERVs? Do they 
provide an evolutionary trait? Are they linked w ith disease? Is there any o f  these ERVs 
that has not been com pletely endogenized yet?).
In a previous study, tlii'ee intact endogenous Betaretroviruses highly related to JSRV 
have been cloned and sequenced from  an OPA tum our D N A  library (Palm arini, 
Hallw irth et al. 2000). These pro viruses, term ed enJS5F16, enJS56A l, and enJS 9A l, 
display high sequence hom ology w hen com pared w ith JSRV and ENTV, U3 being the
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most divergent region. Besides that, only three other variable regions, two in Gag and 
one in Env, have been identified (V R l, VR2, and VR3). While enJS59Al and enJS5F15 
possess major defects in pol, enJS56Al showed a -2 bp deletion at the 3 ’ end o f  the IN 
domain. Therefore, enJS56Al is the only one to maintain full (or nearly full) ORFs in 
all structural genes. The schematic genomic organization o f  enJS56Al (in comparison 
with JSRV) is shown in Figure 13. The -2 bp deletion at the end o f  p o l  in enJS56Al 
causes a frameshift that would render the predicted resulting protein 14 residues shorter 
and with 33 different amino acids at the carboxy terminus as a consequence o f  the ORF 
change. A similar plasmid to the infectious JSRV21 clone was constructed, but bearing 
enJS56Al instead. Surprisingly, expression o f  enJS56Al did not result in viral particle 
release in the supernatant o f  transfected cells. By using JSRV/enJS56Al chimeras, the 
defect in viral release was mapped to the first two thirds o f  Gag, where V R l and VR2 
lie (Palmarini, Hallwirth et al. 2000). Phylogenetic analysis o f  all the JSRV isolates, the 
three enJSRVs, and ENTV results in a three-branched tree. The endogenous loci and the 
exogenous JSRVs constitute two different branches, and the third one is formed by 
ENTV (Palmarini, Hallwirth et al. 2000).
JSRV
orf-x
enJS56Al
Figure 13. Genetic structure of JSRV and enJS56A1
JSRV and enJS56A1 are represented using standard retroviral notation. The names of the open
reading frames and the regulatory sequences are indicated. A premature stop codon in orf-x of 
enJS56A1 is indicated by a vertical bar underlined by an asterisk. A grey box at the end of pol in
enJS56A1 indicates a different peptide sequence due to a frameshift.
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W h ile characterizing transcripts in the uterine epithelium , Thom as Spencer and 
CO workers found that enJSRV s were actively transcribed in the genital tract o f  the ewe 
(Spencer, Stagg et al. 1999). I f  com pared w ith other tissues (i.e. lungs, kidney, bone 
maiTow), the level o f  expression o f  enJSRV s along the genital tract is significantly 
notable. In situ  hybridization and im m unofluorescence studies have shown that high 
levels o f  enJSRV s expression were detected specifically in the endom etrial lumen, the 
uterine glandular epithelium , the epithelia o f  the oviducts and the cervix (Palm arini, 
Gray et al. 2001). M oreover, the activity o f  the LTR o f  enJS59A l displayed a 10-fold 
enhancem ent in the presence o f  progesterone. A further study in w hich foetal expression 
o f  endogenous proviruses was assessed showed that enJSRV s transcripts were detected 
in the cortico-m edullary junctions o f  the thym us, the region where selection o f  T-cells 
seem s to occur (Spencer, M ura et al. 2003). This observation suggests the induction o f 
tolerance tow ards JSRV -related epitopes during developm ent, and could explain the 
lack o f  hum oral response observed in OPA affected anim als (Ortin, M inguijon et al. 
1998). On the other hand, expression o f  enJSRVs seems to block viral entry by receptor 
blockade since JSRV  cannot enter a cell line derived from  the endom etrial lum inal 
epithelium  (oLE cells) that expresses high levels o f enJSRVs. In contrast, viral entry is 
not affected in a cell line derived from  the uterine strom a (oST) where expression o f 
enJSRV s is not detected. Supporting this hypothesis, stable expression o f  the envelope 
protein o f  enJS56A l in oST cells restored receptor blockade (Spencer, M ura et al.
2003).
Based on these data, one can speculate about the past existence o f  JSRV -related 
exogenous retrovirus(es) w ith genital tropism  transm itted via coitus. In this scenario, the 
expression o f  an endogenous virus that blocked infection via receptor interference 
w ould have provided a great evolutionary advantage to the host and favoured the 
selection for exogenous viruses w ith a  different tropism , for exam ple for the respiratory 
tract thi'ough a genital-oral route o f  transm ission.
Expression o f  endogenous retroviruses in the genital tract o f  the ewe has a  crucial role 
in placental moi*phogenesis. As m entioned, it was recently show n that the envelope o f  
enJSRV s regulate trophectoderm  grow th and differentiation in the periim plantation 
conceptus in vivo (Dunlap, Palm arini et al. 2006). W hen the expression o f  enJSRV s env
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was inhibited by intrauterine inoculation o f  m orpholino anti sense oligonucleotides on 
day 8 o f  pregnancy, retarded trophectodeim  outgrow th during conceptus elongation was 
observed, as well as inhibited differentiation o f  trophoblast giant binucleate cells and 
further pregnancy loss by day 20 (Dunlap, Palm arini et al. 2006). A lthough these results 
should not be extrapolated to the role o f  syncytin in hum an placental developm ent, they 
m ay reflect a convergent role o f  ERVs in placentation among distantly-related species.
Restriction factors and their role in intrinsic immunity against 
retroviruses
Because viruses are obligate intracellular parasites, they m ust use the cellular m achinery 
to replicate, som etim es with harm ful consequences to the host. Consequently, 
m ulticellular organism s have developed a variety o f  defense m echanism s with different 
levels o f  com plexity to avoid or clear viral infections. The fact that we study viiuses 
stands by itse lf as p roo f o f fitness and im perfection o f such systems.
Besides possessing physical and chem ical harriers such as the skin and secretions w ith 
antiviral activity, we are equipped w ith a highly sophisticated im m une system  that in 
m ost cases is able to recognize invading viruses and mormt a strong and specific 
response against them. Using classical im m unology term s, these responses can be 
classified as innate and acquired, depending on the cell types and cytokines involved. In 
general, m obilization o f  innate defense takes place within m inutes to hours o f  infection, 
and requires sentinel and cytolytic cells (i.e. m acrophages and natural killer cells), as 
well as the aforem entioned cytokines and an an*ay o f  serum  proteins refened  to as 
com plem ent. Adaptive im m une responses, w hich include custom -m ade activated 
lym phocytes plus the synthesis and release o f  epitope-specific antibodies, are obviously 
m uch slower, taking days to w eeks to be effective (Flint, Enquist et al. 2004). In either 
case, they are both responses, im plying that infection is already in progress. Indeed, 
even the shortest tim e frame required to m ount an innate response m ay he enough to set 
an irreversible viral invasion.
There is a third type o f  im m une defense that takes place at the level o f  the individual 
cell and is constitutively active against viral infection, sparing the cell the dangers o f
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“w aiting” for an im m une response. It is term ed intrinsic  im m unity (Bieniasz 2004), and 
com prises a collection o f  evolutionary selected genes that encode restriction fa c to rs  
capable o f  blocking viral replication (G off 2004). The presence or absence o f  such 
factors in particular cells/tissues is one o f  the determ inants o f  viral tropism . W ith regard 
to retroviruses, an increasing num ber o f  antiretroviral m olecules have been 
characterized over the past few  years. The list includes the previously described F v l  
and Fv4\ TR IM Sa, the APOBEC fam ily o f  cytidine deam inases, and enJS 56A l, that 
w ill be further described in detail (Gardner, Rasheed et al. 1980; O 'Brien, Berm an et al. 
1983; Best, Le Tissier et al. 1996; Sheehy, Gaddis et al. 2002; Strem lau, Owens et al.
2004).
In  theory, restriction factors can target any step o f the retroviral cyele (Figure 14), 
although the m ajority o f  them  have been found to act in early stages. From  a cellular 
perspective and in particular w ith regard to retroviruses, an early bloekade is crucial to 
avoid integration. Pro viruses are extrem ely successful in persisting in the cell once 
integrated, since there is not an effective w ay to elim inate them . However, blockade o f 
late steps is an appealing strategy to avoid spreading o f  infection, especially w hen 
infected cells are not recognized by the im m une system, as seems to be the case in 
OPA. U nderstanding the m olecular basis o f  intrinsic im m unity is o f  utm ost im portance 
in  order to develop effective antiretroviral therapies and to better characterize certain 
aspects o f  the retroviral replication cycle.
TRIMS and Cyclophilin A
F v l,  as described above, is a gag-Vik.Q gene present in the genom e o f  certain strains o f 
m ice whose expression blocks M LV after reverse transcription. The observation that 
distinct hum an cell lines displayed sim ilar resistance to N -M LV  infection, as the one 
described in m urine cells bearing F vl^  (Towers, Bock et al. 2000; Besnier, Y linen et al.
2003) unleashed the search for a new  restriction factor. This new  antiretroviral activity, 
term ed R e fl, exhibited the very sam e determ inant for susceptibility o f  F v l 
(DesGroseillers and Jolicoeur 1983; Ou, Boone et al. 1983; Kozak and Chakraborti
1996), located in residue 110 o f  the CA, although the block seem ed to take place at an 
earlier step o f  the cycle (Figure 14), before reverse transcription. M oreover, R efl not
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TRIMSa
enJS56Al
Figure 14. Schematic representation of the retroviral cell cycle displaying the name and 
step blocked by different restriction factors (see text).
only abrogated MuLV infection but also the distantly related equine infectious anemia 
virus (EIAV) (Towers, Collins et al. 2002) and was further observed in cells from dogs, 
hamsters, pigs, cows, African green monkeys and bats (G off 2004). These findings 
prompted an experimental re-examination o f  non-human primates cells originally 
believed to be non-permissive for HIV-1 infection. Results obtained showed a similar 
effect: virus was restricted before reverse transcription in a dominant and saturable 
fashion, CA being the main determinant for virus susceptibility (Cowan, Hatziioannou 
et al. 2002; Hatziioannou, Cowan et al. 2003; Kootstra, Munk et al. 2003; G off 2004). 
This restriction was referred to as L v l, for Lentivirus restriction factor 1. The gene 
responsible for Lvl activity was cloned using a cDNA library from rhesus macaque 
lung fibroblasts that were resistant to HIV-1 (Stremlau, Owens et al. 2004). The 
resulting gene encodes for TRIM 5a, a member o f  the TRIM family o f  proteins. When 
human cells express TRIMSa, they acquire HlV-1 resistance and concomitantly, 
suppression o f  TRIMSa expression in rhesus cells abrogated the block. Finally, 
although both Fvl and TRIMSa block MLV-N, and the viral determinant for these
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blocks lies in the same CA residue, the two restriction factors act independently and 
com pete for incom ing virions (Passerini, K eckesova et al. 2006).
TRIM  proteins possess an RBCC m o tif containing a RING dom ain plus a one or two B- 
boxes and a predicted coiled-coil region. The dom ains that follow  the RBCC dom ain 
are specific for each TRIM  protein, and in TR IM Sa com prises a  SPRY dom ain that 
confers restriction specificity (Nisole, Stoye et al. 200S). It should be noted that 
T R IM Sa is not the only protein w ith antiretroviral activity. For exam ple, M LV is 
restricted by hum an T R IM l, and the interferon-induced TRIM 22 dow nregulates LTR- 
m ediated transcription o f  FllV-1 (N isole, Stoye et al. 200S).
Cyclophilin A (CypA) is a  ubiquitous cytoplasm ic protein that binds CA  and is 
incorporated into HlV-1 virions (G off 2001; Luban 2007). The presence o f  CypA  is 
required in target hut not in producer cells, since blocking CypA -CA interaction 
abrogates infection at the very same stage as TR IM Sa (G off 2001; Sokolskaja and 
Luban 2006; Luban 2007). Therefore, it is possible that HIV-1 m ay have evolved m eans 
to bind CypA to protect itse lf from  T R IM Sa. Cells from  owl monlcey, a new  world 
prim ate, exhibit a potent anti-H IV -1 restriction activity that is surprisingly abrogated 
w hen shRNAs are directed against CypA. M oreover, expression o f  CypA does not 
restore viral restriction. This seem ingly contradictory effect o f  CypA is explained by the 
fact that owl monlceys express a rem arkable TRIM S-CypA fiision protein term ed 
TR lM Cyp (Sayah, Sokolskaja et al. 2004). TRIM Cyp apparently arose thi'ough 
retrotransposition o f  CypA to the same position where the SPRY dom ain is usually 
found in TR IM Sa (Luban 2007).
APOBECs
Cytidine deam ination constitutes another antiretroviral strategy o f  intrinsic im m unity. 
For m any years it had been know n that the HlV-1 virion infectivity factor (Vif) protein 
was essential to support productive viral infection in prim ary T-cell cultures or T-cell 
derived cell lines. In addition, the observations that V if-deficient viruses could replicate 
efficiently in a num ber o f  cell lines term ed ‘perm issive’ but heterokaryons displayed a 
non-perm issive phenotype, raised the hypothesis that V if was necessary to abrogate a
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host restriction factor (Bieniasz 2004; G off 2004; Holm es, M alim  et al. 2007). The 
protein responsible for such restriction was further identified as APO BEC3G  (hA3G) 
using subtractive cDNA libraries o f  genes selectively expressed in non-perm issive cells 
(Sheehy, Gaddis et al. 2002).
APOBECs comprise a fam ily o f  polynucleotide cytidine deam inases sharing one or two 
deaminase m otifs coordinated by a Zn^"  ^ion. The catalytic activity consists o f  hydrolytic 
deam ination or ‘editing’ that converts cytidines to uridines (Holm es, M alim  et al. 2007). 
During HlV-1 infection, viral reverse transcripts display a high rate o f  guano sine (G) to 
adenosine (A) m utations in the presence o f  hA3G, suggesting that the cytidines o f  the 
negative DNA strand are edited. A lthough hA3G shows the m ost potent antiretroviral 
activity, different m em bers o f  the APOBEC fam ily block w ild type HlV-1 or the m inus 
V if  version. M oreover, APOBECs from  other animal species such as m ouse, rat, and 
non-hum an prim ates can block HIV-1 replication, and conversely, other viruses can be 
targeted for A PO BEC-m ediated restriction: HIV-2, sim ian im m unodeficiency virus 
(SIV) from m acaques or African green m onkey, EIAV, M LV, foam y viruses, and even 
hepatitis B virus (HBV) (Holmes, M alim  et al. 2007). It has recently been shown that 
m ouse A P 0B E C 3 inhibits M M TV replication in vivo (Okeom a, Lovsin et al. 2007).
A P 0B E C 3G  is packaged into virions during viral assem bly and hence acts in the early 
stages o f  the subsequent round o f  infection (Figure 14). To counteract this, HIV-1 
evolved Vif, w hich acts as an adaptor protein betw een hA 3G  and an ubiquitin ligase 
complex, inducing A P 0B E C 3G  polyubiquitination and further proteasom al degradation 
(Yu, Yu et al. 2003).
There are currently two m odels o f  viral inliibition by APOBEC. The classical one in 
which APOBEC accounts for the viral hyperm utation observed in vivo  through cytidine 
deam ination (Harris, B ishop et al. 2003; M angeat, Turelli et al. 2003; Zhang, Yang et 
al. 2003). In this m odel, the resulting proviruses would be m utated to an extent o f  being 
unable to encode progeny virus. A lternatively, the U  residues w ithin the reverse 
transcripts could be recognized and rem oved by host-derived DNA repair enzymes, 
leading to DN A degradation. However, m utations introduced by A P 0B E C 3G  could 
eventually lead to an increase in viral fitness. A recently proposed editing-independent
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m odel has em erged based on the observation that catalytically inactive hA 3G  proteins 
keep certain levels o f  antiviral activity (Holmes, Koning et al. 2007). M oreover, the 
accum ulation o f  reverse transcripts is reduced in target cells in the presence o f  these 
deficient APOBECs. Supporting this m odel, recent w ork from  M ichael M alim ’s 
laboratory showed that chim eric A PO BECs that retain their editing capacity are 
severely im paired for viral inhibition (Bishop, Holm es et al. 2006).
Zinc-finger antiviral protein (ZAP)
A ll the restriction factors described so far in this chapter act in the early stages o f  the 
retroviral infection (i.e. before integration). A part from enJS 56A l, only one antiviral 
gene that acts late in the life cycle has hitherto been described. This gene encodes an 
antiviral protein nam ed ZAP that bears four CCCH-type zinc fingers, an uncom m on 
feature also present in some RN A  binding proteins. Expression o f  ZAP results in 
selective loss o f  viral m R N A  in the cytoplasm  but not in the nucleus (Gao, Guo et al. 
2002; G off 2004), and the cw-acting sequence recognized by the antiviral protein has 
been m apped to the 3 ’LTR (Guo, Carroll et al. 2004). ZAP directly binds to target RNA 
through the CCCH -type m otifs and prom otes degradation o f  the target m R N A  (Figure 
14). M oreover, ZAP can bind the exosom e, a conserved 3 ’-5 ’ exoribonucleases 
com plex that participates in gene expression regulation thi’ough degradation o f  m RN A  
in  the cytoplasm. Specifically, ZA P binds hRrp46p, one o f  the exosom e com ponents, 
and the sequence responsible for this binding was m apped to ZAP residues 224-254 
(Guo, M a et al. 2007). Interestingly, ZA P also inhibits filoviruses (M uller, M oller et al. 
2007) and alphaviruses (Bick, Carroll et al. 2003), although its antiretroviral activity is 
lim ited only to M LV. Based on these studies, a proposed m odel for viral inhibition 
suggests that viral RN A  is boimd by ZA P and further targeted to exosom al degradation 
(G off 2004; Guo, Carroll et al. 2004; Guo, M a et al. 2007).
enJS56Al
enJS56A l is a specific enJSRV locus that has already been described in this 
introductory chapter. enJS56A l possesses intact ORFs for all the retroviral genes, w ith 
a  m inor defect at the end o f  p o l  that results in a shorter integrase protein (Palm arini,
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H allw irth et al. 2000). W hen first isolated, enJS56A l was cloned into the same vector 
as the JSRV 21 proviral clone, resulting in pC M V 2enJS56A l. This clone proved unable 
to release viral particles into the supernatant o f  transfected cells. The “defect” exhibited 
by enJS56A l was overcom e by replacing the first two thirds o f  enJS56A l gag  w ith the 
hom ologous sequence derived from  JSRV  (Palm arini, Hallw irth et al. 2000).
M anuela M ura, a form er PhD student and postdoc in the Palm arini laboratory, carried 
out m ost o f  the w ork that resulted in the first description o f  the interference properties 
displayed by enJS 56A l. She show ed by western blot analysis that 293T cells 
transfected with pCM V 2cnJS56A l not only expressed Gag proteins but also exhibited 
intracytoplasm ic viral particles by electron m icroscopy, usually form ing conglom erates 
in the perinuclear region (M ura 2004). Fui'thermore, w hen enJS56A l was cotransfected 
w ith JSRV, the defective phenotype w as dom inant, as JSRV  viral pailicles could not be 
detected in supernatants. In addition, enJS56A l restriction was specific for JSRV as the 
form er could not abrogate the release o f  neither M -PM V nor M LV. By constructing a 
series o f  enJS56A l/JSR V  chim eras and m utants, the m ain determ inant for 
enJS56A l/JSR V  interference w as m apped to residue 21 o f  the M A protein, where JSRV  
exhibits an Arginine (R) and enJS56A l a Tryptophan (W). A  JSRV -single m utant 
bearing a W  in position 21 displays a  dom inant-negative effect upon the release o f  wild- 
type virus, m im icking the phenotype show ed by enJS56A l. M oreover, substitution o f  
W21 and C98 by R  residues in enJS56A l abrogates restriction and overcom es its 
budding defect. Interestingly, enJSR V ’s transcripts bearing W21 were am plified by RT- 
PC R on ovine endom etrium , suggesting that enJS 56A l-o r enJSRV s carrying this 
critical residue- are expressed in the sheep genital tract (M ura 2004).
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Concluding remarks
In summary, although a vast body o f  inform ation has been generated since the first 
isolation o f  JSRV, several questions rem ain unanswered and m any m ore arise. I w ould 
like to end this introductory chapter w ith a few  examples: what cell type does JSRV  
first infect in vivo!  W hy is there such a long incubation period in the natural disease? 
W hy are only a few  anim als affected w ithin flocks in the absence o f  a detectable 
immune response? Indeed, although w e assum e that the im m une system  o f  sheep is 
tolerant to JSRV, we do not know  how  this is regulated. M oreover, we Icnow the 
sequence o f  only three enJSRV s, probably less than ten per cent o f  those present w ithin 
the sheep genome. V irus and host have been involved in an endless “arms race” for 
m illions o f  years that is far from  being over.
The core w ork o f this thesis aim s to understand the interplay betw een JSRV and 
enJS56A l at the m olecular level, and how  the latter can avoid the spread o f  virus from  
infected cells. Understanding the m echanism s that underpin this block can provide 
further insights to developing novel antiretroviral strategies, as well as additional clues 
to enrich our Icnowledge on the selection forces that shape coevolution betw een 
retroviruses (either endogenous and exogenous) and their hosts.
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Chapter 2 
Materials and methods
Plasmids
PCM V4JS2 I and pCM V 2en56A l are schem atically represented in Figure 15. They 
express the full length JSR V 21 clone and the enJS56A l locus, respectively, and have 
been described elsewhere (Falm arini, Sharp et al. 1999; Palm arini, Hallw irth et al. 
2000). PCM V 4JSRV is an infectious m olecular clone in w hich the U3 region o f  the 3 ’ 
LTR has been replaced by the CM V promoter. PCM V 4JS2 I derives from PCM V 2JS 2 I, 
the first infectious m olecular clone (Palm arini, Sharp et al. 1999), PCM V 4JSRV  lacks 
the m ultiple cloning site that is present at the 3 ’ end o f the LTR o f  PCM V 2JS 2 I , and 
possesses an X bal and Sail restriction sites that have been added for cloning purposes 
by silent m utagenesis in Gag positions 8 8  and 142, respectively (M ura 2004). Infectious 
virus can be recovered from  the supernatant o f  293T cells transfected w ith either 
PCM V 4JSRV or PCM V 2JS 2 I, and this m ethod has becom e the standard for virus 
production for in vivo and in vitro  studies (Palmarini, Sharp et al. 1999; Caporale, 
Centoram e et al. 2005; Caporale, Consens et al. 2006). JSRV and enJS56A l Gag 
proteins were differentially tagged w ith the FLAG (DYK DD DD K) and HA  
(YPYDVPDYA) epitopes at the carboxy-term inal position o f  Gag and w ithin the m atrix 
dom ain before the variable region 1 (V R l)  by overlapping PCR. pJSRV HA -M A , 
pJSRV FLA G-M A, penJS56A lH A -M A  and penJS56A lFL A G -M A  contain the HA or 
FLA G epitopes in the M A  dom ain and w ere derived from  PCM V 4JS2 I or from  
pCM V 4en56A lxs. pC M V 4en56A lxs was derived from p l-142xB e (M ura 2004) and 
possesses an X bal and Sail restriction sites that have been added for cloning purposes 
by silent m utagenesis in Gag positions 8 8  and 142, respectively. pJSRV HA -C is derived 
from  PCM V4JS2 I. In pJSRV H A -C the JSRV Gag is fused at its C-term inal w ith HA 
and is followed by the JSRV  env  gene and the 3 ’LTR o f  JSRV. penJS56A lH A -C  was 
derived from  pJSRV HA -C by replacing the JSRV gag  w ith the enJS56A l gag  gene. 
pJSRV FLA G-C was derived from  PCM V 4JS2 I by introducing the FLAG epitope at the 
carboxyterm inal portion o f  Gag by overlapping PCR. penJS5 6 A 1FLAG-C contains the
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enJS56A l Gag tagged at the carboxy-term inus w ith the FLAG epitope and was derived 
from  the plasm id pGePEx, a chim eric construct that possesses gag  derived from  
enJS56A l and p o l  and env from JSRV  (Palm arini, Hallw irth et al. 2000). For cloning 
purposes, PCR was perform ed using the Pfu  polym erase (Stratagene). Ligation 
reactions w ere done using the Rapid L igation K it (Roche). P lasm id D N A  was produced 
in D H 5a and Top 10 strains o f  E. coli (Invitrogen), using the D N A  M axiprep kit from  
Invitrogen.
M utants JSR21A, JSK19E, JSH20E, JSK19E/H 20E, JSR21A , JSR21E, JSR21K, 
JSG22A, en56G2A , were obtained by site-directed m utagenesis using Q uickChange 
(Stratagene) following the m anufacturers’ instructions. Prim ers for site-directed 
m utagenesis were designed w ith Prim erX , a web-based program  to autom ate the design 
o f  m utagenic PC R  prim ers (http://bioinform atics.org/prim erx/). The nom enclature o f 
the m utants indicates the virus from  w hich they are derived (JS= JSRV; en56= 
enJS 56A l), followed by a single letter indicating the am ino acid m utated, a  num ber 
representing its position in Gag and a letter indicating the amino acid residue o f  the 
resulting m utant. M ultiple m utations are separated by a hyphen. M utants JSR21W , 
JSR98C, en56W 21R and en56W 21R-C98R have been previously described (M ura
2004).
Single and double late dom ain (LD) m utants were obtained by site-directed m utagenesis 
and designated as follows: pJSALD201 carries a m utation in the proxim al LD PSAP 
(Gag position 201-204) to AGAP, w hereas in pJSALD207, the distal Late D om ain 
PPA Y is m utated to AA A Y (Gag position 207-210). Double LD m utant pJSALD201-7 
carries both m utations. M utations were designed according to previous studies 
perfoim ed on M -PM V  (Gottw ein, Bodem  et al. 2003).
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CMV RU5 gag pol env LTR CMV RU5 gag pol env LTR
pCMV^enJSSBAI
Figure 15.Schematic representation of PCMV4JSRV2 I  and pCMV2enJS56A1
Adapted from Palmarini, Sharp et al. 1999.
Mutants penJS56AlACA-NC and penJS56AlANC were derived from 
pCMV2enJS56Al by insertion o f  a stop codon in position 258 and 483 o f  Gag by site- 
directed mutagenesis, respectively. Deletion mutant penJS56Al ANC2 was derived from 
pCM V2enJS56Al by an in-frame deletion (performed by overlapping PCR) o f  Gag 
amino acid residues 490 to 548 in the nucleocapsid (NC) domain. enJS56AlANC2 has a 
functional protease. Mutant JSRVApro is instead a full length JSRV molecular clone 
with a deletion in the pro  gene resulting in a non functional protease and has been 
described before (Mura 2004). Truncated mutant penJS56AlAM HR was obtained by 
overlapping PCR and derived from pCMV2en56Al by deletion o f  Gag amino acid 
residues 403 to 422 encompassing the major homology region o f  the capsid (CA) 
domain.
Plasmids expressing either wild type or mutant Mason-Pfizer monkey virus were 
derived from pSARM4 (kindly provided by Eric Hunter). A myristoylation defective 
mutant carrying a G2A substitution (M-PMVG2A) and a type-C M-PMV carrying an 
R55W mutation in the cytoplasmic targeting/retention signal (CTRS) were obtained by 
site-directed mutagenesis and based in previous reports (Rhee and Hunter 1987; Rhee 
and Hunter 1990).
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To express a HERV -K  chim eric virus we m odified pC M V iJSR V  (Palm arini, Sharp et 
al. 1999) by replacing JSRV gag  w ith  H ERV -K  gag  by PC R  (see Figure 40A in 
Chapter 4). The resulting chim eric plasm id was nam ed pCRUS-HERV-K Gag. From  
pC R U 5“HERV~KGag we derived an expression plasm id encoding a m yristoylation 
defective chim eric virus, in w hich the second glycine was substituted by an alanine by 
site-directed m utagenesis. A  further H ERV -K /JSRV  chim era bearing the N -term inal 
gag  o f  H ERV -K  (from  the initial m ethionine and up to 25 am ino acid residues upstream  
o f  the begiiming o f  capsid) follow ed by JSRV CA, NC and p4 was also constructed. W e 
included the last 25 amino acid residues o f  p i 5 to facilitate assem bly w ith w ild type 
JSRV Gag (Alco-Adjei, Johnson et al. 2005). All constructs were sequenced to ensure 
the presence o f  the introduced m utations.
Cell cultures, transfections, viral preparations and cell lysates
293T, COS, and FleLa cells were cultured in D ulbecco’s m odified Eagle m edium  
supplem ented w ith 10% foetal bovine serum , at 37°C, 5% CO2, and 95%  hum idity. For 
w estern blot analysis, virus was produced by transient transfection o f  293T cells using 
the Calphos M am m alian Transfection kit (Clontech), according to the m anufacturer’s 
instructions. For confocal m icroscopy, cells were transfected w ith Lipofectam ine 
(Invitrogen), following the m anufacturer’s instructions. Cell supernatants were collected 
at 24 and 48 hours post-transfection and viral particles were concentrated by 
ultracentrifugation (100000 x g for 1 hour at 4^C) on a 29%  sucrose cushion. For 
analysis o f  intracellular proteins cells were lysed by standard techniques at 48 hours 
post-transfection. Briefly, cells were rinsed w ith cold phosphate buffer saline (PBS) and 
lysed on ice for 10 m inutes w ith m odified RIPA buffer (150m M  Tris-HCl, pH 7.4; 1% 
N P-40; Im M  EDTA; 150 niM  NaCl, 1 pM  PM SF; 1 m M  N aF) supplem ented w ith a 
cocktail o f  protease inhibitors (Com plete, Roche) according to the m anufacturer’s 
recom m endations. Cells were further snap frozen in liquid nitrogen, thaw ed on ice, and 
sonicated. Lysates were then centrifuged at 14000 x g for 20 m inutes at 4°C. 
Supernatants were collected and protein concentration was determ ined by the Lowry 
method.
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For reverse-phase high pressure liquid chrom atography (RP-HPLC) separation, 
concentrated viral pellets from  sixty 1 0 -cm -plates were purified tw ice by isopycnic 
centrifugation on a 25 to 55% (wt/wt) linear sucrose gradient. Fractions w ith a buoyant 
density betw een 1.146 and 1.176 g/ml were pooled, concentrated by ultracentrifugation 
as above and resuspended in 8 M sequential-grade aqueous concentrate o f high purity 
guanidine-HCl (Pierce), 2%  P-mercaptoethanol. JSRV Gag proteins were then separated 
by RP-H PLC and analyzed by N -term inal protein sequencing at the NCI-SA IC AIDS 
Vaccine Program  as previously described (Henderson, Bowers et al. 1992; Ott, 
Chertova et al. 1999).
Western blot analysis
SDS-PAGE and w estern blotting were perform ed on 25 pi o f  concentrated viral 
particles and 50 pg o f  protein extracts obtained from  cell lysates. A fter SDS-PAGE, 
proteins were transferred to nitrocellulose m em branes (Hybond, Am er sham), and 
blocked for 1 hour at RT w ith blocking buffer (5% skim m ilk in TBS/T [0.1% o f  Tw een 
20]). After blocking, m em branes were rinsed with TBS/T three tim es for five m inutes 
further incubated w ith the selected prim ary antibody. This step was perform ed either for 
one hour at RT or overnight at 4^C. JSRV Gag proteins w ere detected w ith rabbit 
polyclonal sera against JSRV M A, CA, and NC (Proteintech). A nother antiserum  raised 
against the first 100 N -term inal am ino acid residues o f  the JSRV  Gag was also used 
(Proteintech). HERV-K Gag proteins were detected w ith rabbit polyclonal antiserum  
raised against H ERV -K  CA (Proteintech). Gag proteins differentially tagged with either 
the HA or FLAG epitopes, were detected w ith m ouse m onoclonal anti-HA (Covance) or 
anti-FLAG (Sigma) antibodies. Prim ary antibodies were diluted as follows:
Anti-JSRV CA: 1:6000 in blocking buffer.
Anti-JSRV p23 (MA): 1:7500 in blocking buffer.
Anti-JSRV NC: 1:1000 in 5% BSA in TBS/T.
Anti-FIERV-K Gag: 1:5000 in blocking buffer.
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Anti-FLAG: 1:5000 in 5% BSA in TBS/T.
Anti-HA: 1:10000 in 5% BSA  in TBS/T.
After incubation w ith prim ary antibody, m em branes were rinsed tlrnee tim es in TBS/T 
for five m inutes and further incubated w ith the appropriate peroxidase-conjugated 
secondary antibodies for an hour at RT. Secondary antibodies used were donlcey anti­
rabbit (F[ab ’]2 fragm ent) from  A m ersham  (GE), used at a w orking dilution o f  1:40000 
in blocking buffer; and goat anti-m ouse (IgG [H+L]) from  Jackson Research, diluted 
1:10000 also in blocking buffer. Chem ilum inescence was developed using ECL 
(Am ersham , GE). If  m em branes were to be reblotted w ith a different prim ary antibody, 
they were first stripped w ith Restore (Pierce) for an hour at 37°C, and washed three 
tim es w ith TBS/T for 5 m inutes. W hen necessary, signals were quantified by w estern 
blotting by scanning m em branes and m easuring chem ifluorescence in a  M olecular 
D ynam ics Storm 840 im aging system  using Im ageQuant TL software (M olecular 
Dynam ics). For quantification o f  Gag protein in viral pellets, proteins were transfeiTed 
to polyvinylidene fluoride (PVDF) m em branes and chem ilum inescence w as developed 
using ECL plus (Am ersham , GE).
Co-immunoprecipitation assays
Co-im m unoprecipitation assays were perform ed in 293T cells transfected w ith the 
appropriate plasm ids indicated in Chapter 3. 48 hours after transfection cells were lysed 
w ith RIPA buffer supplem ented w ith a protease inhibitors cocktail (Com plete; Roche) 
and 1 mM  PM SF essentially as already described above. Lysates were sonicated and 
then centrifuged for 20 m inutes at 14000 x g to rem ove insoluble material. For the 
evaluation o f  protein-protein interactions, 2 0 0  pg  o f  whole cell extracts were rocked 
with 20 pi o f  protein A  agarose beads (Santa Cruz Biotechnology) and prim ary 
antibody (mouse m onoclonal anti-FLA G  or anti-HA) at 4°C for 3 hours. A fter three 
washes w ith lysis buffer, beads were resuspended in SDS loading buffer, boiled for 5 
m inutes, subjected to SD S-PAG E and w estern blotting as described above.
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Confocal microscopy
H eLa (6.5 x cells/well) or COS (9-10 x lO"^  cells/well) cells were plated onto two 
w ell-cham bered glass slides (Lab-Tek, N alge N unc International) and cultured as 
described above. Cells were transfected w ith Lipofectam ine (Invitrogen) supplem ented 
w ith Plus reagent (Invitrogen) according to the m anufacturer’s instructions. Cells were 
kept w ith the transfection m ixture (w ithout serum or antibiotics) betw een 3 and 5 hours. 
A fter this tim e the transfection m ixture was replaced by com plete m edium . Forty-eight 
hours after transfection, cells were w ashed w ith PBS and fixed on ice-cold m ethanol for 
5 m inutes at -20°C. W hen cells were fixed w ith 3% paraform aldehyde (PFA), fixation 
was perform ed for 15 m inutes at RT. After fixation, cells were processed as follows; 
cells fixed in PFA  were quenched w ith 10 m M  am m onium  chloride and further 
perm eabilized w ith PBS containing 0.1%  Triton X-100 (10 m inutes at RT). Q uenching 
was not perform ed w hen cells were fixed w ith cold m ethanol. A fter perm eabilization, 
slides were blocked tw ice for five m inutes, firstly w ith PBS containing 0.4%  fish skin 
gelatine and 0.2% Tw een 20, and secondly with PBS containing 2.5%  norm al goat 
serum  and 0.2%  Tw een 20. The prim ary antibody was diluted in PBS containing 2.5%  
norm al goat serum  and 0.2%  Tw een 20 and incubated for 45 m inutes at 37°C. Slides 
were further w ashed with PBS containing 0.2% Tw een 20 and blocked a second tim e as 
described above. Fluorescently-labelled secondary antibodies (A lexa 488 and 594 
[M olecular Probes, Invitrogen]) were diluted in PBS containing 2.5%  noraial goat 
serum  and 0.2%  Tw een 20 and incubated for 30 m inutes at 37°C. Slides were w ashed 
w ith PBS containing 0.2%  Tw een 20 and m ounted w ith V ectashield (Vector Labs) 
m ounting m edium  with DAPI. Slides were analyzed w ith a Leica TCS SP2 confocal 
m icroscope. To detect JSRV  and enJS56A l Gag we used a rabbit polyclonal anti-M A 
(Proteintech) preadsorbed w ith H eLa cell extracts to m inim ize background. Serum  was 
pre-adsorbed as follows: four 10-cm plates cultured with H eLa cells were lysed as 
described above, and lysis buffer w as added to reach a final volum e o f  8 ml. Anti- 
JSRV -M A  (2 ml) was m ixed w ith the lysate-containing solution, rocked at 4°C for 3 
hours, and further centrifuged at 14000 g for 30 m inutes at 4°C. The supernatant was 
collected and used as prim ary antibody. M -PM V Gag was detected w ith a rabbit 
polyclonal raised against M -PM V  capsid (Proteintech) diluted 1:1000. A nti-M -PM V  
CA was used w ithout prior preadsorbtion. To detect HA and FLA G tagged Gags, m ouse
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m onoclonal anti-HA (Covance) and anti-FLA G  (Sigma) were diluted 1:400 and 1:100, 
respectively.
Recombinant expression and purification of JSRV matrix 
protein
The coding sequence coiTesponding to the N-term inal 90 amino acids o f JSRV Gag 
(sequence A F 105220) was am plified by PCR and cloned into the pET24b vector 
(Novagen). The insert o f  the resulting plasm id (pET24bJSM A) w as sequenced to rule 
out accidental m utations introduced by PCR. Because the aim  o f  the cloning strategy 
was the expression o f  JSRV M A  w ith no tags that could eventually alter the expression 
and/or the tertiary structure o f  the protein, the T7 tag included in the vector was 
disrupted by using N hel in the cloning procedure, and a stop codon was introduced at 
end o f  the JSRV M A sequence to avoid fusion w ith the H is-tag present at the 3 ’ end o f  
the m ultiple cloning site. Protein expression and purification o f  BL21 (DE3) cells 
transform ed w ith pET24bJSM A  was perform ed as follows: single colonies were 
cultured overnight in 40 ml o f  M 9 M inim al M edium (47,74 m M  N a2H P 0 4 -7 H 2 0 ; 22,04 
m M  KH 2PO 4; 8,55 m M  NaCl; 18,69 m M  N H 4CI; 0,2%  Glucose; 2 m M  M gS0 4 -7 H 2 0 ; 
0,1 mM  CaCl2-2 H 2 0 ; 0,001%  Thiam ine, 0,001%  FeS0 4 -7 H2 0  ) supplem ented w ith 
K anam ycin (30 pg/m l). The resulting culture was further inoculated into flasks 
containing 960 ml o f  the same m edium . Optical density at 600 m n was m easured at 
different tim e points and cells were induced w ith IPTG (at a  final concentration o f  1 
m M ) w hen they reached a value o f  0.6. A fter IPTG induction, cells were cultured for 
another 3 hours, w hen they were pelleted and resuspended in 50 m l o f  10 m M  
N aH 2PÜ 4, pH  6 .8 . Resuspended cultures were sonicated and further centrifuged at 
12000 X g for 30 m inutes at 4°C. The supernatant was dialysed against 10 m M  
N aH 2P 04 , 0.5 m M  DTT, pH  6 .8 , using Spectra/Por 7 tubing w ith a m olecular w eight 
cut o ff  (M W CO) o f  3500. After dialysis, the pH o f  the solution containing JSRV M A 
was adjusted to 6 .8  and loaded onto an ion exchange colum n containing 170 ml o f  SP 
Sepharose Fast Flow  resin (Am ersham  Biosciences Corp., Piscataway, NJ) and 
equilibrated w ith 10 m M  N aH 2P 0 4 , 0.5 m M  DTT, pH 6 .8 . The colum n was w ashed 
with equilibration buffer after the solution containing JSRV M A  w as loaded. A fter this 
washing step, JSRV M A  was eluted w ith IL  o f  a  0 -lM  N aC l gradient. Fractions w ith a
1
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volum e o f  8 ml were collected and 500-pl aliquots were taken for further analysis by 
SDS-PAGE. These aliquots were precipitated for 20 m inutes at -20^C with 100% 
Trichloroacetic acid at a final concentration o f  10% (vol/vol). The precipitated protein 
w as pelleted (10000 x g for five m inutes) and further resuspended in i 5 pL o f  0.1 N  
NaOH. A fter this last step, samples o f  different fractions were analysed by SDS PAGE 
followed by Coom asie staining, and selected fractions were subject to further 
purification by H igh Pressure Liquid Chi'omatography (HPLC). Prior to HPLC, the 
protein m ixture was dialyzed against 10 m M  K H 2PO 4, 10 mM  KCl, pH 6.5, 0.5 m M  
DTT, and concentrated in a stirred cell containing a YM3 m em brane. HPLC was 
perform ed using a 250 x 4.6 m m  x 10 pm  colum n (Luna, Phenom enex) linked to a 
W aters 600E m ultisolvent delivery system. JSRV M A was eluted through a standard 
gradient (5 to 95%  A cetonitrile). The corresponding peak was collected and dialyzed 
against 50 m M  KCl, 50 m M  KH 2PO 4, 1 m M  DTT, pH 6.2, and further concentrated 
w ith a stirred cell containing a YM3 m em brane.
Circular dichroism spectroscopy
A 300 pL-aliquot containing 15 pM  JSRV  m atrix protein in 50 m M  KH2PO4, 50 m M  
KCl, 0.5 m M  DTT was loaded into a 0.1 cm  quartz cuvette. C ircular dichroism  (CD) 
spectra were collected from  250 to 190 nm  using a JASCO J-710 spectropolarim eter. 
Spectra analysis was perform ed using the CD SSTR algorithm  available at the 
D ICH RO W EB website (Lobley, W hitm ore et al. 2002; W hitm ore and W allace 2004): 
(http ://www. cry st.bbk. ac.uk/cdweb/htm l/hom e.htm l).
Analytical ultracentrifugation
Sedim entation equilibrium  experim ents were perform ed using a Beckm an O ptim a XL- 
A  analytical ultracentrifuge. Three different concentrations were evaluated at three 
different speeds. The absorbance values (280 nm ) used were 0.1, 0.25, and 0.4. W hen 
equilibrium  was attained, scans were taken after 24 hours o f  centrifugation at the 
following speed values: 24000, 30000, and 40000 RPM. Sedim entation equilibrium  data 
were analysed using the U ltrascan 6.2 software package.
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NMR spectroscopy
N M R  spectra were acquired w ith a V arian IN O V A  spectrom eter at 600 M Hz. Sam ples 
containing JSRV M A labelled isotopically labelled w ith ^^N were assayed at different 
concentrations o f  N aCl, DTT. Various pH  values and tem peratures were also assayed.
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Chapter 3
Functional characterization JSRV and enJS56A1 Gag 
poiyproteins.
Summary
enJS56A l is an endogenous retrovirus that blocks JSRV at a late stage o f the retroviral 
replication cycle (M ura 2004). The m olecular m echanism  underpinning JSRV late 
restriction (hereafter term ed JLR) and its precise tim ing are currently unlaiown. This 
section will cover the experim ental work perform ed to answer the following question: 
how  does enJS56A l block JSRV  release? W e hypothesized two possible scenarios: (i) 
direct interactions betw een endogenous and exogenous Gag proteins result in aberrant 
chim eric particles that are imable to exit the cell, or (ii) enJS56A l Gag w ould sequester 
a cellular factor required for JSRV  exit.
The experim ental design applied will be illustrated in detail, as well as the results 
obtained and the w ay we interpreted them. A  description o f  m aterials and m ethods has 
been included in Chapter 2. It should be noted that this w ork constitutes a fraction o f  a 
larger project carried out w ith Frederick A rnaud and M anuela M ura in the V iral 
Pathogenesis laboratory at the Institute o f  Com parative M edicine o f the G lasgow  
University Veterinary School. Therefore, their data will be m entioned and discussed to 
add clarity to our current understanding o f  JLR. However, only the experim ents that I 
perform ed will be presented here. Some o f  our com bined results have been published 
and the original articles are attached to this thesis (Mura, M urcia et al. 2004; Arnaud, 
M urcia et al. 2007; M urcia, Arnaud et al. 2007).
introduction
It is assum ed that endogenous retroviruses (ERVs) are fixed in the genom e o f  virtually 
all vertebrates because they have been found in every species where they have been 
sought (Boeke and Stoye 1997; Stoye 2001). ERVs are thought to arise as a
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consequence o f  germ  line infections o f  past exogenous retroviruses (horizontally 
transm itted), although they can also originate by retrotransposition. Throughout 
evolution, the great m ajority o f  ERVs have accum ulated different kind o f  m utations (i.e. 
substitutions, deletions and/or insertions) that have altered their genom ic structure. As a 
result, the great m ajority o f  ERVs are not infectious and non-pathogenic (Gifford and 
Tristem  2003; Coffin 2004). Indeed, the m ost probable fate o f  any given ERV is a  long 
decay process that results in an unidentifiable source o f  “ju n k ” DNA.
ERVs that provide benefits to their hosts can escape this fate, as positive selection could 
avoid extinction o f  the ERV lineage, or even further, reverse this process. This notion is 
supported by the observation o f  transcriptionally active endogenous retroviruses that 
have m aintained intact open reading fram es despite having integrated into the genom e 
o f  the host several m illion years ago. A m ongst the different biological functions that 
ERVs can exert, protection o f  the host against infection by exogenous retroviruses has 
been unam biguously docum ented. In the previous chapter, I described that some m ouse 
and chicken ERVs can block viral entry o f  exogenous retroviruses by receptor 
interference (Boeke and Stoye 1997). O ther retroviral restriction factors block a post­
entry step. This is the case o f  F v l, a  Gag-like m urine gene derived from  an endogenous 
retrovirus that restricts infection in m ice by the Friend strain o f  m urine leukaem ia virus. 
F v l  acts after reverse transcription and before integration o f  the proviral genom e (Best, 
Le Tissier et al. 1996; Boeke and Stoye 1997).
Ovine Betaretroviruses com prise both exogenous and endogenous m em bers. The form er 
include the exogenous Jaagsiekte sheep retrovirus (JSRV) and enzootic nasal tum our 
virus o f  sheep and goats (ENTV) (Consens, M inguijon et al. 1999; Palm arini, Sharp et 
al. 1999). W ithin the sheep genom e there are approxim ately 30 endogenous retroviruses 
highly related to JSRV , hereafter referred to as enJSRV s (Carlson, Lyon et al. 2003; 
DeM artini, Carlson et al. 2003; Palm arini, M ura et al. 2004; A rnaud, Caporale et al. 
2007). enJSRV s have not been associated w ith disease and are highly expressed in the 
genital tract o f  the ewe (Spencer, Stagg et al. 1999; Palm arini, H allw irth et al. 2000), 
where they have been shown to play a crucial role in placental developm ent as 
described in the introductory chapter (Dunlap, Palm arini et al. 2006). Our subject o f
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study is a unique restriction m echanism  displayed by an endogenous Betaretrovirus o f  
sheep that takes place at a late step o f  the retroviral replication cycle (M ura 2004).
To date, three en JSRV proviruses have been cloned and characterized: enJS 56A l, 
enJS5F16, and enJS59A l (Palm arini, Flallwirth et al. 2000). One particular locus, 
term ed enJS 56A l, possesses intact open reading fram es in all its genes although a 
fram eshift in the last portion o f  p o l  likely results in a non-functional viral integrase 
(Palm arini, H allw irth et al. 2000). Transfection o f  cells w ith an expression plasm id for 
JSRV results in the release o f  abundant infectious virus in the culture m edium  
(Palm arini, Sharp et al. 1999). In contrast, w hen a sim ilar construct expressing 
enJS56A l is transfected into cells, no virus can be detected in the supernatant although 
cell lysates exhibit conspicuous am ounts o f  Gag by western blot and intracytoplasm ic 
viral particles are observed by electron m icroscopy (Palm arini, H allw irth et al. 2000; 
M ura 2004). Rem arkably, the defect displayed by enJS56A l camiot be rescued by 
com plem entation w ith JSRV. On the contrary, coexpression o f  these two viruses results 
in a defective transdom inant phenotype as JSRV can no longer be detected in the 
m edium  o f  transfected cells (M ura 2004). Because our experim ental setting is based on 
the transfection o f  cells w ith virus-expressing constructs, early events o f  the replication 
cycle are by-passed, lim iting the tim e frame o f  JLR to the late steps o f  the virus 
replication cycle.
The m ain determ inant o f  JLR has been m apped to residue 21 o f  the enJS56A l Gag 
polyprotein (M ura 2004). Gag is the structural polyprotein o f  the retroviral nucleocapsid 
core that plays a central role in retroviral assem bly and budding (Sw anstrom  and W ills
1997). Interestingly, the residue displayed in position 21 o f  JSRV  Gag is an arginine 
(R), w hich is highly conserved am ong different m em bers o f  the genus Betaretro virus. In 
enJS 56A l, R21 is substituted by a tryptophan (W). There are other differences in the 
am ino-term inal portion o f  Gag betw een enJS56A l and JSRV. Am ino acid residue 
cystine 98 (instead o f  arginine) and valine 102 (instead o f  leucine) are responsible for 
further defects in viral release, although m utants carrying these m utations are not 
transdom inant (M ura 2004). The m olecular m echanism  and the exact tim ing o f  JLR are 
not yet understood. N evertheless, the aforem entioned observation o f  viral particles by 
electron m icroscopy in cells expressing enJS56A l (or co-expressing enJS56A l and
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JSRV) suggests that JLR is dependent on a defect in Gag trafficking, possibly occurring 
after assembly. Based on studies perform ed on M ason-Pfizer M onkey Virus it is 
hypothesized that Betaretroviruses assem ble in the cytoplasm  in a pericentrosom al 
region and further traffic to the plasm a m em brane by not com pletely characterized 
m echanism s involving the recycling endosom es and the viral envelope glycoprotein 
(Sfakianos and H unter 2003; Sfakianos, LaCasse et al. 2003).
In other retroviruses, a  variety o f  determ inants o f  Gag assem bly and trafficking have 
been characterized to date. They include the m em brane binding (M ), interaction (I), and 
late (L) dom ains (Swanstrom  and W ills 1997; Bowzard, Bennett et al. 1998; D em irov 
and Freed 2004). W hether these dom ains play any role in JLR has not been established 
yet. M ost retroviruses have a bipartite M  dom ain composed o f  a m yri state linked to the 
N -term inal Gag, and a stretch o f  basic am ino acid residues located in the N-term inal 
m atrix (MA) dom ain (Swanstrom  and W ills 1997). M utation o f  the M -dom ain alters the 
ability o f  retroviral Gag to reach the cell m em brane (Zhou, Parent et al. 1994; Parent, 
W ilson et al. 1996; Ono and Freed 1999), som etim es resulting in further abrogation o f  
particle foim ation (Rein, M cClure et al. 1986). JSRV  m utants that possess a 
m yristoylation defective Gag cannot release viral particles form  transfected cells, nor 
can they interfere w ild-type virus (M ura 2004). I dom ains have been m apped to N C and 
m ediate Gag-Gag interactions during retroviral assembly. V irions harbouring m utated I 
dom ains display low er density w hen com pared w ith their w ild type counteiparts 
(Swanstrom  and W ills 1997; Bowzard, Bennett et al. 1998; Lee and Linial 2004). L 
dom ains are short am ino acid sequences required during viral exit for virus-cell 
separation (Freed 2002; D em irov and Freed 2004). Typical L dom ain m utants are 
unable to pinch o ff  the cell and hence rem ain tethered to the p lasm a m em brane (Freed 
2002).
To elucidate the m olecular basis o f  JLR, we functionally characterized JSRV and 
enJS56A l Gag poiyproteins. W e identified putative JSRV  M  and L dom ains and 
determined their lack o f  involvem ent in JLR. W e show that truncation o f  enJS56A l 
Gag poiyproteins, or deletion o f  the m ajor hom ology region (M HR) o f  enJS56A l 
abrogates its ability to block JSRV. Furtherm ore, we determ ined the intracellular 
distribution o f  w ild type JSRV , enJS56A l, and a variety o f  m utants by confocal
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m icroscopy. W e also provide evidence that JSRV and enJS56A l co-localize and 
associate in trans. These results suggest that enJS56A l blocks JSRV m ost likely by 
form ing chim eric viral particles (or Gag m ultim ers) that are unable to exit from the cell. 
Com plem entary studies perform ed sim ultaneously by Frederick Arnaud in our 
laboratory showed that the dom inant negative phenotype displayed by enJS56A l 
depends on its ability to m isplace JSRV  Gag localization. In a norm al viral cycle, JSRV  
Gag concentrates in the pericentrosom al area unless enJS56A l is co-expressed in the 
same cell, and the m ain determ inant for such localization is also arginine 21  o f  Gag. 
Altogether, our results argue that enJS56A l Gag blocks JSRV in trans by ham pering 
the progression o f  the latter to the centrosome.
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Results
Intracellular distribution of JSRV and enJS56Al by confocal microscopy
Our initial experiments were aimed to determine whether enJS56Al and JSRV 
exhibited differential intracellular distribution. JSRV particles are released in the 
supernatant o f  transfected cells while enJS56Al particles remain within the cell. Thus it 
was reasonable to expect that cells expressing JSRV, enJS56A l, and selected mutants 
displayed distinct phenotypes, possibly allowing us to differentiate between an 
“endogenous” and an “exogenous” staining pattern by confocal microscopy. We 
therefore set up an immunofluorescence protocol to study virus-expressing cells by 
confocal microscopy (Figure 16) using a rabbit polyclonal antibody against the JSRV 
MA. It should be noted that this anti serum does not discriminate between JSRV and 
enJS56Al Gag proteins.
enJS56A1
Figure 16. Confocal microscopy of HeLa cells expressing JSRV, enJSSSAI, and mock- 
transfected.
Gag staining is in green, nuclei are stained with DAPI (blue) or indicated with an N. Bar is 
approximately 10 |im.
Cells displaying positive staining were classified into three different basic phenotypes: 
diffuse, dispersed  and concentrated  (Figure 17). Cells that exhibited a diffuse phenotype 
displayed uniform cytoplasmic staining usually more intense in the perinuclear region. 
Instead, a dispersed  phenotype was characterized by the presence o f  fluorescent dots or
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specks scattered in the cytoplasm . W hen cells exhibited a prom inent rounded area o f  
intense staining in the vicinity o f  the nucleus, they were classified as concentrated. The 
term s dispersed and concentrated are in agreem ent w ith previous descriptions o f  cells 
expressing M ason-Pfizer m onkey virus, w hich is assem bled in a  pericentrosom al region 
o f  the cell (Sfakianos, LaCasse et al. 2003). V irus-expressing cells often displayed a 
m ixed diffuse-dispersed phenotype, in w hich case they were classified as dispersed. 
Cells expressing JSRV, enJS56A l, and selected m utants were counted according to the 
aforem entioned classification criterion. JSRV  and enJS56A l did not show  significant 
differences in the distribution o f  the tlu’ee phenotypes (Table 2), nor did the single 
m utant p J S R 2 lW . O f note, cells expressing enJS56A l always show ed the highest 
num ber o f  positive cells and stronger fluorescent staining than  JSRV. This w as 
consistent w ith Gag accum ulation o f  the form er and viral release o f  the latter. 
M oreover, the fluorescent specks observed in enJS 5 6A 1-expressing cells were m uch 
bigger than the ones observed in cells expressing JSRV or any other m utant. Cells 
cotransfected w ith JSRV and enJS56A l exhibited a high proportion o f  diffuse cells, in 
contrast w ith the ones expressing only enJS56A l. This was surprising, as we expected a 
sim ilar phenotype to the one observed in enJS56A l-expressing cells due to the 
dom inant-negative property o f  endogenous Gag (M ura 2004). Two o f  the single 
m utants assessed repeatedly showed the highest percentage o f  cells w ith a  concentrated 
phenotype: the m yristoylation-defective JSG2A , and JSR98C. B oth m utants have been 
previously proved to be incom petent for viral exit but not transdom inant over JSRV 
(M ura 2004).
Overall, these experim ents gave us a general idea about the intracellular distribution o f 
enJS56A l and JSRV Gag in transfected cells. Because all the tested constructs 
displayed the tlu'ee staining patterns that we originally defined, we could not determ ine 
a clear cut phenotype to objectively differentiate cells releasing virus versus non­
releasing cells. N evertheless, certain m utants (i.e. JSG2A, and JSR98C) showed a high 
proportion o f  cells w ith a concentrated phenotype w hen com pared w ith the other 
constructs, likely reflecting a specific trafficking defect. In agreem ent with the results 
obtained by electron m icroscopy (M ura 2004), enJS56A l and the defective m utants did
The nomenclature o f  the mutants indicates the virus fi'om which they are derived (JS= JSRV; en56= 
enJS56Al), followed by a single letter indicating the amino acid mutated, a number representing its 
position in Gag and a letter indicating the amino acid residue o f the resulting mutant.
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not accumulate at the plasma membrane, suggesting a post-assembly trafficking 
deficiency.
Diffuse Dispersed Concentrated
enJS56A1 JSRVG2AenJS56A1
JSRVR98CJSRV+enJS56A1 JSRV+enJS56A1
Figure 17. Staining phenotypes of transfected cells.
Confocal microscopy of HeLa cells expressing or co-expressing JSRV, enJS56A1, and selected 
critical mutants. Positive cells were classified in three distinct phenotypes; diffuse, dispersed, 
and concentrated (see text). Each column displays three examples of the phenotype indicated 
on the top. Transfected constructs are indicated on the top right of each photograph. Gag 
staining is in green and nuclei are in red or indicated with the letter N. Scale bar is 
approximately 10 pm.
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Plasmids
enJS56A l
Diff. (%) Disp. (%) Cone. (%) Total
73 22 717
JSRV 57 33 10 193
JSR V +enJS56A l 91 456
JSR21W
JSG 2A
JSR98C
M ock
58
50
44
37
10
14
40
42
0
93
58
117
0
Table 2. Quantification of the observed Gag staining phenotypes in a representative 
experiment.
Values are Indicated as relative percentage of each phenotype, and the last column on the right 
indicates the total number of positive cells counted for each transfection.
JSRV viral exit is affected by residues K19, H20 and R21, but only the latter 
is involved in JLR
W e wanted to determ ine whether dom ains know n to participate in retroviral Gag 
trafficking were involved in JLR. Am ino acid residue in Gag W21 is the m ain 
determ inant o f  JLR since JSRV single m utant JSR21W  is defective and transdom inant 
like the endogenous enJS 56A l. Interestingly, residue R21 in Gag is highly conserved 
among Betaretroviruses (Figure 18A). In JSRV, R21 lies in close proxim ity to two other 
basic residues: lysine (K) 19 and histidine (H) 20 (Figure 18A), We therefore 
hypothesized that R21 could be part o f  the basic stretch o f  residues that constitutes the 
JSRV M  domain. Consequently, JLR m ight be the result o f  a trans-dom inant defective
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JSRV
ENTV
MPMV
SRV-2
Tv-ervD
MMTV
HERV-K
B
M G ----- QTHSR-QLFVHMLSVML£^RG-I7VSKFKLIKFLSFIEEV
M G ----- QTHSR-QLFVHMLSVMLKHRG-ITVSKPKLINFLSFIEEV
M G ----- QELSQHELYVEQLKKALKTRG-VKVKGNDLLKFFDFVKDT
M G ----- QELSQHELYVEQLKKALKTRG-VKVKGNDLLKFFDFVKDT
M G ----- SPLSKEQVFLKDLKQSFKERG-IRIKKKDLLKFFIFIDKV
MG-VSGSKG QKLFVSVLQRLLSF.RG-LHVKESSAIEFYOFLIKV
MG-QTKSKTKSKYASYLSFIKILLK-RGGVRVSTKNtlKLFQIIEQF
/ /  / /  / / / / / /
I — ir 3 - c a
-Gag
Cell Lysates
JSRV +
Virus
r a i r
Cell Lysates
Gag
Figure 18. Mutational analysis of JSRV Gag amino acid residues 19, 20, and 21.
(A) Alignment of the N-terminal Gag peptides from the indicated viruses, using ClustalW 
(Thompson, Higgins et al. 1994), showing that R21 and G22 are conserved among 
Betaretroviruses. Highly conserved residues are highlighted in bold. R21 and G22 are indicated 
with vertical arrows. K19 and H20 are underlined. Consensus symbols are displayed below the 
alignment: “*” indicates identical residues in all sequences in the alignment, indicates 
conserved substitutions, and indicates semi-conserved substitutions. ENTV, enzootic nasal 
tumour virus; M-PMV: Mason-Pfizer monkey virus; SRV-2: simian retrovirus-2; TV-ervD: 
brushtail possum type-D endogenous retrovirus; MMTV: mouse mammary tumour virus; HERV- 
K: human endogenous retrovirus K. (B) Analysis of JSRV mutants bearing mutations in the 
basic region of the M domain. Viral pellets and cell lysates of cells transfected with the indicated 
plasmids were resolved by SDS-PAGE and immunoblotted using a JSRV CA antiserum. (C) 
Western blot analysis of cells cotransfected with expression plasmids for wild type JSRV and 
indicated mutants. Viral pellets and cell lysates of cells transfected with the indicated plasmids 
were resolved by SDS-PAGE and immunoblotted using a JSRV CA antiserum.
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M  phenotype displayed by enJS56A l. I f  this was the case, disruption o f  the basic 
dom ain in the JSRV M A  w ould likely reproduce the interfering phenotype even in the 
presence o f  R21. To test this hypothesis, we derived JSRV m utants where K19, H20 
(individually or in com bination) and R21 where substituted by glutam ic acid (E), a 
negatively charged am ino acid residue.
W hen assessed by w estern blot using an anti JSRV CA polyclonal antiserum , viral 
release o f  JSH20E, JSK 19E/H 20E and JSR21E was severely impaired, while JSK 19E 
did not display any gross defect in viral exit (Figure 18B). How ever, w hen cotransfected 
with JSRV , only JSR21E blocked JSRV exit in a trans-dom inant fashion (Figure 18C), 
suggesting that JLR  is not the result o f  a  dom inant-negative M  dom ain phenotype but it 
is specifically dependent on Gag residue R21. W e further focused on residue 21 and 
substituted the original R  to a neutral alanine (A) and to a basic and m ore conservative 
lysine (K). M utant JSR21A  showed a transdom inant phenotype as the one observed by 
JSR21W  and JSR21E (Figs. 18B and 18C). To our surprise, m utant JSR21K  did not 
release viral particles nor did it b lock JSRV release (Figs. 18B and 18C).
As previously shown, confocal m icroscopy o f  cells expressing a m yristoylation- 
defective JSRV m utant (JSG2A) showed a relative increase in cells exhibiting a 
‘concentrated’ perinuclear staining. M utant JSK19E/H 20E also displayed a relative 
increase o f  cells w ith a concentrated phenotype when com pared to w ild type JSRV, 
although not as pronounced as JSG 2A  (Table 3 and Figure 19). On the contrary, cells 
expressing JSR21W  and JSR21E showed, if  anything, a  relative decrease in 
concentrated Gag staining, further supporting the hypothesis that the block induced by 
R21 m utations is not related to trafficking defects involving the JSRV M  domain.
From the alignm ent shown in Figure 18, we noticed that a glycine (G) in Gag position 
22 is also highly conserved am ong Betaretroviruses. W e therefore hypothesized the R21 
and G22 could be part o f a  previously uncharacterized functional dom ain required for 
JSRV trafficking/exit. To test this, we constructed m utant JSG22A , which was 
incom petent for viral exit, but did not block viral release w hen co-expressed w ith JSRV 
(data not shown). However, this m utant exhibited a curious phenotype: w hen assessed 
by confocal m icroscopy, not a single cell expressing JSG 22A  displayed a concentrated
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phenotype in two independent experim ents (Table 3 and Figure 19), suggesting that this 
m utation induces a different defect from the ones observed by the other constructs 
carrying m utations in R21 or H19/K20.
As a whole, these results indicate that the highly conserved R21 and G22 are 
specifically required for JSRV exit, although only the form er appears to be involved in 
JLR. In addition, the Gag residue W21 that naturally substitutes R21 in enJS56A l is not 
strictly needed to block JSRV release, since other amino acid substitutions are still 
transdom inant (i.e. R21A and R21E). Finally, both JSRV K19 and H20 seem  to 
contribute to JSRV  exit and be part o f its M  dom ain as already characterized in other 
retroviruses (Swanstrom  and W ills 1997).
Plasmids Diffuse (%) Dispersed (%) Concentrated (%) Total
enJS56A l 58 37 5 100
JSRV 33 57 10 100
JSG 2A  16 22 62 100
JSK19E/H 20E 35 46 19 100
JSR21E 38.5 56 5.5 200
JSR21K  41 43 16 300
JSG 22A  48.5 51.5 0 200
Table 3. Intracellular distribution of Gag in cells expressing JSRV, enJS56A1, and the 
indicated M domain mutants.
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JSR 21K JS K 19 /H 20E
Figure 19. Confocal microscopy of HeLa cells expressing JSRV mutants
JSR21K (left), JSK19/H20E (middle) and JSG22A (right). Gag staining is in green, nuclei are 
stained with DAPI (blue) or indicated with an N. Scale bar is approximately 10 gm.
Myristoylation of enJS56Al Gag is not required for JLR
Some murine defective endogenous retroviruses bud solely from the endoplasmic 
reticulum membrane, resulting in immature intracistemal A-type particles (lAPs) 
(Swanstrom and Wills 1997; Vogt 1997). lAPs can be regarded as type-C retroviruses 
that are following a “wrong” course. The wild type lAP element MIA 14 is a clear 
example o f  this. Addition o f  the membrane binding domain o f  the Src protein to the N 
terminus o f  MIA 14 Gag results in redirection o f  the virions to the plasma membrane, 
followed by maturation and subsequent virus release (Welker, Janetzko et al. 1997).
The presence o f  a myristoylation signal in enJS56Al Gag together with the observation 
o f  intracytoplasmic virus-like particles in cells expressing this endogenous virus 
prompted us to determine whether membrane targeting o f  the endogenous Gag was a 
functional requirement for JLR. We therefore constructed mutant enJS56AlG 2A, in 
which the myristoylation signal was disrupted by substituting the N terminal glycine o f  
Gag with an alanine by site-directed mutagenesis. The phenotype exhibited by this 
mutant in confocal microscopy was quite different from the one observed by its 
exogenous counterpart JSG2A: 59 out o f  100 enJS56AlG2A-expressing cells counted 
displayed a dispersed phenotype (Figure 20). When cotransfected with JSRV,
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enJS56AlG 2A kept its ability to interfere with JSRV, indicating that myristoylation o f  
enJS56Al Gag is not required for JLR (Figure 2GB).
B
enJS56A1G2A
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JSRV +
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Figure 20. Myristoylation of enJS56A1 Gag is not required for JLR.
(A) Confocal microscopy of HeLa cells expressing the endogenous myristoylation-defective 
mutant enJS56A1G2A. The majority of cells expressing enJS56A1G2A displayed a dispersed 
pattern of staining, unlike JSG2A expressing cells that show accumulation of Gag staining in a 
perinuclear region. Anti-MA staining is displayed in green and nuclei in blue. The scale bar is 
approximately 12 gm. (B) Viral pellets (upper panels) and cell lysates (lower panels) of cells 
transfected with the indicated plasmids were resolved by SDS-PAGE an immunoblotted with a 
JSRV CA antiserum. enJS56A1G2A is defective and transdominant over wild type JSRV.
Identification of JSRV L domains
During our functional characterization o f  JSRV Gag, we searched for putative L 
domains to experimentally rule out their involvement in JLR. We identified tandem 
PSAP and PPAY domains in position 201-204 and 207-210 o f  Gag, respectively (Figure 
21 A). Both the sequence and relative position o f these domains in JSRV Gag are 
analogous to the M-PMV L domains, although the order is inverted (Yasuda and Hunter 
1998; Gottwein, Bodem et al. 2003). To establish whether these sequences were bona 
fide L domains, we constructed single (JSALD201 and JSALD207) and double
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(JSALD201-7) L domains mutants (Figure 21 A). Mutations were designed according to 
previous studies performed on M-PMV (Gottwein, Bodem et al. 2003). We further 
transfected these JSRV L mutants in 293T cells side by side with wild type JSRV, and 
compared the amount o f  virus produced by western blot (Figure 21 A). It has been 
suggested with other retroviruses that defects in viral budding due to L domain 
mutations can be overcome by Gag overexpression (Strack, Calistri et al. 2002). Thus, 
our experiments have been performed using decreasing amounts o f  plasmid DNA  
expressing JSRV LD mutants to avoid artefacts due to overexpression.
JSRV PSAPPFPPAY
JSRVALD201 AGAPPFPPAY 
JSRVALD207 PSAPPFAAAY 
JSRVALD201-7 AGAPPFAAAY
Virus
8 3 -
2 6 - M CA
Figure 21. Identification of JSRV L domains.
(A) Viral pellets of cells transfected with increasing amounts of the indicated plasmids were 
resolved by SDS-PAGE and immunoblotted with a JSRV antiserum towards MA. The names of 
the transfected constructs and their L-domain sequence are indicated on the left of each panel, 
while the amount of plasmid DNA transfected is shown on top of the upper panel. Wild type 
tandem L domains are underlined and mutations are highlighted in red. (B) Lysates of cell 
transfected with the indicated plasmids were resolved by SDS-PAGE and immunoblotted with 
an antiserum towards JSRV CA. Cells expressing JSRVALD201-7 exhibited more intense 
bands for both mature and immature Gag, indicative of a defect on viral exit for this virus.
Expression o f  single mutant JSALD201 and double mutant JSALD201-7 resulted in 
reduced virus production compared to JSRV. On the other hand, no major differences in 
virus production were observed between wild type JSRV and JSALD207 (Figure 21 A). 
Lysates o f  cells expressing double mutant JSALD201-7 showed an increased amount o f  
mature Gag by western blot (Figure 2 IB), consistent with a defect at late stages o f  the 
retroviral cycle.
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Confocal microscopy experiments complemented the aforementioned western blot 
results; cells expressing either JSALD201 or JSALD201-7 displayed variable 
accumulation o f  Gag staining at the cell membrane (Figure 22). This characteristic L 
domain phenotype was more pronounced in cells expressing the double L domain 
mutant. In contrast, expression o f  JSALD207 did not result in significant accumulation 
o f  Gag staining (Figure 22).
JSRVA LD207JSRV
JSRV\LD201 JSRVALD201-7
Figure 22. Confocal microscopy of HeLa cells expressing JSRV and JSRV L domain 
mutants.
Anti-JSRV MA staining is displayed in green and nuclei in blue. White arrows indicate Gag 
staining accumulation at the plasma membrane. Cells expressing JSRVALD201-7 show a 
characteristic L domain staining at the cell membrane. Scale bar is approximately 10 pm.
Based on our observations by electron (Mura 2004) and confocal microscopy, we had 
hypothesized that JLR was not the result o f  a dominant-negative L-domain phenotype. 
To experimentally rule out any involvement o f  L domains in JLR, we coexpressed 
JSRV with JSALD201-7 and analysed virus pellets and cell lysates by western blot. We
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chose this mutant because it displayed defective viral release when compared with 
JSALD201 and JSALD207. JSALD201-7 was unable to block JSRV. On the contrary, it 
seemed to be rescued by the wild type virus based on the amount o f mature Gag 
detected in the supernatants by western blot (Figure 23). Collectively, the data presented 
so far suggest that the mechanisms governing JLR appear to be unrelated to known 
signals/mechanisms o f  Gag trafficking.
-  m h
Virus
MA
] — Gag
Cells
Figure 23. JLR Is not due to a transdominant L domain phenotype.
Viral pellets (upper panel) and cell lysates (lower panel) of cells transfected with the indicated 
plasmids were resolved by SDS-PAGE and immunoblotted with a JSRV MA antiserum. 
JSRVALD201-7 is defective for viral exit but is not transdominant over wild type JSRV.
Truncated enJS56Al Gag mutants do not block JSRV
Since the main determinant o f  JLR is located within the N-terminal Gag, it was o f  great 
interest to determine whether truncated enJS56Al Gag mutants could still block JSRV 
release. In general, retroviral Gag defective mutants are functionally complemented and 
further rescued by homologous wild type viruses (Muriaux, Costes et al. 2004; Lee, 
Boyko et al. 2007). This is not the case for enJS56A l, which is instead, defective and 
transdominant. As previously mentioned, one o f  the possible mechanisms postulated for 
JLR is that enJS56Al Gag could saturate (or capture) cellular factors required for Gag
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trafficking. I f  this was the case, enJS56A l-G ag truncated m utants could still bind these 
factors and interfere w ith  JSRV exit. W e therefore decided to construct enJS56A l 
deletion m utants lacking entire Gag dom ains and test their ability to block JSRV.
W e first aim ed to determ ine the exact boundaries o f  the JSRV Gag m ature proteins as 
these were unloiown at the tim e o f  these studies. To determ ine the JSRV Gag 
organization, we produced a highly concentrated purified virus preparation and analysed 
it by reverse-phase high pressure liquid chrom atography (RP-HPLC) and sequenced the 
N-term inal protein by Edm an degradation. Sixty 10-cm plates were transfected w ith an 
expression plasm id for JSR V  and supernatants containing virus were collected at 24, 48, 
and 72 hours to m axim ize viral recovery. Collected m edium  was clarified by 
centrifugation and viral pellets were obtained by further ultracentrifugation. Viral 
pellets were resuspended in TNE buffer, pooled together, and purified tw ice by 
isopycnic centrifugation on a 25 to 55%  (wt/wt) linear sucrose gradient. Fractions w ith 
a buoyant density betw een 1.146 and 1.176 g/ml were pooled, concentrated by 
ultracentrifugation as described above and resuspended in 8M guanidine-HCl. This 
concentrated viral preparation was subm itted to the N ational Cancer Institute 
(Frederick, M D, USA) for analysis o f  individual viral proteins. Briefly, viral proteins 
were separated by reverse-phase high pressure liquid cltrom atography (RP-HPLC). 
Each peak was individually collected and fractions were further N -term inally sequenced 
by Edm an degradation. Results obtained suggest that JSRV Gag is cleaved into at least 
5 products in the follow ing order: M A (p23)- p l5 -  CA (p26)- N C (plO ) - p4 (H enderson 
and Sowder, personal com m unication). The sequence and predicted boundaries o f  the 
mature JSRV Gag are indicated in Figure 24. These data are in agreem ent with previous 
studies on ^^S-labelled JSRV virions w hich revealed the presence o f  5 polypeptides 
(excluding the surface and transm em brane dom ain o f  the envelope glycoprotein) w ith 
an apparent m olecular w eight in a  SDS-PAGE gel o f  26, 23, 15, 10 and 5 kD a 
(Palm arini, Sharp et al. 1999). W e confirm ed that p26 is CA, p23 is M A, and plO is NC 
by w estern blot analysis using a panel o f  specific polyclonal antisera and JSRV 
expression plasm ids bearing HA epitopes w ithin M A (not shown). Besides Gag, the 
mature surface (SU) dom ain o f the JSRV envelope glycoprotein and cellular ubiquitin 
were also detected in purified viral particles (Henderson and Sowder, personal 
com m unication). The N -term inal SU sequence started at Env am ino acid residue 81
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M G Q TH SR Q LFVH M LSVM LK H RG ITVSK PK LINFLSFIEEVCPW FPREG TVN
LE TW K K V G EQ IR TH YTLH G PEK VPVETLSFW TLIR DC LDFDND ELK R LG N
LLKQEEDPLHTPDSGPSYDPPPPPPPSLKM HPSDNDDLLSSTDEAELDEEAAK
YHQEDW GFLAQEKGALTSKDELVECFKNLTIALQNAGISLPHNNTFPSAPPFP
MA -►p15
PAYTPSVM AGLDPPPGFPPPSKHM SPLQRALRQAQRLGEVVSDFSLAFPVFEN
I ►CA
NNQRYYESLPFKQLKELKIACSQYGPTAPFTIAM IENLGTQALPPNDW KQTA
RACLSGGDYLLW KSEFFEQCARIADVNRQQGIQTSYEM LIGEGPYQATDTQL
NFLPGAYAQISNAARQAW KRLPSSSTKTEDLSKVRQGPDEPYQDFVARLLDTI
GKIM SDEKAGM VLAKQLAFENANSACQAALRPYRKKGDLSDFIRICADIGPS
YM QGIAM AAALQGKSIKEVLFQOQARNKKGLQKSGNSGCFVCGQPGHRAA
I ► NC
VCPQKQQGPVNTPNLCPRCKKGKHW ARDCRSKTDVQGNPLPPVSGNW VRG
QPLAPKQCYGATLQVPKEPLQTSVEPQEAARDW TSVPPPIQY  
I ► p4
M
I 163 ,^ 256
MA pi 5
p23
CA
p26
490 579
NC
piO p4
Figure 24. JSRV Gag sequence and schematic organization.
Top: amino acid sequence of JSRV Gag. Vertical arrows indicate cleavage sites. Boundaries 
between the different polypeptides are indicated. Bottom: Schematic representation of JSRV 
Gag: the names of the Gag cleavage products are displayed inside the boxes (with the 
exception of p4, which is indicated below). Vertical lines indicate cleavage sites. The numbers 
above refer to the position of the boundaries in the mature Gag of the JSRV21 infectious
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molecular clone (Palmarini, Sharp et al. 1999). The myristate is represented by a blue circle. 
The relative position of L and M domains is also indicated. The apparent molecular weights of 
MA, CA, and NC are indicated below.
(A A FW A Y ....) in agreem ent with the cleavage site o f  the leader peptide previously 
predicted (Palm arini, Sharp et al. 1999; Palmarini, Hallw irth et al. 2000).
Once the boundaries o f  JSRV Gag were established, we introduced stop codons at the 
end o f  either p i 5 or CA  by site-directed m utagenesis (Figure 25A). The resulting 
m utants lacked CA and N C  (enJS 56A 1 ACA-NC), or only N C  (enJS56A lA N C ), 
respectively. After transfection o f  293T cells and fuither w estern b lot analysis o f  cell 
lysates and viral pellets, we observed that both truncated m utants expressed Gag 
proteins o f  a lower m olecular w eight (Figure 25B, lower panel). W hen they were 
cotransfected w ith JSRV, none o f  them  w as able to block viral release (Figure 25B, 
upper panel), indicating that an entire enJS56A l Gag is necessary for JLR. W e noticed 
that expression o f en J S 5 6 A 1 AC A-N C was severely dim inished, probably by nonsense 
m ediated m RN A  decay, and this low  level o f  expression could account for its inability 
to restrict JSRV. In contrast, expression o f  enJS56A lA N C  w as comparable to that 
observed w ith full length enJS56A l (Figure 25B, lower panel).
JSRV and enJS56Al Gag proteins colocalize
As m entioned above, we considered the possibility that Gag-Gag interactions betw een 
JSRV and enJS56A 1 -derived m olecules could constitute a m echanistic basis for JLR. 
To initially address this, we investigated whether enJS56A l and JSRV Gag colocalize 
w ithin the cell as this w ould be suggestive o f  a restriction m echanism  occurring in 
trans. As stated above, our anti-JSRV M A  used in confocal m icroscopy does not 
discrim inate betw een JSRV and enJS56A l Gag, probably because these two proteins 
are 95%  identical (Palm arini, Hallw irth et al. 2000). Therefore, we differentially tagged 
JSRV and enJS56A l Gag by fusing the FLAG and HA  epitopes at the carboxy-term inal 
o f  p4 or w ithin the M A dom ain (Figure 26). The biological properties o f the parental 
viruses were not altered by the addition o f  the epitopes since all the tagged JSRV and
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enJS56Al constructs were competent for viral release and interference, respectively 
(Figure 27).
enJSS6A1
pi 5 CA I NC
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MA-p15-CA
MA-p15
Cell lysates
Figure 25. Truncated enJS56A1 Gag mutants do not block JSRV exit.
(A) Schematic representation of enJS56A1 Gag and truncated mutants. Vertical arrows indicate 
the position where stop codons were inserted by site-directed mutagenesis. (B) Western blot 
analysis of enJS56A1-deletion mutants. Viral pellets (upper panel) and cell lysates (lower panel) 
of cells transfected with the indicated plasmids were resolved by SDS-PAGE and 
immunoblotted with a JSRV MA antiserum. Truncated constructs did not interfere with JSRV 
exit.
Immunostaining o f  labelled Gags with anti-FLAG or anti-HA was comparable to the 
one observed when a JSRV MA anti serum was used (not shown). To test our system for 
colocalization experiments, we first co-transfected HeLa cells with homologous 
constructs bearing different tags. As expected, they strongly colocalized regardless o f  
the location o f  the epitope (Figure 28). When JSRV and enJS56Al were co-expressed. 
colocalization between endogenous and exogenous virus was evident in cells displaying 
both dispersed and concentrated phenotype (Figure 28). We essentially obtained the
Pablo R Murcia, 2007 Chapter 3, 103
same results with all our different constructs despite the different position o f  the 
labelling epitope within Gag (i.e. at the C-terminal end or within the MA domain).
JSRVFLAG-C
JSRVHA-C
FLAG
MA p15 CA NC MA p15 CA NC
m
MA p15 CA NC
enJS56A 1FLA G -C
enJS56A 1H A -C
FLAG
HA
MA p15 CA NC
m
MA p15 CA
JSRVHA-MA
NC
FLAG
MA p15 CA NC ]
enJS56A1FLAG-M A
p15 CA NCMA
JSRVFLAG-MA
HA
MA p15 CA NC
enJS56A1HA-M A
Figure 26. Schematic representation of JSRV and enJS56A1 tagged constructs.
Epitopes were inserted either at the C-terminal end of Gag or within MA. The FLAG and HA 
epitopes are indicated as green and red flags, respectively. JSRV and enJS56A1-derived 
constructs are drawn as white and grey boxes, respectively.
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pCDNAS + + + + + - - - -
JSRVHA-MA - + - - - + - + -
JSRVFLAG-MA - - + - - + - - +
enJS56A1FLAG-MA - - - + - - + + -
enJS56A1HA-MA - - - - + - + - +
1 2 3 4 5 6 7 8 9
Virus
- g " n g l -
MA
Gag
Cells
B
pCDNAS 
JSRVHA-C 
JSRVFLAG-C 
enJS56A1 HA-C 
enJS56A1FLAG-C 
JSRV
+ + 
+
pCDNA3 + + +
enJS56A1HA-C — + -
enJS56A1FLAG-C
Anti-HA
1 2 3 4 5 6  7 8
Gag
Anti-FLAG
Cell ly sa tes Virus
Figure 27. Western blot analysis of plasmids expressing differentially tagged Gag 
proteins.
Viral pellets of cells transfected with the indicated plasmids were resolved by SDS-PAGE and 
immunoblotted with a JSRV CA antiserum. Gag labelling did not affect JSRV viral exit nor did it 
abrogate enJS56A1 ability to perform JLR. Panels A shows constructs bearing epitopes within 
the MA protein, and panel B displays C-terminally tagged constructs.
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Figure 28. JSRV and enJS56A1 Gag colocalize (see legend on next page).
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(From previous page). Representative images of confocal microscopy of HeLa cells co­
expressing differentially tagged JSRV and enJS56A1. Strong colocalization of JSRV and 
enJS56A1 is observed in all cases. Both dispersed and concentrated phenotypes are 
represented (see text). Transfected constructs are indicated on the upper left corner of each 
image. FLAG staining is displayed in green, HA staining in red, and nuclei in blue. Scale bar is 
approximately 10 pm, with the exception of the bottom row, where it is approximately 2pm. The 
bottom row shows a high power magnification of the area within the rectangle indicated in the 
pictures of the fifth row from the top.
JSRV and enJS56Al interact in trans
Results obtained by confocal microscopy using epitope-labelled viruses suggest that 
JLR is likely due to an interaction in trans between JSRV and enJS56Al Gag. To test 
this, we performed co-immunoprecipitation experiments using lysates o f  cells 
coexpressing our differentially tagged JSRV and enJS56A l. As expected, JSRV and 
enJS56Al co-immunoprecipitate (Figure 29) suggesting that they associate in trans.
pCDNAS
enJS56A1HA-MA
JSRVFLAG-MA
+ + +  - 
+ - +
+  +  
1 2  3 4
IP: HA WB: FLAG
IP: FLAG WB: HA 
WB: MA
-  Gag 
Gag 
Gag
Figure 29. Association between JSRV and enJS56A1 Gag proteins.
293T cells were co-transfected with enJS56A1HA-MA and JSRVFLAG-MA. Cell lysates were 
immunoprecipitated (IP) at 48 hours post-transfection and analyzed by SDS-PAGE followed by 
Western blotting as indicated beside each panel. Gag expression was assessed by Western 
blotting using a JSRV MA antiserum. enJS56A1-JSRV Gag association is evident in lysates 
from cells cotransfected with both viruses (lane 4). Note that the JSRV MA antiserum is 
polyclonal and more sensitive than monoclonal anti-HA or anti-FLAG in Western blotting.
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The previously described co-im m unoprecipitation experim ents gave us strong evidence 
to support the hypothesis o f  Gag-G ag interaction betw een JSRV  and enJS56A l in JLR. 
We therefore w anted to see w hether this was reflecting a co-assem bly process betw een 
endogenous and exogenous Gag proteins resulting in JSR V -enJS56A l chim eric 
particles. Hence, we perfoim ed com plem entation assays using a JSRV  virus lacking the 
protease (JSRVApro*), and an enJS56A l virus bearing a m ajor deletion in NC w ith  an 
in frame intact Pro (enJS56A lA N C 2). W hen expressed in 293T cells, the form er 
releases only im m ature viral particles in the supernatant. In contrast, the latter does not 
exit from  transfected cells, nor does it block JSRV. As show n in Figure 30, co­
expression o f  these two plasm ids results in the release o f  viral particles bearing both 
mature and im m ature Gag. Thus, JSRVApro rescues and likely co-assem bles w ith 
enJS56A l ANC2 since Gag cleavage can only occur when the viral protease is contained 
w ithin a retroviral particle (Rabson and Graves 1997). This result suggests that 
enJS56A l and JSRV can potentially eo-assem ble, and prom pted us to wonder w hether 
co-assem bly was a required step for JLR. If  this was the case, im peding enJS56A l 
assem bly w ould abrogate its capacity to block JSRV. W e experim entally addressed this 
by m aking an in-fram e deletion o f  the m ajor hom ology region (M HR) o f  enJS56A l 
Gag. This strategy was based on previous data generated on M -PM V , where it has been 
shown that deletion m utants lacking the M H R are unable to assem ble into viral particles 
(Stram bio-de-Castillia and H unter 1992).
Our enJS56A l M H R  deletion m utant (enJS 56A 1AMHR) was unable to interfere with 
JSRV despite its high levels o f  expression in cell lysates (Figure 31). These data 
indirectly suggest that enJS56A l-JSR V  co-assem bly is required for JLR, given that the 
retroviral M H R  is required for proper assem bly o f  viral particles.
As a whole, our results presented here together w ith previous observations o f 
intraeytoplasm ic viral particles by electron m icroscopy in cells expressing enJS56A l, 
with or without JSRV (M ura 2004), suggest that enJS56A l and JSRV associate in trans 
and likely co-assemble.
Constructed by Manuela Mura.
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pCDNAS
JSRV
JSRVApro
enJS56A1
enJS56A1ANC2
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Figure 30. enJSSSAlANC can complement JSRVAPro.
Supernatants of cells transfected with the indicated plasmids were resolved by SDS-PAGE and 
immunoblotted with a JSRV CA antiserum. Note that JSRVApro releases viral particles into the 
supernatant with an immature Gag (lane 5) because of the absence of a functional protease in 
this virus. Coexpression of JSRVApro and enJS56A1 ANC2 (lane 8) results in the release of viral 
particles with both mature and immature Gag.
pCDNA3
JSRV
enJS56A1
enJS56A1AMHR
+  +  +  +  -  
-  +  -  -  +  +
-  -  -  +  -  +
M A -
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Virus
G ag-[ I  1
Cells
Figure 31. Deletion of the Major homology region abrogates JLR.
Supernatants (upper panel) and lysates (lower panel) of cells transfected with the indicated 
plasmids were resolved by SDS-PAGE and immunoblotted with a JSRV MA antiserum. 
enJS56AlAMHR is highly expressed (lane 4, lower panel) but does not interfere with JSRV exit 
(lane 6, upper panel).
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Discussion
Expression o f  enJS56A l, an endogenous sheep Betaretrovirus, blocks the release o f 
JSRV in a transdom inant fashion at a late stage o f  the retroviral cycle (M ura 2004). The 
late tim ing o f  this block, referred to as JLR in this thesis, is unique w hen com pared w ith 
the earlier replication steps affected by other well characterized retroviral and cellular 
restriction factors described in the introductory chapter (i.e. F v l, Fv4, T rim 5a, 
A P0B E C -3G , etc.)
In this section, we showed that JSRV  and enJS56A l Gag co-localize, associate in trans, 
and likely co-assemble. Furtherm ore, by system atic characterization o f  JSRV and 
enJS56A l Gag polyproteins, we were able to establish other Gag requirem ents for JLR. 
W ith regard to the tim ing at w hich the late block occurs, we shortened the possible tim e 
fram e by ruling out any involvem ent o f  L dom ains in JLR. Com plem enting these 
results, w ork done by Frederick Arnaud in our laboratory indicates that enJS56A l 
displaces the intracellular localization o f Gag. M ore specifically, his data argue that JLR 
is due to a block in JSRV Gag targeting to the pericentrosom al region w ith a m echanism  
independent from  other previously known Gag trafficking dom ains (see attached papers 
by M urcia, A rnaud and Palm arini [Journal o f  Virology, 81: 1762-72], and A rnaud, 
M urcia and Palm arini [Journal o f  Virology, in press]).
W e previously m apped the m ain determ inant o f  JLR to am ino acid residue R21 w ithin 
JSRV Gag (M ura 2004), a  conserved residue am ong Betaretroviruses that is naturally 
m utated into a tryptophan in enJS56A l (Figure 18A). The m ain determ inant o f  JSRV 
Gag centrosomal targeting is also residue R21 (see attached paper by Mui'cia, Aimaud 
and Palmarini). The naturally occurring R21W  substitution observed in enJS56A l is not 
strictly necessary for JLR, since JSRV single m utants carrying other amino acid 
residues than R  in position 21 are incom petent for viral release and trans-dom inant over 
JSRV, the only exception being the conservative m utant JSR21K.
The centrosom e has been hypothesized to be the site o f  assem bly for M -PM V (another 
Betaretrovirus). Once assem bled, M -PM V particles traffic to the cell m em brane by yet 
uncharacterized m echanism s that require the viral envelope and recycling endosom es
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(Sfakianos and H unter 2003; Sfakianos, LaCasse et al. 2003). Because M -PM V appears 
to assem ble at the centrosom e one could hypothesize that JLR  results from altered 
assembly. It is reasonable to conjecture that JSRV and enJS56A l eo-assem ble 
considering that (i) JSRV and enJS56A l Gag eo-loealize and associate in trans; (ii) we 
observed viral particles w ithin the cytoplasm  o f  cells expressing enJS56A l or co­
expressing enJS56A l and JSRV by EM  (M ura 2004); (iii) enJS56A l truncation m utants 
are defective but do not block JSRV and (iv) an enJS56A l m utant w ith the M H R 
deleted is not transdom inant. Furtherm ore, in a com plem entation assay we have shown 
that an enJS56A l m utant w ith an in fram e deletion in N C  (enJS56ANC2) and a 
functional protease co-assem bles w ith JSRVApro. A lthough it can be argued that 
enJS56ANC2 is not transdom inant and consequently does not com pletely recapitulate 
the enJS56A l phenotype, it is also true that CA dictates co-assem bly (Ako-Adjei, 
Johnson et al. 2005) and both enJS56A l and enJS6ANC2 have identical CA domains. 
Thus, there are indications that JSRV and enJS56A l Gag eo-assem ble (at least partially) 
and possibly co-assem bly is required for JLR.
The precise m echanism s o f  JLR action are not know n at present. It is possible that even 
a m inority o f  enJS56A l Gag m olecules alter the overall conform ation o f  chim eric 
JSR V /enJS56A l viral particles (or m ultim erized Gag m olecules) so that they are unable 
to bind cellular factors that direct them  to the centrosome. The nature o f  the association 
betw een any cellular protein assisting Gag trafficking w ould have to be reversible or 
tem porary. Thus, the defect o f  enJS56A l could even result from  its Gag protein binding 
cellular factors irreversibly (or m ore tightly than necessary). A lternatively (or 
additionally) enJS56A l Gag m ight actively target, in a  transdom inant fashion, a cellular 
com partm ent where viral particles cannot reach the cell m em brane and egress from  the 
cell.
In M -PM V a region o f  18 am ino acids w ithin the M A, know n as the cytoplasm ic 
targeting-retention signal (CTRS) is responsible for directing Gag m olecules to the 
centrosome. A  single m utation in this dom ain (R55W ), abolishes centrosom al targeting, 
but the resulting m utant is still able to assem ble at the cell m em brane like those viruses 
that follow  the so-called C-type assem bly (i.e. HIV, M LV, FeLV and others) (Rhee and 
Hunter 1990; Choi, Park et al. 1999). Thus, centrosomal targeting does not appear to be
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absolutely necessary for betaretroviral assembly. JSRV bears a threonine at the 
corresponding R55 and it has not been determ ined whether a CTRS dom ain is present in 
this virus. The JSRV  R21 m ight be part o f  an equivalent dom ain, but i f  this was the case 
we w ould expect the JSR21W  m utant to display a C-type assem bly follow ed by viral 
release from  the cell rather than a dom inant-negative phenotype.
Studies on the m olecular biology o f  JSRV Gag were lacking despite the vast body o f 
Icnowledge o f  this protein in other retroviruses (Freed 1998; Dem irov and Freed 2004). 
To better understand the m olecular m echanism s underpinning JLR, we identified Icnown 
trafficking signals and evaluated their functionality w ithin the context o f  JSRV. This 
approach allowed us to identify putative JSRV  L and M  dom ains and to rule out their 
involvem ent in JLR. M oreover, w e determ ined that m yristoylation o f enJS56A l Gag is 
not a requirem ent for JLR  since the enJS56A lG 2A  m utant efficiently blocked JSRV 
release.
From  an evolutionary perspective, the strict requirem ent for R21 in JSRV release 
suggests that the R  to W  m utation becam e fixed in the sheep genom e after integration. 
This seems feasible since in enJS56A l a TGG codon encodes for W  w hile AGG 
encodes for R  in other enJSRV s loci (Arnaud, Caporale et al. 2007). Thus, a  single 
nucleotide substitution would have been sufficient to select a  provirus w ith dom inant- 
negative interfering properties. enJSRV s (including enJS56A l or sim ilar proviruses 
possessing W21 in Gag) are highly expressed in the genital tract o f the ewe (Spencer, 
Stagg et al. 1999; Palm arini, H allw irth et al. 2000; Palm arini, Gray et al. 2001; M ura 
2004; Dunlap, Palm arini et al. 2005). enJSRV s are also able to interfere w ith JSRV by 
receptor com petition (Spencer, Mui'a et al. 2003). Therefore, enJSRV s m ight have been 
selected in sheep because they protected the host against exogenous retroviral infection 
by a seem ingly pow erful two-step interference m echanism . How ever, interference with 
exogenous pathogenic retroviruses is not the only biological function o f  enJSRVs. 
Recently, w ork done in collaboration betw een Tom Spencer at Texas A & M  and our 
laboratory has show n that enJSRV s are absolutely required for sheep eonceptus 
developm ent (Dunlap, Palm arini et al. 2006; Dunlap, Palm arini et al. 2006) further 
reinforcing the hypothesis that endogenous retroviruses have benefited the evolution o f 
their host (Boeke and Stoye 1997). This unique viral block provides additional clues on
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the variety o f  m echanism s shaping co-evolution o f  endogenous/exogenous retroviruses 
and their hosts.
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Chapter 4
Temporal distribution of late events of JSRV/enJS56A1 
cell cycle.
Summary
In the previous chapter we established that JSRV late restriction (JLR) is likely due to 
interactions in trans betw een enJS56A l and JSRV Gag proteins. M oreover, Frederick 
Arnaud in our laboratory determ ined that while JSRV Gag is targeted to a  pericentriolar 
region, enJS56A l/JSR V  chim eric particles/m ultim ers are unable to reach this area. The 
centrosom e is thought to be the site o f  assem bly for Betaretroviruses, hence the 
im portance o f  centrosom al Gag targeting (Sfakianos, LaCasse et al. 2003). A lthough we 
have established that JLR takes place at a late stage o f  the retroviral cycle, its precise 
tim ing was unknown. This is w hat we sought to determine in this section.
Introduction
Once integrated w ithin the host genome, proviruses express their genes to give origin to 
progeny virions (G off 2001). Gag is the m ajor structural protein o f  the retroviral virion, 
and plays a critical role in viral assem bly and budding (Swanstrom  and W ills 1997). 
This notion is supported by the fact that the sole expression o f  Gag is sufficient to 
assem ble virus-like particles. As was review ed in Chapter 1 o f  this thesis, several 
dom ains within Gag display various activities required to form a com plete viral particle. 
The m em brane-binding (M ) dom ain directs Gag to the plasm a m em brane. The capsid 
(CA), interaction (I), and nucleocapsid (NC) dom ains are responsible for 
m ultim erization o f  structural proteins and packaging o f  genom ic RNA. The late (L) 
dom ains are in charge o f  virus-cell separation.
An infectious virion is com posed o f  thousands o f  individual elem ents that include 
structural proteins, viral enzym es, lipids and glycoproteins o f  the envelope, genomic 
RNA, and even host cell proteins, and genomic RNA. Little is loiown about how  all
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these com ponents come together to the site o f  assem bly and constitute a viral particle. 
However, it is evident that viruses have evolved efficient strategies to transform  the 
cellular m achinery o f  the infected cell into viral factories.
Retroviral assem bly is a m ultistep process in which each step is spatially and tem porally 
regulated. There are two distinct m orphogenic pathways: the so called C-type and the 
B/D-type. V iruses classified w ithin the form er category assem ble at the p lasm a 
m em brane, where they are targeted by m eans o f  the aforem entioned m em brane-binding 
domain. This has been recently show n for a Lentivirus like HIV-1 (Jouvenet, N eil et al. 
2006), and also for HERV-K, a Betaretro virus (Dewannieux, H arper et al. 2006; Lee 
and Bieniasz 2007). In contrast, type B/D retroviruses assem ble w ithin the cytoplasm  o f 
the infected cell (Swanstrom  and W ills 1997; G off 2001). Som e type B/D retroviruses, 
like M ason-Pfizer m onkey virus (M -PM V ), possess an 18-amino acid sequence w ithin 
the M A dom ain, referred to as cytoplasm ic targeting/retention signal (CTRS). The 
CTRS seems to constitute a  dom inant signal for intraeytoplasm ic assem bly o f  im m ature 
capsids (Rhee and Hunter 1990). A  single substitution o f  an arginine to alanine in the 
CTRS abrogates its dom inant activity and allows M -PM V  to follow  a C-type 
m orphogenic pathw ay (Rhee and H unter 1990). Conversely, insertion o f  the CTRS o f 
M -PM V into m urine leukaem ia virus (M LV) results in intraeytoplasm ic assem bly o f  an 
otherwise type-C  retrovirus (Choi, Park et al. 1999).
Previous studies on M -PM V suggested that the subcellular site o f  assem bly for this 
virus is the pericentriolar region. M -PM V Gag centriolar targeting occurs 
cotranslationally via dynein-m ediated transport, is determ ined by the CTRS, and 
depends on intact m icrotubules (Sfakianos, LaCasse et al. 2003). Once assem bled, 
capsids traffic to the cell m em brane by a process depending on the viral envelope and 
the recycling endocytic pathw ay (Sfakianos and Hunter 2003).
M anuela M ura in our laboratory has show n that a m yristoylation deficient JSRV 
(JSG2A) m utant is defective for viral exit although not transdom inant over w ild type 
virus (M ura 2004). Cells expressing JSG 2A  exhibited by confocal m icroscopy a m arked 
increase in the num ber o f  cells w ith  a  concentrated phenotype com pared to cells 
expressing JSRV . Colocalization studies perform ed by Frederick Arnaud determ ined
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that JSG 2A  Gag concentrates in the vicinity o f  the centrosom e (see paper by M urcia, 
A rnaud and Palm arini attached to this thesis). The inability displayed by JSG 2A  to 
reach the plasm a m em brane is consistent w ith sim ilar studies perform ed on M -PM V 
where it has been show n that m yristoylation is required for intracellular trafficking but 
not for assem bly o f  viral particles (Rhee and H unter 1987).
In this chapter we study JSRV and enJS56A l kinetics by confocal m icroscopy. W e also 
com pared the tem poral intracellular distribution o f  JSRV and enJS56A l Gag w ith that 
o f  M -PM V and HERV-K. M oreover, we determ ined that JSRV  release is dependent on 
dynein transport and establish that JLR  occurs before centrosom al tai'geting as the 
typically concentrated phenotype o f  JSG 2A  is lost in the presence o f  enJS56A l. 
Confocal experim ents using m yristoylation-defective m utants o f  JSRV and M -PM V 
suggest distinct trafficking pathw ays although both viruses assem ble w ithin the 
cytoplasm. Finally, a JSRV /H ERV -K  chim era bearing the m atrix dom ain o f  HERV-K 
exhibits a sim ilar confocal phenotype to the one observed in cells expressing H ERV -K  
Gag, w ith conspicuous staining at the p lasm a m em brane consistent w ith  a  type-C 
m orphogenic pathway. The fact that this chim era is not interfered by enJS56A l raises 
the possibility that changing the site o f  assem bly can overcom e JLR.
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Results
Temporal distribution of JSRV and enJS56Al Gag proteins
In the previous chapter w e classified cells expressing JSRV , enJS 56A l, and selected 
m utants in thi'ce distinct phenotypes according to their Gag staining pattern by confocal 
m icroscopy: diffuse, dispersed, and concentrated. In all cases, cells were fixed and 
im m unostained at 24 or 48 hours post-transfection. Because the synthesis o f  Gag 
proteins and subsequent assem bly o f  viral particles is a m ultistep process, w e thought 
that what we were observing at those late tim e points was a m ixture o f  different stages 
o f  the retroviral cycle. To separate these events in a tem poral fashion we decided to 
perform  confocal m icroscopy experim ents on cells expressing JSRV, enJS56A l and 
JSG 2A  at different intervals post-transfection. Cells were transfected w ith 
L ipofeetam ine and m edia was changed thi'ee hours after adding the transfection 
m ixture. This stage was taken as “tim e zero” . W e also included in these studies JSG2A, 
as this m utant follows a dead-end pathw ay that finished at the pericentriolar region (see 
paper by A iuaud, M urcia, and Palm arini attached to this thesis), and w ould therefore 
provide us w ith an accurate tim e fram e corresponding to the tim e betw een Gag 
synthesis and its localization to the pericentrosom al region. The results o f  two 
independent experim ents are shown in Figure 32. A t two hours post-transfection (hpt) 
we began to detect JSRV Gag under our w orking conditions, w hen the vast m ajority o f  
the few positive cells exhibited a diffuse phenotype (Figure 32, top panel). Cells w ith 
diffuse Gag staining show ed a steady reduction throughout tim e, from  alm ost 90%  at 2 
hpt to 6% at 12 and 24 hpt (Figure 32, top panel). In contrast, cells with dispersed 
phenotype were rare to find at 2 hour's post-transfection, but progressively increased to 
reach their first peak at six hpt, and after a  tem porary decline, reached a second plateau 
o f  alm ost 80% at 12 and 24 hpt. Concentrated Gag staining w as only obsei’ved after 4 
hours post-transfection, and peaked at 8 hpt, in concom itance w ith  a  reduction o f  cells 
w ith dispersed staining. A fter 12 hpt, cells w ith concentrated Gag gradually declined 
(while the num ber o f  cells w ith dispersed phenotype increased, [Figure 32, top panel]).
A s expected, the m yristoylation-defective m utant JSG2A exhibited quite a  different 
tem poral distribution pattern (Figure 32, m iddle panel): although at 2 and 4 hpt the
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distribution o f  confocal phenotypes w as com parable to the one observed w ith wild type 
virus, after 6 hours the num ber o f  cells w ith concentrated Gag staining m arkedly 
increased and constituted the preponderant phenotype. The distribution o f  cells 
expressing JSG 2A  w ith diffuse Gag staining was sim ilar to the one displayed by JSRV 
expressing cells throughout the experim ents. The increased proportion o f  JSG 2A  
expressing cells w ith a concentrated phenotype corresponded to a sm aller proportion 
(com pared to cells expressing w ild type JSRV) o f  cells w ith a “dispersed” phenotype, 
consistent w ith the notion that Gag accum ulation in the perinuclear region is a  transient 
step in the viral replication cycle (see below). W ith regard to enJS 56A l, m ost o f  the 
positive cells observed during the tim efram e o f  this experim ent showed either a diffuse 
or a dispersed phenotype, as only a m inor proportion displayed concentrated Gag 
staining (Figure 32, bottom  panel). N otably, the size o f  the fluorescent specks w as in 
general larger in cells expressing enJS56A l Gag when com pared w ith the ones 
exhibited in JSRV -expressing cells.
Based on these results, we built a  m odel on the intracellular pathw ay follow ed by JSRV  
Gag from protein synthesis to viral exit that is depicted in Figure 33. The diffuse 
staining phenotype observed at early tim epoints likely represents synthesis o f  Gag 
m olecules at the polyribosom es (Figure 33, 2hs). A t later stages. Gag proteins m ust 
assem ble or m ultim erize, w hich is reflected by the appearance o f  characteristic discrete 
dots in cells w ith a dispersed phenotype. These newly assem bled particles or Gag 
m ultim ers m ust reach the pericentrosom al region before being targeted to  the cell 
m em brane (Figure 33, 4-6 hs). Centrosom al targeting probably encom passes an 
obligatory step in the JSRV replication cycle that acts as a  bottleneck, since the num ber 
o f  cells displaying a concentrated phenotype reaches a  m om entary and reproducible 
peak (Figure 33 8 hs). A fter reaching the pericentrosom al region, viral particles m ust 
traffic to the plasm a m em brane to be released (Figure 33, 12-24 hs). This step requires 
an intact M dom ain since JSG 2A  cannot progress any further.
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Figure 32. Kinetics of the intracellular distribution of JSRV, JSG2A and enJS56A1.
HeLa cells were transfected with the indicated plasmids and fixed at different times post­
transfection. After immunostaining, cells were quantified according to their Gag staining 
phenotype. Each bar represents a specific time-point at which cells were fixed, immunostained 
and classified according a predefined staining criterion (see text).
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12-24 h s
Figure 33. Kinetics of JSRV Gag intracellular distribution.
Model of JSRV Gag trafficking. From left to right: JSRV Gag is synthesized by the 
polyribosomes in the cytoplasm, exhibiting a diffuse Gag staining at 2 hours post-transfection 
(hpt). At 4-6 hpt. Gag molecules multimerize in discrete fluorescent dots that are directed to the 
pericentriolar region. Gag multimers/viral particles form a perinuclear cluster at 8 hpt, from 
where they are targeted to the plasma membrane for further release.
Dynein is required for JSRV Gag centrosomal targeting
The cytosol is an exceptionally crowded environment where free movement is 
particularly restricted for molecules with a size over 20 nm (Luby-Phelps 2000). 
Microtubules direct intracellular organization by providing a dynamic structure in 
which motor proteins engage to carry their cargo to specific compartments within the 
cell (Dammermann, Desai et al. 2003). The polar nature o f  microtubules allows motor 
proteins to follow  a unidirectional course. Given their size, intracellular Gag multimers 
and newly formed virions must use cellular motors to traffic within the cytoplasm  
(Leopold and Pfister 2006). It has been shown that M-PMV centrosomal targeting 
depends on the integrity o f  the microtubule network as well as on dynein-mediated 
transport (Sfakianos, LaCasse et al. 2003). We hypothesized that JSRV Gag could use 
the same motor proteins to reach the pericentriolar region. If this was the case, 
transfection o f  dynamitin would affect both JSRV release and intracellular distribution, 
as its overexpression disrupts dynein-mediated transport towards the minus end o f  
microtubules (Echeverri, Paschal et al. 1996). We cotransfected JSRV with a GFP- 
tagged dynamitin (GFP-p50), and quantified the levels o f  Gag protein in western blots 
o f  viral pellets. As expected, JSRV release exhibited a drastic reduction when 
coexpressed with GFP-p50 (Figure 34). Moreover, in confocal experiments, the number
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o f  cells w ith a  concentrated phenotype was consistently reduced from  5% to 1% w hen 
JSRV and p50-GFP were coexpressed (Figure 35A). To further confirm  this result, we 
repeated this experim ent using JSG 2A  instead o f  w ild type JSRV , as the m ajority o f  the 
cells expressing the form er virus exhibit Gag perinuclear accum ulation. The num ber o f 
cells expressing JSG 2A  w ith concentrated Gag w as m arkedly dim inished in the 
presence o f  p50-G FP from  59% to 11% (Figure 35B), corroborating the results obtained 
w ith w ild type virus. A s a whole, these experim ents indicate that dynein transport is 
necessary for Gag trafficking to the centrosom e and that JSRV  tai’geting tow ards this 
area is a required step during the virus cellular cycle.
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Figure 34. Overexpression of p50-GFP reduces JSRV exit.
Viral pellets of cells transfected with the indicated plasmids were subject to SDS-PAGE and 
immunoblotted with a JSRV MA antiserum. The amount of JSRV Gag protein in the viral pellet 
was quantified by chemiluminescence.
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Figure 35. Overexpression of pSO-GFP alters the intracellular distribution of JSRV Gag.
Cells transfected with the indicated plasmids were fixed and immunostained using an anti-JSRV 
MA antiserum. Positive cells were classified as described in Chapter 2. (A) The percentage of 
cells expressing concentrated JSRV Gag staining is consistently reduced when p50-GFP is 
overexpressed. (B) The effect of p50-GFP is more evident if a myristoylation-defective JSRV  
(JSG2A, which normally exhibits a high percentage of cells with concentrated phenotype) is 
used. Vertical arrows show the reduction in the percentage of cells expressing a concentrated 
phenotype.
JLR takes place before JSRV Gag centrosomal targeting
Because our data suggest that Gag centrosom al targeting is an obligatory step in the 
JSRV replication cycle, we can thus arbitrarily divide the post-integration viral 
replication events as “pre-centrosom al” or “post-centrosom al” depending on whether 
they take place before or after Gag reaches the centrosome. Since JSG2A accum ulates 
in this region and cannot proceed any further, we could use it as a tool to determ ine the 
tim e frame in which JLR occurs. I f  JLR was a pre-centrosom al event, JSG2A w ould no 
longer accum ulate at the pericentriolar region in the presence o f  enJS56A l. On the 
contrary, if  enJS56A l blocked JSRV after centrosom al targeting, the intracellular 
distribution o f  JSG 2A  would not be affected. To address this, we transiently expressed 
JSG2A in HeLa cells either in single transfections or in cotransfections with enJS 56A l. 
At 24 hours post-transfection, cells were fixed, im m unostained and assessed by 
confocal m icroscopy. Cells with accum ulated perinuclear Gag staining were severely 
reduced when JSG 2A  was coexpressed with enJS56A l (Figure 36). The same results
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were obtained when this experiment was repeated using an HA-tagged version o f  
JSG2A (not shown). These results suggest that JLR takes place before JSRV Gag can 
reach the pericentriolar region.
Temporal distribution of M-PMV Gag proteins
As a whole, the results hitherto presented in this thesis suggest that JSRV Gag 
trafficking to the centrosome is an absolute requirement to complete the viral cycle. In 
the presence o f  enJS56A l, JSRV cannot reach this region because direct interactions 
between endogenous and exogenous Gag molecules abrogate centrosomal targeting o f  
the latter, resulting in JLR.
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Figure 36. JLR occurs before JSRV Gag reaches the centrosome.
Cells expressing the indicated plasmids were immunostained with a JSRV MA antiserum. 
Positive cells were classified as previously described (see text). The number of JSG2A- 
expressing cells with a concentrated phenotype is markedly reduced in the presence of 
enJS56A1 (vertical arrows) indicating that JLR takes place before JSRV Gag is targeted to the 
pericentriolar region.
Pablo R Murcia, 2007 Chapter 4, 123
HERV-IC and M -PM V  also belong to the genus Betaretrovim s. N evertheless, they 
follow  distinct m orphogenic pathw ays: the form er assem bles at the plasm a m em brane 
(Dewannieux, Harper et al. 2006; Lee and Bieniasz 2007) and the latter w ithin the 
cytoplasm  (Vogt 1997). Despite the apparent discrepancy betw een these two assem bly 
strategies, they m ust share com m on requirem ents since a single am ino acid m utation 
w ithin the CTRS o f  M -PM V transform s this virus into type-C (Rhee and H unter 1990). 
Although both JSRV  and M -PM V  are targeted to the centrosom e, assem ble in the 
cytoplasm , and require Gag m yristoylation to reach the plasm a m em brane (Rhee and 
H unter 1987; this work), it should not be assum ed that they fo llow  the exact same 
intracellular assem bly pathway. W hile in M -PM V, the CTRS is apparently responsible 
for directing Gag nascent m olecules to the centrosom e (Sfakianos, LaCasse et al. 2003), 
the presence o f  a CTRS w ithin JSRV has not been established. Hence the m ain 
determ inants for JSRV  intracytoplasm ic assem bly rem ain unknown. M oreover, our 
previous observations o f  intracellular virus-like particles in cells coexpressing 
enJS56A l and JSRV (M ura 2004), together w ith our results that indicate that JLR is a 
pre-centrosom al event, suggest that enJS56A l does not assem ble in  the pericentriolar 
region. Furtherm ore, results obtained by M anuela M ura in our laboratoiy show  that 
substitution o f  arginine 22 w ith a tryptophan in M -PM V Gag results in  partial restriction 
o f  w ild type virus, although not as m anifest as observed w ith  JSR21W  (M ura and 
Palm arini, unpublished).
W e w anted to determ ine w hether JSRV  and M -PM V shared a com m on intracellular 
distribution pattern by confocal m icroscopy. W e assessed w ild type M -PM V and two 
other m utants: a m yristoylation-defective M -PM V, where the am ino-term inal glycine 
was replaced by an alanine (M -PM V G2A) (Rhee and H unter 1987), and a “type-C ” M- 
PM V, where arginine 55 in the CTRS was replaced by a tryptophan as previously 
reported (M -PM V R55W ) (Rhee and Hunter 1990). Cells were transfected w ith the 
aforem entioned plasm ids, fixed at 48 hours post-transfection and im m unostained for 
fuither analysis by confocal m icroscopy. Besides the previously described diffuse, 
dispersed and concentrated phenotypes, we observed several cells w ith  Gag staining at 
the plasm a m em brane that were hence classified as such (PM ) (Figure 37). It should be 
noted that we could rarely observe cells w ith a  diffuse phenotype at 24 and 48 hours 
post-transfection. The PM  phenotype was som etim es m ixed w ith a dispersed staining in
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the cytoplasm, in w hich case cells were classified as dispersed + PM. A lthough in the 
present study we included a broader range o f  staining phenotypes, the intracellular 
distribution o f  w ild type M -PM V w as consistent w ith a previous study where positive 
cells were classified either as dispersed or concentrated, w ith  81% and 19% o f  cells 
exhibiting the form er and latter phenotypes, respectively (Sfakianos, LaCasse et al. 
2003). W e expected M -PM V G 2A  to display a sim ilar phenotype to the one observed 
w ith JSG2A, w ith the vast m ajority o f  cells exhibiting concentrated Gag staining in the 
perinuclear region, because w ild type M -PM V  is directed to  the pericentriolar region 
(Sfakianos, LaCasse et al. 2003) and disruption o f  the m yristoylation signal abrogates 
m em brane targeting but not assem bly (Rhee and H unter 1987). However, that w as not 
the case in four independent experim ents perform ed at late and early tim epoints (Figure 
38 and see below). M -PM V G 2A  displayed big positive fluorescent specks and lacked 
Gag staining at the plasm a m em brane, w hich was in agreem ent w ith previous electron 
m icroscopy observations (Rhee and H unter 1987). As predicted, the M -PM V  m utant 
bearing an altered CTRS (M -PM V R55W ) showed the highest num ber o f  positive cells 
w ith a plasm a m em brane phenotype (Figure 38). W hile these results confirm  previous
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Figure 37. Confocal microscopy of COS cells expressing Mason-Pfizer monkey virus.
Immunofluorescence was performed using a polyclonal antiserum towards M-PMV CA and a 
monoclonal antibody against gamma-tubulin, a centrosomal marker. Positive cells were 
classified according to their staining pattern (see text). Phenotypes are indicated on the top left 
of each row. Gag staining is in green, centrosomes in red, and nuclei in blue. White arrows 
indicate centrosomes (middle column) or Gag staining at the plasma membrane (right column). 
Scale bar is approximately 10 pm.
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studies (Rhee and Hunter 1987; Rhee and Hunter 1990; Sfakianos, LaCasse et al. 2003), 
the differences observed betw een JSRV and M -PM V Gag intracellular distribution may 
reflect distinct trafficking pathw ays during assembly.
We decided to perform  confocal experim ents at different tim epoints using the same 
constructs described above (Figure 39). At 2 hpt, few cells transfected with wild type 
M -PM V exhibited Gag positive staining and the m ajority o f  them  displayed a diffuse 
phenotype (Figure 39, top panel). A fter 4 hours, cells with dispersed intracellular 
fluorescence prevailed. Concentrated Gag staining was visible from early tim epoints but 
did not reach a m arked peak as observed with JSRV. The num ber o f  cells with a PM 
phenotype increased with tim e and peaked to 20%  at 24 hpt (Figure 39, top panel).
M-PMVR55WM-PMVG2AM-PMV
Figure 38. Confocal microscopy of COS cells expressing M-PMV, M-PMVG2A, and M- 
PMVR55W.
Transfected plasmids are indicated on the top left of each photograph. Most representative 
phenotypes are shown. Note the bigger size of the fluorescent dots in M-PMVG2A when 
compared with wild type M-PMV. Gag staining is in green and nuclei in blue. Scale bar is 
approximately 10 pm.
The m yristoylation-defective M -PM V G 2A  exhibited an unexpected tem poral 
distribution pattern as few cells displayed a concentrated phenotype throughout the 
whole tim efram e o f  the experim ent (the m axim um  observed value was 2% at 12 and 24 
hours), in m arked contrast with JSG 2A  (com pare the m iddle panels o f  Figures 32 and 
39). A nother particular (although predictable) feature o f  this m utant was the total lack 
o f  Gag staining at the plasm a m em brane, even at late tim epoints. The opposite was 
observed with the CTRS m utant M -PM V R55W , as the num ber o f  cells with a plasm a
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Figure 39. Kinetics of the intracellular distribution of M-PMV, M-PMVG2A and M- 
PMVR55W.
COS cells were transfected with the indicated plasmids and fixed at different times post­
transfection. After immunostaining, cells were quantified according to their Gag staining 
phenotype. Each bar represents a specific time-point at which cells were fixed, immunostained 
and classified according a predefined staining criterion (see text).
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m em brane phenotype accum ulated w ith tim e and reached a peak value o f  62%  at 24 
hours post-transfection (Figure 39, bottom  panel).
Overall, these data indicate that although JSRV and M -PM V assem ble w ithin the 
cytoplasm , they display different kinetics o f  intracellular trafficking (or the same 
determ inants influence Gag trafficking in a different m anner). First, despite the fact that 
both viruses exhibit a  concentrated phenotype, JSRV shows Gag accum ulation in  a 
perinuclear region at earlier tim epoints than M -PM V. M oreover, only JSRV  displayed a 
bottleneck pattern at th is stage, as the  num ber o f cells w ith concentrated phenotype 
increased and decreased in a reproducible tem poral fashion. Second, cells expressing 
JSRV do not show accum ulation o f  Gag staining at the plasm a m em brane, in contrast 
w ith cells transfected w ith  M -PM V  at late tim e points. These differences m ay reflect 
either distinct intracellular trafficking pathw ays or diverse kinetics along the same 
pathway. How ever, w hen the m yristoylation signal o f  these two viruses is disrupted 
they exhibit different phenotypes, as JSRV  accum ulates in the pericentriolar region and 
M -PM V rem ains m ainly dispersed w ith in  the cytoplasm.
A JSRV/HERV-K chimera exhibits different intracellular distribution than 
JSRV and escapes JLR
JLR appears to be the result o f  altered intracellular trafficking o f  JSRV Gag m olecules. 
In the presence o f  en J56A l, JSRV  can no longer reach the pericentriolar region, which 
seems to be a crucial event for the assem bly o f  type-B/D  Betaretroviruses. It is therefore 
plausible to speculate that changing the site o f  assem bly o f  JSRV by bypassing its need 
to reach the centrosom e could abrogate the sensitivity to JLR. H ERV -K  is a 
B etaretrovim s but assem bles at the p lasm a m em brane (D ew annieux, H arper et al. 2006; 
Lee and Bieniasz 2007). W e hence constructed a chim eric v im s in w hich H ERV -K  Gag 
replaced JSRV Gag (pCRU 5-H ERV -K G ag, Figure 40A). Transfection o f  pCRU5- 
HERV -K G ag in 293T cells resulted in the release o f  viral particles into the supernatants 
(Figure 40B). A  tagged version o f  this plasm id bearing the H A  epitope at the end o f  NC 
was also constructed. In confocal m icroscopy experim ents, cells expressing H ERV -K  
Gag displayed diffuse, dispersed, and plasm a m em brane phenotypes (Figure 40D), and
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only four cells out o f  the two hundreds counted exhibited concentrated Gag staining, 
consistent w ith a type-C  assem bly (Figure 40D). D isruption o f  the m yristoylation signal 
o f  pCR U 5-H ER V -K G ag resulted in a reduction on the num ber o f  cells w ith fluorescent 
signal at the plasm a m em brane and a concom itant increase in the dispersed phenotype 
(Figure 40C and D). W hen H ER V -K  Gag was coexpressed w ith either JSRV or 
enJS 56A l, we did not observe colocalization (Figure 41), w hich was consistent w ith 
distinct m orphogenic pathw ays. O ur antiserum  directed tow ard JSRV  M A did not 
im m unodetect H ER V -K  Gag in cells transfected neither in confocal m icroscopy (not 
shown) nor in w estern b lot (Figure 40B). Because the m ain trafficking signals that 
direct Gag to the site o f  assem bly lie w ith in  the M A dom ain, we m ade an HA -tagged 
HERV-IC/JSRV chim eric construct bearing HERV -K  M A  and the CA, N C  and p4 from 
JSRV (Figure 42A). In theory, this chim era could still m ultim erize w ith Gag m olecules 
from w ild type JSRV as they share the same CA (Ako-Adjei, Johnson et al. 2005), but 
because the dom ains that lie at the N -term inus o f  CA ai*e derived from  HERV-K, should 
assem ble at the plasm a m em brane, constituting a chim eric “type-C ” HERV-K/JSRV . 
This chim eric virus, referred to as p H V K maJS canc, was assessed by confocal 
m icroscopy and w estern blotting. The confocal phenotypes observed by 
p H V K maJS canc were rem iniscent o f  cells expressing H ER V -K  Gag (Figure 42 B). W e 
observed some degree o f  colocalization in cells expressing p H V K maJS canc and JSRV 
or enJS 56A l, but nevertheless m uch low er than the one observed w hen JSRV and 
enJS56A l are expressed in the same cell. W e could detect viral particles in supernatants 
o f  293T cells transfected w ith p H V K maJScanc by w estern blot, indicating that this 
chim eric virus was com petent for viral exit (Figure 42A). M oreover, this chim era was 
able to release viral particles even in the presence o f  enJS56A l (Figure 42A). Because 
p H V K maJScanc lacks the viral protease, it only releases im m ature Gag (Figure 42A). 
W hen an HA -tagged version o f  this construct w as cotransfected w ith JSRV or 
enJS 56A l, we could detect cleaved H A -tagged Gag in the supernatants, indicative o f  
some level o f  co-assem bly (Figure 42A, black arrow). Overall, these results show  that 
this chim era displayed an intracellular distribution resem bling a type-C  retrovirus, was 
com petent for viral release, coassem bled w ith JSRV (at least partially), and m ost 
im portantly, could escape JLR.
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Figure 40. Characterization of a chimeric HERV-K/JSRV construct (see legend on next 
page).
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(from previous page) pCRU5HERV-KGag is budding competent and exhibits Gag staining at 
the plasma membrane. (A) pCMV4JSRV and pCRU5HERV-KGag plasmid constructs. In 
pCRU5HERV-KGag the gag gene of HERV-K replaces JSRV gag and the frameshift required to 
express pol is disrupted, inhibiting Pol expression. JSRV genes are represented in black and 
HERV-K gag is represented in red. (B) Viral pellets of 293T cells transfected with HERV-K Gag 
or JSRV expression plasmids were resolved by SDS-PAGE an immunoblotted with anti-HERV- 
K Gag or anti- JSRV CA, as indicated below each panel. Note that the construct possessing 
HERV-K Gag lacks the viral protease and thus releases immature particles. There is no cross­
reaction between the two antisera. (C) Confocal microscopy of COS cells expressing HA-tagged 
versions of HERV-K Gag and a myristoylation defective mutant (HERV-KG2A). Anti-HA staining 
is displayed in red and nuclei in blue. The scale bar is approximately 10 pm. Characteristic 
phenotypes of each construct are shown. (D) Disruption of the myristoylation signal of HERV-K  
decreases Gag accumulation at the plasma membrane. COS cells expressing the indicated 
plasmids were immunostained, assessed by confocal microscopy and counted. HERV-K Gag 
accumulation at the plasma membrane is dramatically reduced when myristoylation is 
abrogated, with a consequent increase in cells with a dispersed phenotype.
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Figure 41. JSRV and enJS56A1 exhibit distinct intracellular distribution than HERV-K 
Gag.
Confocal microscopy of COS cells coexpressing an HA-tagged HERV-K Gag with either JSRV 
or enJS56A1. Anti-HA staining is displayed in red, anti-JSRV MA in green and nuclei in blue. 
White arrows indicate HERV-K Gag at the plasma membrane, which contrasts with the 
intracellular staining of JSRV and enJS56A1 Gag. Scale bar is approximately 10 pm.
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Figure 42. A budding-competent HERV-K/JSRV chimera is directed to the plasma 
membrane and can escape JLR (see legend on next page)
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(From previous page) (A) Left: schematic representation of JSRV and HVKMAJSCANC tagged 
constructs. The HA epitope (indicated as a red flag) was inserted at the C-terminal end of Gag. 
JSRV and HVKMAJSCANC are drawn as white and green boxes, respectively. Right: 
HVKMAJSCANC is budding-competent and escapes JLR. Viral pellets of 293T cells transfected 
or cotransfected with HVKMAJSCANC, enJS56A1, and JSRV expression plasmids were 
resolved by SDS-PAGE and immunoblotted with anti-HA. HVKMAJSCANC releases immature 
viral particles because it lacks the viral protease. Cotransfection of this chimera with JSRV or 
enJS56A1 results in partial Gag cleavage (horizontal arrow), indicating some level of 
coassembly. (B) Left: cells expressing HVKMAJSCANC display Gag accumulation at the 
plasma membrane resembling HERV-K. Right: cells expressing either HVKMAJSCANC or 
JSRV exhibit distinct intracellular distribution. Note that HVKMAJSCANC is observed near the 
plasma membrane and JSRV in the perinuclear region. JSRV is in green, HVKMAJSCANC in 
red, and nuclei in blue. (C) HVKMAJSCANC partially colocalizes with JSRV and enJS56A1. 
JSRV and enJS56A1 are in green, HVKMAJSCANC in red, and nuclei in blue. Scale bar is 
approximately 10 |xm.
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Discussion
JLR is the result o f  Gag-G ag interactions betw een JSRV and enJS56A l. N orm al 
targeting o f  JSRV  Gag is altered in the presence o f  the enJS56A l Gag and the viral 
cycle cannot be com pleted. Previous studies on M ason-Pfizer m onkey virus, a 
B etaretrovim s closely related to JSRV , have shown that an 18-amino acid sequence 
w ithin the M A dom ain, term ed the cytoplasm ic targeting/retention signal, directs Gag 
m olecules to a pericentriolar region, where assem bly is thought to occur (Rhee and 
H unter 1990; Sfakianos, LaCasse et al. 2003). M oreover, disruption o f  the 
m yristoylation signal affects trafficking but not assem bly o f  M -PM V (Rhee and Hunter 
1987).
In this chapter we could determ ine the tim efram e in w hich JLR occurs. W e 
chai'acterized the intracellular distribution o f  JSRV, enJS56A l and JSG 2A  in a tem poral 
fashion and showed that centrosom al targeting o f  Gag proteins is an obligatory step o f 
the JSRV cell cycle. These experim ents allowed us to divide the post-integration events 
that occur in the JSRV replication cycle as pre- and post-centrosom al. W e also 
determ ined that JSG2A , a m yristoylation-defective m utant, reaches the pericentriolar 
region, where it accum ulates and cannot proceed any further. Because JSG 2A  cannot 
reach the centrosom e in the presence o f  enJS 56A l, we concluded that JL R  takes place 
at a pre-centrosom al stage. In our experim ental setting, we determ ined that JSRV Gag is 
targeted to the pericentriolar region as early as 4 hours post-transfection. Frederick 
A rnaud’s observation o f  cells coexpressing JSRV and enJS56A l Gag displaying strong 
colocalization at 4 hours post-transfection supports this view  (see paper by Arnaud, 
M urcia and Palm arini attached to this thesis).
JSG 2A  proved to be a valuable tool in providing further insight on the m olecular 
biology o f  JSRV. W e could determ ine that JSRV Gag uses the dynein/dynactin 
m olecular m otor com plex to reach the centrosom e, as JSG 2A  can no longer accum ulate 
in this region and JSRV viral release is drastically reduced if  the dynein-m ediated 
transport is disrupted by overexpression o f  dynamitin.
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Gag m yristoylation constitutes a crucial signal for m em brane targeting (Rein, M cClure 
et al. 1986; Rhee and H unter 1987; Sw anstrom  and W ills 1997). A ccording to studies 
perform ed on M -PM V, viral particles assem ble in the pericentriolar region, where they 
colocalize with Env-containing vesicles and are further transported to the p lasm a 
m em brane by yet uncharacterized trafficking pathw ays that include recycling 
endosom es (Sfakianos and H unter 2003; Sfakianos, LaCasse et al. 2003). JSRV Gag 
colocalizes w ith recycling endosom es, and siRNA knockout o f  Rah 11 affects viral 
release (see paper by Arnaud, M urcia and Palm arini attached to this thesis). W e 
speculate that JSRV binding to its cognate vesicles m ay require proper interactions w ith  
lipid m em branes, and hence the lack o f  am ino-term inal m yristate in JSG 2A  could 
ham per its ability to engage in vesicular transport to the plasm a m em brane.
Based on previous studies on M -PM V , it has been proposed that type-B/D  retroviruses 
assem ble at the pericentriolar region, where nascent Gag m olecules are directed by the 
CTRS (Sfakianos, LaCasse et al. 2003). D ifferent lines o f  investigation from  our 
laboratory support the notion that assem bly o f  enJS56A l m ay not occur in this region. 
First, viral particles can be observed by electron m icroscopy in cells expressing 
enJS56A l despite the fact that its Gag staining is rarely observed close to the 
centrosom e by confocal m icroscopy (M ura 2004, and paper attached to this thesis by 
M ura, M urcia et al.). Second, the data presented here suggest that JLR is a  pre- 
centrosom al event, and virus-like particles have also been observed by EM  in cells 
coexpressing JSRV  and enJS56A l (M ura 2004). This is w hy we repeated the same 
tem poral confocal experim ents using a variety o f  M -PM V -based constm cts. The first 
noticeable difference w as the observation o f  Gag staining at the plasm a m em brane w ith 
wild-type M -PM V. W e have never observed JSRV (or enJS 56A l) Gag accum ulating at 
the plasm a m em brane, the only exception being the double L-dom ain m utant o f  JSRV 
described in the previous chapter. Such difference in Gag staining localization can be 
due to different budding rates (i.e. JSRV  budding out m uch faster than M -PM V), or to 
active targeting o f  M -PM V  to the plasm a m em brane for other reasons than budding.
On the other hand, we expected that disruption o f  the m yristoylation signal in M -PM V 
w ould result in Gag centrosom al accum ulation as observed for JSRV. To oui* surprise, 
M -PM V G 2A  did not exhibit any accum ulation in the perinuclear region. O n the
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contrary, the m ajority o f  M -PM V -expressing cells showed either diffuse or dispersed 
Gag staining and only a handful o f  cells displayed a concentrated phenotype. A 
previous report showed that the CTRS-pericentriolar targeting o f  M -PM V  Gag depends 
on dynein-m ediated transport along m icrotubules (Sfakianos, LaCasse et al. 2003). Our 
results suggest that Gag m yristoylation m ay com prise an extra requirem ent for M -PM V 
Gag m olecules to traffic to the centrosome. A n older report from  the same laboratory 
showed that a m yristoylation-defective M -PM V assem bles intracytoplasm ic type-A  
particles (ICAPS) (Rhee and H unter 1987). A lthough in that w ork Gag pericentriolar 
targeting was not assessed, the authors described that ICAPs were observed “deep in the 
cytoplasm ”. The aforem entioned reports (Rhee and H unter 1987; Sfakianos, LaCasse et 
al. 2003) apparently contradict our observations. I f  the centrosom e is the site o f  
assem bly for M -PM V (Sfakianos, LaCasse et al. 2003), and m yristoylation is required 
for M -PM V centrosom al targeting (this work), how  can the presence o f  ICAPs be 
explained for a m yristoylation-defective M -PM V (Rhee and H unter 1987)? A  simple 
explanation could be that M -PM V G 2A  assem bles in a different cell com partm ent. 
However, differences in the cell types used or the levels o f  expression achieved by 
different transfection protocols could also explain these apparently contradictory results. 
It is clear that further experim ental work should be done to address this issue.
To determ ine w hether the site o f  assem bly had a significant role in JLR, we constructed 
a HERV -K /JSRV  budding-com petent chim era (p H V K maJScanc)- W e chose HERV -K  
because it belongs to the genus Betaretrovirus (like JSRV ) and assem bles at the plasm a 
m em brane (Dewannieux, Harper et al. 2006; Lee and B ieniasz 2007). Since the 
trafficking signals that determ ine the site o f  assem bly are located at the N -term inal 
region o f  Gag, we replaced JSRV  M A and p i 5 w ith hom ologous sequences derived 
from  HERV-K. To allow  this chim eric Gag to interact w ith w ild type JSRV Gag, we 
kept CA, N C and p4 intact from  JSRV  (Ako-Adjei, Johnson et al. 2005). Hence, 
p HV K maJScanc was expected to be targeted to the plasm a m em brane but still to 
m aintain its ability to bind JSRV -derived Gag m olecules. By confocal m icroscopy this 
chim era exhibited Gag staining at the plasm a m em brane, sim ilar to the one observed 
w ith HERV-KH A-C, a budding-com petent plasm id bearing the full-length H ERV -K  
Gag that displays a type-C  phenotype. Notably, this budding-com petent chim era was 
able to “escape” JLR w hen coexpressed w ith enJS56A l. The observation o f  cleaved
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Gag in the supernatant o f  transfected cells suggested some degree o f  coassem bly (and 
therefore rescue) betw een H V K maJScanc and enJS56A L A lthough we did not quantify 
the intensities o f  the bands detected by w estern blot, it seem ed that our H ERV -K /JSRV  
chim era exhibited a higher degree o f  cleavage w hen expressed w ith JSRV (com pare the 
bands indicated w ith an arrow  in Figure 42A). W e experienced a sim ilar im pression 
w hen colocalization betw een p H V K maJS canc and JSRV or enJS56A l was assessed 
(com pare the upper and low er panels o f  Figure 42C).
These data m ay suggest that a  “type-C” JSRV escapes JLR because it can reach the site 
o f  budding by an alternative pathw ay that cannot be blocked by enJS56A L However, in 
the previous chapter we have shown that an intact enJS56A l Gag was required for JLR, 
and also that an enJS 56A 1 -derived construct bearing a m ajor deletion in the N C  but 
w ith an intact CA  was able to coassem ble w ith JSRVAPro in functional 
com plem entation assays. Those experim ents suggest that proper assem bly betw een 
enJS56A l and JSRV  is required for JLR  to occur. Hence, it is possible that enJS56A l 
camiot block our H ERV -K /JSRV  sim ply because their Gag m olecules cannot 
interact/assem ble appropriately.
D ata generated by M anuela M ura in our laboratory have show n that an M -PM V single 
m utant bearing an arginine to tryptophan substitution (M -PM V R22W ) like the one 
observed in enJS56A l partially blocks the exit o f  w ild-type M -PM V . Notably, w hen a 
second m utation that disrupts M -PM V  CTRS is added, the degree o f  the restriction 
observed is com parable to JL R  (M ura and Palm arini, unpublished). Based on those 
results and the ones presented in this thesis, we could speculate that because M -PM V 
can potentially assem ble w ithin the cytoplasm  or at the p lasm a m em brane (RJiee and 
Hunter 1987; Rliee and H unter 1990), a  blockade that takes place before centrosom al 
targeting could result in partial restriction as the virus possesses the infoim ation to 
assem ble at the plasm a m em brane. It is also feasible that coassem bly betw een M - 
PM V R22W  and w ild-type M -PM V abrogates the dom inant activity o f  the CTRS in a 
sim ilar way as the R55W  m utation does, and thus M -PM V is targeted to the plasm a 
membrane. This m odel should require some degree o f  interaction betw een Gag 
m olecules before centrosom al targeting. JSRV may, instead, have only one available
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pathw ay as the presence o f  a  CTRS has not been determ ined yet. I f  that is the case, 
blockade o f  centrosom al targeting could explain the dram atic effects o f  JLR.
It is appealing to thinlc that restriction m echanism s sim ilar to JLR can be extended to 
other retroviruses. A lthough encouraging results have been obtained in our laboratory, 
m ore experim ents are required to determ ine such possibility.
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Chapter 5
Recombinant expression and purification of JSRV 
matrix protein.
Summary
This section w ill cover the developm ent o f  a protocol for recom binant overexpression 
and purification o f  the m atrix protein o f  JSRV. This schem e was aimed as a  first step o f 
future high resolution structural studies (i.e. nuclear m agnetic resonance and/or 
crystallography) to characterize JSRV M A  at the atom ic level. G iven the crucial role 
played by JSRV M A in JLR, such studies could provide insight in the structural basis o f 
this late block. This part o f  the project was m ainly developed at Je ff U rbauer’s 
laboratory, located in the D epartm ent o f  Chem istry o f  the U niversity o f  Georgia.
Introduction
From  a structural point o f  view , retroviruses could be regarded as an arrangem ent o f  
proteins surrounding two m olecules o f  viral RN A  that constitute the central core o f  the 
viral particle, w hich is enveloped in a  cell-derived lipid coat. The inner architectural 
platform  o f the viral particle is provided by the polyprotein Gag, where the viral 
structural proteins constitute at least three linear dom ains that always follow  the same 
order (from amino to carboxy term inus): m atrix (M A), capsid (CA), and nucleocapsid 
(NC). During m aturation. Gag is cleaved at specific sites by the viral protease into the 
individual dom ains. M aturation is required for viral infectivity, takes place upon viral 
release, and does not change the spatial distribution o f  the cleaved products. W ithin the 
viral particle, the amino term inal end o f  Gag faces the viral envelope while the carboxy 
term inal end faces the centre o f  the particle.
Because Gag is the m ajor structural retroviral protein, its sole expression is sufficient to 
assem ble into virus-like particles. As described in previous sections, retroviruses can 
follow  two different m orphogenic pathways. The so-called type-C  viruses are targeted
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to the plasm a m em brane, where assem bly and budding take place concurrently. In 
contrast, for type-B and type-D  retroviruses, those two events are separated in tim e and 
space, as they first assem ble w ithin the cytoplasm  o f  the infected cell and then traffic to 
the plasm a m em brane to be released. Gag possesses different m otifs that are essential 
for viral particle trafficking and m orphogenesis, such as targeting o f  Gag m olecules 
tow ards specific subceilular sites (i.e. the pericentriolar region or the plasm a 
m em brane); interaction am ong Gag proteins, or viral budding once viral particles have 
been assembled. The spatio-tem poral tim ing o f  these events is finely regulated.
Regardless o f  the m orphogenic pathw ay followed, Gag m olecules m ust travel to the 
plasm a membrane. The trafficking signals responsible for m em brane targeting lie w ithin 
the m atrix protein, whose interaction w ith biom em branes is highly dynamic. D uring 
viral egress, M A associates w ith the inner leaflet o f  the plasm a m em brane (which will 
be then part o f  the viral envelope) during or after assembly. This association is transient, 
since M A dissociates from  the viral envelope w hen entering a target cell. M ost 
retroviruses possess two m em brane targeting signals w ithin M A: a positively charged 
surface area that interacts w ith the acidic heads o f  the m em brane phospholipids in an 
electrostatic fashion, and an am ino-term inal m yristate w hich partitions into the 
m em brane (Conte and M atthew s 1998). A lthough not all retroviral m atrix proteins are 
m yristoylated, they all bear a basic surface patch (M urray, Li et al. 2005). 
M yristoylation is a  cotranslational m odification that consists on the addition o f  a 
m yristate m oiety to the am ino term inal glycine o f  the Gag polyprotein. The 
hydrophobic nature o f  the fatty acid chain o f  the m yristate allows m yristoylated proteins 
to partition into the m em brane hydrocarbon. Structural studies perform ed on HIV M A 
suggest that exposure o f  the m yristate is regulated by an “entropie switch” that depends 
on the oligom eric state o f  the protein (Tang, Loeliger et al. 2004).
A nother im portant trafficking m o tif  that lies within M A is the cytoplasm ic/targeting 
retention signal (CTRS), first described in M ason-Pfizer m onkey vim s. This 18-residue 
long sequence is responsible for targeting M -PM V  Gag m olecules to the pericentriolar 
region, the proposed site o f  assem bly for this virus (Rhee and Hunter 1990; Choi, Park 
et al. 1999; Sfakianos, LaCasse et al. 2003). It has been shown that a single m utation 
w ithin the CTRS is sufficient to direct assem bly o f  M -PM V to the plasm a m em brane
Pablo R Murcia, 2007 Chapter 5, 141
(Rhee and Hunter 1990). Conversely, introduction o f  the M -PM V  CTRS sequence into 
M oM LV causes the latter to assem ble im m ature capsids in the cytoplasm  (Choi, Park et 
al. 1999).
Structural biochem ical studies on retroviral proteins are o f  utm ost im portance to 
understand m olecular events at to the atom ic level and to design specific tailored-m ade 
drugs that could block viral infections w ith m inim um  (or null) side-effects to the host. 
The structure o f  the entire Gag in any retrovirus has not been solved yet. How ever, 
several individual retroviral proteins (structural and non-structural) have been solved at 
the atom ic level by m eans o f  nuclear m agnetic resonance (NM R) or crystallography. To 
date, the three-dim ensional structures o f  the M A proteins o f  eight retroviruses have 
been solved: HIV, SIV, M TV, BLV, M -PM V, HTLV-II, RSV, and EIAV (M atthews, 
Barlow et al. 1995; Rao, Belyaev et al. 1995; Christensen, M assiah et al. 1996; 
M atthews, M ildiailov et al. 1996; Conte, K likova et al. 1997; M cDonnell, Fuslim an et 
al. 1998; Hatanaka, lourin  et al. 2002; Riffel, Flarlos et al. 2002).
In vitro expression o f  the endogenous locus enJS56A l blocks the release o f  Jaagsiekte 
sheep retrovirus. The m ain determ inant for JSRV late restriction is a conserved arginine 
residue in position 21 (R21) o f  the m atrix protein, w hich is naturally substituted by a 
tryptophan in enJS56A l (M ura, 2004; this work). G ag residue R21 is absolutely 
required for viral release, as replacem ent o f  this residue even w ith a conservative lysine 
abrogates viral exit (this work). D uring the retroviral cycle, JSRV  Gag is targeted to the 
eentrosome in a dynein-dependent fashion (see Chapter 4 and paper attached by 
Arnaud, M urcia and Palm arini). W e have shown in previous sections o f  this thesis that 
centrosom al targeting is a required step for efficient com pletion o f  the JSRV retroviral 
cycle. Expression o f  dynam itin (which disrupts the dynein-m ediated transport to the 
pericentriolar region) dram atically reduces the num ber o f  JSRV -positive cells w ith Gag 
accum ulation near the centrosom e as well as the am ount o f  virus in the supernatant o f  
transfected cells. D ata generated by Frederick Arnaud in our laboratory suggest that 
centrosomal targeting o f  JSRV Gag is altered in the presence o f  enJS 56A l, and the 
experiments described in this thesis indicate that such m islocalization is due to the 
form ation o f  chim eric m ultim ers/viral particles. Such Gag m ultim ers are form ed at a 
pre-centrosom al stage, ham pering their ability to reach the pericentrosom al region.
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Because in previous sections we studied JSRV and enJS56A l Gag proteins from  a 
functional perspective, we w anted to address the structural basis o f  their distinct 
biological behaviour. First, we tried to overexpress and purify recom binant Gag proteins 
o f  JSRV and enJS56A l to study their conform ation in solution. U nfortunately we did 
not m anage to express the entire Gag in  bacteria. The m ost probable reason for the lack 
o f  protein expression is that the codons o f  num erous am ino acid residues o f  enJS56A l 
and JSRV Gag are rare in several strains o f  bacteria. Therefore, we tried to overexpress 
the M A proteins o f  JSRV  and enJS56A l but we only m anaged to obtain good levels o f  
expression o f  JSRV  MA. Consequently, the w ork described in this section is focused 
solely on the M A  protein o f  JSRV.
Since residue R21 is located w ithin the M A and our data suggest that it is the m ain 
determ inant for JLR and centrosom al tai*geting, we m odelled the tertiaiy structure o f  
JSRV and enJS56A l M A based on the solved structure o f  the highly hom ologous 
m atrix protein o f  M -PM V (Conte, K likova et al. 1997). To pursue biophysical and 
biochem ical studies on JSRV  M A, we developed a m ethod for high level 
overexpression and high-yield/high purity  production o f  this protein. W e cloned JSRV  
M A into a com m ercially available vector bearing an inducible T7 prom oter for 
overexpression in Escherichia coli. The recom binant protein produced was then purified 
using a classical purification scheme. W e obtained a high yield o f  protein w ith an 
excellent level o f  purity. M oreover, heteronuclear N M R  spectra o f  isotopically labelled 
JSRV M A indicate that the purified protein is properly folded. On the other hand, native 
JSRV M A form ed crystals that diffracted at 1.4 Â (W illiam  Lanzilotta, personal 
com m unication). W e therefore developed a m odified purification m ethod for the 
production o f  JSRV  M A labelled w ith  selenom ethionine for crystallographic studies. 
Finally, we determ ined the secondary structure o f  JSRV M A by circular dichi'oism and 
the quaternary structure using analytical ultracentrifugation. The high yield/high purity  
m ethod that we developed for JSRV M A  production w ill allow  future high resolution 
studies either by N M R  or crystallography.
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Results
Modelling of the matrix proteins of JSRV and enJS56Al
A s aforem entioned, eight retroviral m atrix proteins have been hitherto solved. Despite 
their low  sequence sim ilarity, their thi'ee dim ensional structures display a rem arkable 
resem blance (Conte and M atthew s 1998; M urray, Li et al. 2005) since they all exhibit a 
com pressed fold with a  core o f  four a  helices (Muii'ay, Li et al. 2005). Because the 
m atrix proteins o f  JSRV and M -PM V display 39% identity and 64%  sim ilarity, we 
m odelled JSRV  M A  using M -PM V -M A  as a tem plate to estim ate the  spatial position o f  
arginine 21 and the possible structural consequences o f  an R  to W  substitution. There is 
only one available m odel o f  M -PM V M A at the protein databanlc o f  the Research 
Collaborative for Structural Bioinform atics (RCSB), w hich is based on N M R  data 
(Conte, K likova et al. 1997) and can be found at the RCSB PDB website under the PDB 
ID Ibax (http://w w w .rcsb.org/pdb/hom e/hom e.do). U nfortunately, this structure lacks 
the side chains o f  the proteins because the pdb file deposited is only an alpha-carbon 
trace. Therefore, we first added the side chains by using M ax Sprout, a w eb-based 
algorithm  for generating side chains coordinates from  a Carbon (alpha) trace 
(http://w w w .ebi.ac.uk/m axsprout/). To m odel JSRV M A, we used Sw iss-M odel, a web- 
based fully autom ated protein structure hom ology-m odelling server 
(http://sw issm odel.expasy.Org//SW ISS-M O DEL.htm l). Based on the m odel we 
obtained, R21 is positioned at the end o f  the first a -helix  o f  M A, in  an exposed area o f  
the protein (Figure 43). As described in Chapter 3, two other basic residues lie by R21 : 
K19 and H20. This basic patch m ay provide a favourable electrostatic charge to 
prom ote interactions betw een the m atrix protein (or Gag) and phospholipid m em branes 
at different stages o f  the retroviral replication cycle. The R  to W  m utation in Gag 
position 21 present in enJS56A l alters the net charge o f  the M A protein and 
furtherm ore introduces a  highly hydrophobic amino acid that could potentially change 
the thi'ee dim ensional conform ation o f  the protein.
Based on this m odel, we can hypothesize that the m utation observed in enJS56A l can 
result in structural changes that could affect the association betw een M A and
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phospholipid membranes, and/or the normal folding o f  the protein, thus altering the 
biological functions o f  MA/Gag and resulting in JLR.
JSRV
JL*^&V%
enJS56A1
Figure 43. Modelling of the putative JSRV and enJS56A1 MA proteins.
The tertiary structures of the matrix proteins of enJS56A1 and JSRV were modelled by using 
the Swiss Model Server (http://swissmodel.expasy.org). The matrix protein of MPMV (Protein 
Data Bank ID code IB A X [PDB] ) was used as a template (see text). Models are displayed in 
ribbons, and the W21 and R21 are displayed in green in a ball-and-stick format. The N and 0  
terminals are indicated. The first a-helix is shown in blue. Both models were derived from the 
amino-terminal 92-aa residues of JSRV and enJS56A1 Gag.
Cloning of the JSRV MA
We amplified by PCR the sequence corresponding to the amino-terminal 90 and 120 
amino acid residues o f  the JSRV MA using the pro viral clone JSRV21 (Palmarini, Sharp 
et al. 1999) as a template. PCR products were cloned into the Nhe\ and EcoRI sites o f  
pET-24b, a bacterial overexpression vector bearing the T7 promoter. We introduced a 
stop codon at the 3 ’ end o f  the cloned sequence to avoid fusion o f  the JSRV MA with 
the histidine tag included in pET24b. We decided not to include the histidine tag as a 
fusion protein with JSRV MA to avoid possible technical complications such as 
decreased expression, alteration in structure and/or function o f  the fused protein, and 
proteolytic tag removal with subsequent proteolysis o f  the target protein. Because
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overexpression o f  JSRV M A was excellent and we could further purify it using classical 
m ethods rapidly and with high yields, it was not at this stage beneficial to include an 
affinity tag.
Growth and overexpression of JSRV MA in E. coli
We transform ed the BL21(DE3) Escherichia coli cell strain with the expression plasm id 
construct for overexpression o f  JSRV M A (pET24bJSM A). To allow easy isotopic 
labelling, we used m inim al m edia in all our overexpression studies and growths. In our 
hands, the use o f  m inim al m edia was suitable to grow BL21(DE3) because it does not 
reduce the overall yield o f  the target protein. We assessed overexpression levels o f  
JSRV MA by analyzing aliquots o f  induced cultures at specific tim e intervals by SDS- 
PAGE. We observed high yield expression o f  JSRV M A at all tim e points (Figure 44), 
with the m ajority o f  the recom binant protein localized in the soluble fraction, even at 5 
hours post-induction. Based on this expression profile, we lim ited our induction tim e for 
JSRV MA to 3 hours. The predicted m olecular weight o f  JSRV M A (1-90) is 10563.3, 
and is in agreem ent with the m obility displayed in SDS gels (Figure 44).
W hole cells Soluble Insoluble
21 .5-
14.4- JSRV MA 
(10.5 kDa)
M U 1 3
Figure 44. Recombinant overexpression of JSRV MA.
Lysates of BL21(DE3) cells expressing JSRV MA were analyzed by SDS-PAGE (15%) at 
different post-induction times. Samples of whole cells, soluble and insoluble fractions were 
taken at 1, 3, and 5 hours after the addition of IPTG. M: molecular marker, U: uninduced. The 
band corresponding to JSRV MA is indicated with an arrow. A high yield expression of soluble 
JSRV MA was obtained.
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Purification of the JSRV MA
The purification protocol for JSRV  M A  was based on classical m ethods, starting with 
precipitation and rem oval o f  contam inant proteins w ith am m onium  sulphate, followed 
by ion exchange chrom atography and further h igh pressure liquid chrom atography 
(HPLC) (see Figure 45). Panels A, B, and D o f  Figure 45 depict the SD S-PAG E 
analysis o f  samples taken at each purification step. The whole procedure was perform ed 
at 4°C. Because the theoretical p i o f  JSR V  M A was 8.71 we used an ion exchange step 
w ith a  cation exchanger (SP Sepharose Fast Flow) equilibrated at pH 6 .8 . JSRV M A- 
containing fractions w ere subsequently subjected to HPLC, and high yield/high purity 
protein was recovered after this latter stage. Good levels o f  purification were achieved 
w ith the cation exchange chrom atography step (com pare the soluble fraction lanes in 
Figure 44 w ith the lanes corresponding to fractions 60 to 90 shown in Figure 45B), 
although some contam inant proteins still rem ained. The subsequent HPLC step proved 
successful to “clean” JSRV  M A o f  contam inants (Figure 45D), HPLC fractions 
containing JSRV M A  were pooled, dialyzed against buffer (50 m M  KCl, 50 m M  
KH 2PO 4, 1 m M  DTT, pH  6.2), and concentrated. JSRV M A kept its stability in solution 
during the whole purification schem e. The level o f  purification achieved w ith this 
protocol is shown in Figure 46. In three consecutive rounds o f  purification, we 
consistently obtained over 7 m g/m l o f  pure protein. The yield and purity  o f  the protein 
was not affected w hen we isotopically labelled JSRV M A w ith (not shown). We 
also labelled JSRV  M A  w ith selenom ethionine (SeM et) for crystallographic studies. 
SeM et-labelled JSRV M A purification schem e was essentially sim ilar to the one 
described above, w ith  the only difference that the second step o f purification was 
perform ed by using size exclusion chrom atography instead o f  HPLC. The purity and 
yield o f  the protein were not affected by this m odification, although the latter was 
m odestly reduced (to 5.5 m g/m l). The identity o f  the overexpressed purified protein was 
confirm ed by electrospray m ass spectom etry.
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Figure 45. Purification scheme of JSRV MA.
(A) 15% SDS-PAGE analysis of samples containing JSRV MA at various stages during the 
purification procedure. Lane 1, sonication pellet; lane 2, sonication supernatant; lane 3, salt 
precipitation pellet; lane 4, dialysis pellet; lane 5, dialysis supernatant. (B) SDS-PAGE analysis 
of selected samples taken after cation exchange chromatography. Fraction numbers are 
indicated above. (C) HPLC spectrum of pooled fractions obtained by cation exchange 
chromatography. Peak 1 corresponds to JSRV MA (D) SDS-PAGE of samples corresponding 
to peaks 1 and 2 in panel C.
Structural studies on the JSRV MA
We performed preliminary structural studies on JSRV MA. We used circular dichroism  
spectroscopy, nuclear magnetic resonance, and analytical ultracentrifugation to assess 
secondary, tertiary, and quaternary structure, respectively. The CD spectrum indicates 
that JSRV MA possesses an abundant percentage o f  a-helices. We calculated the 
approximate percentages o f  secondary structural elements using the CDSSTR algorithm 
o f  the DICHROWEB online server for protein secondary structure analysis (Lobley, 
Whitmore et al. 2002; Whitmore and Wallace 2004) (Figure 47A). Obtained results
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suggest that JSRV MA possesses 63% o f  helical structure, 4% o f  strands, 16% o f  turns, 
and 18% is unordered.
31
21.5
14.4
6.5 .—  JSRV MA
M U I R
Figure 46. Analysis of JSRV MA purification.
Samples containing JSRV MA at different stages of the purification scheme were analyzed by 
SDS-PAGE. M: molecular marker; U: uninduced whole cell lysate; I: induced whole cell lysate; 
P: purified protein. The band corresponding to JSRV MA is indicated with a horizontal arrow.
To further study JSRV MA using heteronuclear NM R methods, we assessed the 
presence o f  tertiary structure o f  the purified protein. We produced JSRV MA uniformly 
labelled with and acquired a variety o f  NM R spectra on samples under different 
conditions o f  temperature, pH, DTT and EDTA concentration. Figure 47B shows a 
two-dimensional '^N-HSQC spectrum o f  '^N-labeled JSRV MA. The spectrum is 
consistent with the presence o f  tertiary structure.
We also determined the quaternary structure o f  JSRV MA by performing sedimentation 
equilibrium experiments. Recombinant JSRV MA was purified as described above and 
analytical ultracentrifugation data were collected in triplicate at different concentrations 
and speeds. Velocity profiles were obtained and analyzed using the Ultrascan 6.2 
software package. The values recorded in three experiments were fitted to a single ideal 
species model and resulted in random residuals and a monomer molecular weight o f  
10,488 kDa (Figure 47C), which is in good agreement with the molecular weight 
derived from the protein sequence. Overall, JSRV MA seems to be folded and stable at 
fairly high concentrations, which makes it an attractive protein for high resolution 
structural studies using NMR.
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Figure 47. Structural studies on purified recombinant JSRV MA.
(A) Purified JSRV MA exhibits tertiary structure. Two-dimensional 15N-HSQC spectrum of 
isotopically labelled (15N) JSRV MA. (B) Purified recombinant JSRV MA behaves like single 
ideal species in solution. Equilibrium analytical ultracentrifugation data acquired at 280 nm for 
JSRV MA was fitted to a single ideal species model. (C) Circular dichroism spectrum of JSRV 
MA. This spectrum was acquired on a sample of 15N-labelled JSRV MA. The percentage of 
secondary structural elements of JSRV MA was calculated based on these data (see text).
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Discussion
The  m atrix protein o f  JSRV  possesses the m ain determ inants for Gag centrosom al and 
m em brane targeting. W e have previously shown that enJS56A l blocks JSRV  by 
ham pering the ability o f  the form er to reach the pericentriolar region. Notably, arginine 
21 is the m ain determ inant for both centrosom al tai'geting and JLR. A  thorough 
understanding o f  the structure o f  these two polyproteins w ill provide insight on JLR 
from a different angle than the biochem ical approach described in previous sections. 
M oreover, com parison o f  the three dim ensional structure o f  JSRV  and enJS56A l M A 
with solved retroviral m atrix proteins will also contribute to our laiowledge o f  basic 
aspects on retroviral biology. U nfortunately our attem pts to overexpress the whole Gag 
polyproteins or the enJS56A l M A  were fruitless despite the use o f  a variety o f  strains o f  
bacteria as well as different culturing and induction conditions (not shown). A nalysis o f  
JSRV and enJS56A l Gag coding sequences indicates that several amino acid residues 
are encoded by codons that are rare (or present in very low  am ounts) in such bacterial 
strains. A  possible w ay to overcom e this issue is by reconstructing the Gag coding 
sequences w ith codons that are preferentially used in bacteria (codon optim ization). 
Here, we have show n that JSRV M A can be considerably overexpressed using m inim al 
media, labelled isotopically and purified using classical schem es w ith  exceptional yield 
and high purity, w ithout the need o f  incorporating affinity tags. Structurally, JSRV M A 
exhibits a  high level o f  a-helices that are in agreem ent w ith other retroviral m atrix 
proteins (Conte and M atthew s 1998; M urray, Li et al. 2005). M oreover, JSRV M A  is 
stable w ith seem ingly w ell-defined tertiary structure and does not aggregate at the high 
concentrations required for N M R  studies. These results encourage future functional and 
high resolution structural studies that could pave the way for the design o f  m olecules 
w ith antiretroviral activity.
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Conclusions and general discussion
The aim o f  this final chapter is to discuss the data presented in this thesis and their 
implications. Retroviruses have been studied during the years for different reasons and 
under different perspectives. In the early days o f  retrovirology, retroviruses were 
studied because o f  their ability to cause cancer and to unravel the m echanism s o f  
carcinogenesis. Even today we look for retroviruses as aetiological agents o f  tum ours in 
several species (M urcia 2002; Paul, Q uackenbush et al. 2006; Bindra, M uradrasoli et al. 
2007; De las Heras, M urcia et al. 2007). On the other hand, the AIDS epidem ic and the 
discovery o f  HIV  over 20 years ago resulted in the investm ent o f  a vast am ount o f  
resources w ith the aim  o f  developing either an efficient therapy or a vaccine for this 
devastating disease. As a consequence, HIV is probably the m ost thoroughly studied 
virus in science history and the w hole field o f  retrovirology has benefited from  this. 
How ever, the scientific and social challenge posed by HIV/AID S is far from  being over.
Retroviruses have not been studied solely as causative agents o f  diseases. Because o f  
their unique replication strategy that includes integration into the host’s genome, 
endogenous retroviruses (ERVs) have heavily colonized every animal species (G ifford 
and Tristem  2003; W eiss 2006). Thus, ERVs can be used as D N A  fossils to study their 
ow n evolution, the coevolution betw een virus and host, and the evolution o f  the host p e r  
se (Coffin 2004).
Retroviruses have been also successfully used as m olecular tools. The ability o f  reverse 
transcriptase to synthesize cDN A revolutionised m olecular biology. Despite some 
recent problem atic experiences (H acein-Bey-A bina, Von Kalle et al. 2003), retroviral 
vectors are still a  prom ising tool for gene therapy.
This thesis focused specifically on the interaction betw een endogenous and exogenous 
retroviruses. From  a traditional perspective, the host responds to a viral infection by 
m ounting and im m une response that, depending on the cells and cytokines involved, 
can be classified as innate or acquired. In recent years however, a new  kind o f  im m unity
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against viral infections has been proposed. This “intrinsic im m unity” com prises a 
collection o f  genes that encodes for restriction factors that have the ability to block viral 
replication. In contrast w ith im m une responses, which generally take place after viral 
infection, genes involved in intrinsic im m unity are constitutively expressed (Bieniasz 
2004). H ost and tissue-specific expression o f  such factors are fundam ental in 
determ ining viral tropism . Several antiretroviral m olecules have been discovered, such 
as A P 0B E C 3G , T R IM 5a, and F v l and it is likely that m any m ore w ill be discovered in 
the future. Some o f  these restriction factors are cellular in origin while others are 
derived from  ERVs. Thus, in some cases ERVs have been co-opted by the host against 
incom ing retroviral infections.
Sheep are an exceedingly interesting m odel system  to study the evolutionary interplay 
betw een exogenous and endogenous retroviruses in a natural setting. The exogenous 
and pathogenic JSRV /EN TV  coexist w ith at least 27 copies o f  enJSRV s that are highly 
expressed in the sheep genital tract (Palm arini, Hallw irth et al. 2000; Carlson, Lyon et 
al. 2003; DeM artini, Carlson et al. 2003; Palm arini, M ura et al. 2004). enJSRV s can be 
taken as an exam ple o f  the evolutionary sym biosis betw een ERVs and host. W ork done 
in our laboratory has provided evidence on the necessity o f  the expression o f  the env 
genes from  enJSRV s during placental m orphogenesis in sheep (Dunlap, Palm arini et al. 
2006). In this particular case, enJSRV s have becom e assim ilated to  the extent o f  playing 
specific roles in the reproductive physiology o f  the host species. On the other hand, 
because sheep is a candidate species for xenotransplantation strategies based on a 
“sheep-hum an” chim era, the existence o f  enJSRVs should also be taken into 
consideration (Alm eida-Porada, Porada et al. 2004; Narayan, Chase et al. 2006). In this 
proposed system , hum an stem  cells are inoculated into foetal sheep, thus the potential 
risk o f  transm itting xenotropic viruses that could cause iatrogenic zoonoses should be 
evaluated.
The fact that the great m ajority o f  ERVs do not possess exogenous counterparts 
supports the view  o f  endogenous retroviruses playing a protective role against related 
exogenous infections. ERVs can block infection o f  exogenous viruses by different 
m echanism s, the m ost com m on being receptor interference. Fv-1, another ERV-derived 
restriction factor that acts at a  post-entry stage has also been described. A lthough it has
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no t been form ally proved, such genetic traits could contribute to the elim ination o f  the 
virus from  the species.
The work presented in this thesis has aim ed to better understand the m olecular basis o f  
JLR. In our experim ental setting we used a variety o f  in vitro  approaches that included 
the construction o f  several JSRV  and enJS56A l m utants bearing either deletions or 
amino acid substitutions. Chim eras betw een JSRV and H um an endogenous retrovirus-K  
(HERV-K) w ere also constructed. Because JLR  blocks viral exit, the experim ents 
perform ed in this thesis m ainly consisted on transfection (and cotransfection) o f  cell 
lines w ith virus-expressing plasm ids follow ed by w estern blot analysis o f  cell lysates 
and viral pellets obtained from supernatants. W ithin this experim ental approach, we 
perform ed assays to address interference, interaction, and com plem entation betw een 
Gag m olecules. W e also perform ed confocal m icroscopy to study intracellular 
distribution (and its kinetics) and colocalization o f  the tested constructs. Finally, for 
future studies aim ed to resolve the tridim ensional structure o f  the JSRV m atrix protein 
either by crystallography or nuclear m agnetic resonance (NM R), we developed a 
protocol for overexpression and purification o f  recom binant JSRV  MA. It should be 
also m entioned that we did not succeed in expressing JSRV and enJS56A l Gag proteins 
in different strains o f  bacteria for in vitro  assem bly experim ents (not shown).
The studies presented here cover relevant biological aspects o f  the JSR V /enJS56A I 
biology, and how  their sim ultaneous expression w ithin the sam e cell results in JLR. 
First, we functionally characterized JSR V  and enJS56A l Gag proteins, and in doing so 
we provided basic inform ation about JSR V /enJS56A l biology that had not been 
previously available. For exam ple, w e determ ined the identity and boundaries o f  the 
individual proteins that constitute Gag. W e also identified and assessed the function o f 
well loiown retroviral dom ains such as late (L) and m em brane (M) domains. M oreover, 
we determ ined that JLR is not due to a transdom inant M or L dom ain phenotype and 
provided evidence that supports the necessity o f  an intact enJS56A l Gag to block 
JSRV. In addition, w e show ed that arginine 21 w ithin the m atrix protein (which is 
highly conserved am ong different m em bers o f  the genus B etaretrovim s) is required for 
viral exit, and that non-conservative substitutions o f  this residue w ithin JSRV result in 
transdom inant m utants. W e also proposed a m odel for JSRV  intracellular kinetics that
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includes dynein-dependent centrosom al targeting as an obligatory step in the viral cycle. 
W ithin this m odel, m yristoylation is required for the transport o f  viral particles to the 
plasm a m em brane but only after JSRV  has reached the centrosom e. W ith regard to JLR, 
the experim ental data generated in this thesis, together w ith com plem entary results 
obtained in our laboratory by Frederick A rnaud suggest that enJS56A l blocks JSRV 
before the latter reaches the centrosom e. enJS56A l and JSRV Gag m olecules seem ingly 
assem ble into chim eric m ultim ers or viral particles that cannot reach the pericentriolar 
region and are therefore unable to com plete the viral cycle. These chim eric particles 
appear to form  m icroaggregates that are further degraded by the proteasome. Finally, a 
chim eric construct bearing the m atrix protein o f  H ERV -K  (a type-C  Betaretrovim s), but 
the capsid, nucleocapsid and p4 o f  JSRV, was targeted to the plasm a m em brane and 
displayed reduced susceptibility to JLR.
A  key point to address in this section is the relevance o f  the w ork presented here. In our 
opinion, the im portance o f  JLR can be considered from different perspectives. From  an 
evolutionary point o f  view, JLR constitutes a  further exam ple o f  the interplay or “arm s 
race” that takes place betw een virus and host. As m entioned above, endogenous 
retroviruses arise from  exogenous infections o f  the germ  line, or, in rare cases they can 
also originate by retrotransposition. W hen enJS56A l was originally isolated and 
characterized, it was estim ated that it integrated into the sheep genome betw een 0.9 to 
1.8 m illion o f  years ago (Palm arini, H allw irth et al. 2000). Based on the results 
presented in this thesis, we hypothesized that the exogenous vim s from  which 
enJS56A l derives (that integrated into the germ line) m ust have possessed an arginine in 
position 21 o f  the m atrix protein in order to be able to exit from  infected cells. This 
assum ption was firstly based on the fact that even a conservative m utation (R21K) 
abolished the capacity o f  JSRV  to be released (see Results section in chapter 3), and 
secondly because R21 is highly conserved among different m em bers o f  the genus 
B etaretrovim s  (see Figure 18A). Therefore, the R  to W  substitution displayed by 
enJS56A l in position 21 m ust have taken place after entering the germ  line. A  recent 
study perform ed in our laboratory further supports this view: while enJS56A l displays 
W21 in all dom estic sheep tested so far, sam ples obtained from  the Argali sheep {Ovis 
ammon, a w ild sheep) exhibited enJS56A l as a provirus bearing either R21 or W 21. 
M oreover, all the samples exam ined from  other w ild sheep species, such as Ovis
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nivicola, Ovis Canadensis, and Ovis dalli, present the non-interfering R21 w ithin 
enJS56A l M A (Arnaud, Caporale et al. 2007), indicating that the dom inant-negative 
version o f  enJS56A l m ust have been positively selected before or after dom estication, 
approxim ately 9000 years ago (Ryder 1983). W e reason that dom estication produced 
ecological changes to the host’s environm ent that favored the spread o f  infectious 
diseases and hence the selection o f  resistant anim als. Because anim als were forced to 
live in dense populations that had not existed before, it is likely that the incidence o f  a 
disease associated to a JSRV -related virus o f  the tim e rose. M orbidity and m ortality ( if  
any) m ust have exerted selective pressure for anim als bearing an interfering enJS 56A l, 
as they would have been protected against such disease. A  further piece o f  evidence 
supports this hypothesis: another enJSRV , term ed enJSRV -20, has been recently 
isolated. This endogenous JSRV , like enJS 56A l, harbors W21 w ithin the m atrix protein 
in all sam ples so far exam ined from  dom estic sheep. enJSRV -20 effectively blocks 
JSRV exit in cotransfection experim ents sim ilar to the ones described in this thesis 
(Arnaud, Caporale et al. 2007). M oreover, this locus displays a parallel polym orphism  
to the one observed in enJS56A l as enJSRV -20 also possesses either R21 or W21 in 
A rgali sheep. How ever, Ovis nivicola, Ovis canadensis and Ovis dalli lack enJSRV -20 
(Arnaud, Caporale et al. 2007). The fact that arginine 21 was found substituted by the 
dom inant-negative tryptophan in two pro viruses highlights the evolutionary im portance 
o f  this specific codon.
W ithin the context o f the aforem entioned “arms race” betw een virus and host, the 
em ergence o f  anim als bearing transdom inant-interfering enJS56A l and enJSRV -20 
m ust have exerted selective pressure for the appearance o f  exogenous counterparts that 
could escape JLR. Exogenous viruses could have used different ways to escape 
transdom inant enJSRVs. A  possible strategy for exogenous viruses could be the 
developm ent o f  a different tissue tropism  than the one exhibited by the interfering 
endogenous viruses. I f  the LTR  o f  the transdom inant virus can only be active in specific 
tissues, a given JSRV -like virus could avoid JLR by replicating in tissues where 
interfering ERVs are absent. This view  is supported by the high level o f  sequence 
identity observed betw een JSRV  and enJS56A l within the coding regions, in  contrast 
w ith the m uch lower levels o f  sim ilarity at the LTR level (Palm arini, H allw irth et al. 
2000). The fact that enJSRV s are highly expressed in the genital tract o f  the ewe.
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whereas JSRV expression reaches high levels in tum or cells in the lungs let us speculate 
that JSRV m ay have adopted this strategy. (Spencer, Stagg et al. 1999; Palm arini, D atta 
et al. 2000; Palm arini, Gray et al. 2001; Spencer, M ura et al. 2003). A lternatively, since 
JLR is saturable (JSRV can be released in the presence o f  enJS56A l w hen its level o f 
expression is 15 tim es higher than enJS56A l [Mura 2004]), an exogenous JSRV -related 
virus w ith a m uch higher level o f  expression than enJS56A l can overcom e JLR simply 
by outnum bering the quantity o f  interfering Gag m olecules (this could be achieved by 
developing a m ore efficient promoter). A nother strategy to escape this restriction could 
be by establishing highly specific Gag-Gag interactions w ith such elevated affinity that 
only identical m olecules will assem ble into viral particles, hence excluding the 
transdom inant Gag m olecules from  form ing chim eric particles o f m ultim ers. Such 
strategy would possibly require some am ino acid substitutions at the level o f  the capsid 
protein. A third possibility w ould include an exogenous, JSRV -related vim s that was 
targeted to a different intracellular com partm ent than enJS56A l, for exam ple, by 
assem bling at the plasm a m em brane (see below). Finally, another possible w ay to 
overcom e JLR could be by selective shutting o ff o f  the expression o f  interfering 
endogenous viruses. Obviously, we do not rule out other possible strategies to escape 
JLR.
Curiously, a further example o f  selective fitness betw een endogenous and exogenous 
JSRV s has recently been reported: enJSRV -26 has been isolated from a single Texel 
sheep among m ore than 330 sheep exam ined (including direct relatives) (Arnaud, 
Caporale et al. 2007). enJSRV -26 can escape JLR w hen cotransfected either with 
enJS56A l or enJSRV -20 (Arnaud, Caporale et al. 2007). Results obtained in that study 
argue that enJSRV -26 derives from  an exogenous retrovirus that integrated into the host 
w ithin the last 200 years. Possibly, enJSRV -26 is the result o f  a  unique event infecting 
the single sheep where it has been detected. This finding raises the possibility that an 
exogenous counterpart o f  enJSRV -26 m ay be circulating w ith unknow n ( if  any) 
pathogenic effects. A  sim ilar situation has been recently docum ented w ith the koala 
retro v im s (KoRV) that is currently in the transition betw een an exogenous and an 
endogenous elem ent (Tarlinton, M eers et al. 2006). H ow  does enJSRV -26 escape JLR? 
Further studies are needed to address this question and are currently under way.
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Overall, JSRV , enJS 56A l, enJSRV -20 and enJSRV -26 are exam ples o f  the 
evolutionary interplay that takes place betw een retroviruses and host, and how  the 
environm ent affects this interaction. It is notew orthy that two endogenous pro viruses 
(enJS56A l and enJSRV-20) have acquired an analogous m utation (R21W ) in two 
tem porally distinct events. A lthough this fact m ay suggest selective pressure over this 
specific codon (Bush 2001), the high level o f  sim ilarity betw een enJS56A l and 
enJSRV -20 and the identity o f  their 3 ’ flanlcing region m akes the presence o f  a 
transdom inant Gag in enJSRV -20 m ore likely due to a  gene conversion event rather 
than independent m utations (Arnaud, Caporale et al. 2007). Further supporting this view  
is the fact that in both proviruses the observed substitution was arginine to tryptophan, 
and we show ed that W21 is not strictly required for JLR. In general, few  codons per 
gene are positively selected and the residues they encode are usually  located in distinct 
positions w ithin the protein that are generally exposed to external selective forces. 
Interestingly, the m odeling o f  JSRV  m atrix that we showed in Figure 43 shows that R21 
is likely located in an exposed loop, where it m ay interact w ith other proteins.
W hat is the function o f  R21? W hat is the importance o f  an arginine in that position for 
the overall topology o f  JSRV Gag? Structural and biochem ical studies are needed to 
address this question, and in this w ork we developed a protocol for recom binant 
expression and purification o f  the JSRV m atrix protein that will pave the way to solve 
its tridim ensional structure. However, it should be considered that the folding o f  the 
m atrix in the context o f  the Gag polyprotein m ay be different from  the tertiary structure 
o f  M A once it has been released by the viral protease. Since JLR  takes place before 
m aturation, it w ould be probably m ore appropriate to determ ine the structure o f  the 
whole JSRV  Gag and then establish how  M A is folded w ithin this structural frame. 
Alternatively, studies to determ ine the conform ation o f  JSRV and enJS56A l Gags in 
solution could also provide clues on the im portance o f  R21 for the overall folding o f  the 
protein. Unfortunately, no full retroviral Gag protein has been solved to date due to 
technical constrains (Gag proteins are too dynam ic to crystallize and too big for N M R  
studies). However, m any individual dom ains have been determ ined either by 
crystallography, N M R, or both, and we consider that solving the structure o f JSRV M A 
will still provide valuable data. Therefore, at the present tim e we can only speculate
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that R21 is part o f  a functional trafficking dom ain unrelated to the ones so far described 
(M, L, and I domains).
From  a functional perspective, we show ed that R21 is necessary for JSRV to reach the 
pericentrosom al region. This observation is linlced to another relevant aspect regarding 
JSRV biology: while dissecting the m olecular m echanism s o f  JLR, we determ ined the 
nature and chronology o f  d istinct events o f  the JSRV replication cycle. W e show ed that 
JSRV m ust get to the pericentriolar region in order to com plete its cycle. A lthough we 
do not Icnow why Gag traffics to the centrosom e, we established that this targeting is 
dependent on the presence o f  R21 and dynein-m ediated transport. Based on this finding 
we arbitrarily divided JSRV  late events into “pre-centrosom al” and “post-centrosom al” . 
Once the centrosom al region has been reached, JSRV m ust travel to the p lasm a 
m em brane. W ork done in our laboratory indicates that this specific step requires an 
intact endocytic pathw ay and slow  recycling endosom al trafficking. W e also showed 
here that m yristoylation is absolutely necessary to reach the plasm a m em brane, as a 
m yristoylation-deficient JSRV is defective for viral exit and accum ulates at the 
pericentriolar region. O ur results seem  to indicate that the m yristoyl group o f  JSRV  Gag 
is im portant for the interaction w ith m em branes o f  the recycling endosom es instead o f  
the plasm a m em brane as for type-C  assem bly. M oreover, our findings suggest that in a 
norm al cycle, JSRV Gag m olecules assem ble -o r  at least interact w ith each other and 
form  m ultim ers- before they are targeted to the centrosom e, because JLR requires 
interaction betw een Gag m olecules and takes place before centrosom al targeting. M- 
PM V, another Betaretrovim s, has been proposed to assem ble at the m icrotubule 
organizing center (M TOC) (Sfakianos, LaCasse et al. 2003). Because the M TO C is 
located at the pericentriolar region, and M -PM V Gag is targeted to this subcellular 
com partm ent via dynein-m ediated transport depending on intact m icrotubules like 
JSRV, we assayed the intracellular kinetics o f  JSRV, enJS 56A l, and M -PM V. Based on 
the results we obtained, and despite their close relatedness and targeting to sim ilar 
com partm ents, JSRV and M -PM V , display different intracellular kinetics and m oreover, 
w hen m yristoylation is abrogated they exhibit different intracellular distribution. It is 
hence possible that Gag m olecules from  JSRV and M -PM V  bind different intracellular 
proteins during assem bly and/or trafficking. On the other hand, it has been previously 
show n that M -PM V possesses an 18-amino acid sequence w ithin the M A dom ain,
Pablo R Murcia, 2007 Chapter 6, 159
regarded as cytoplasm ic targeting/retention signal (CTRS). The CTRS acts as a 
dom inant signal for the assem bly o f  intracytoplasm ic im m ature capsids (Rhee and 
Hunter 1990; Choi, Park et al. 1999). Substitution o f  R55 w ith a W  causes disruption o f 
the CTRS and an M -PM V virus bearing this m utation assem bles at the plasm a 
m em brane (Rhee and H unter 1990). A lthough we do not Imow w hether JSRV bears a 
CTRS, we believe that the R21W  m utation that causes JLR is different from  a CTRS 
disruption simply because enJS56A l and JSR21W  (a JSRV single m utant bearing an 
R21W  substitution) do not assem ble at the plasm a m em brane nor do they exit (M ura 
2004; this work). M anuela M ura in our laboratory observed that m utation o f  R22 to W  
in M -PM V partially abrogates viral exit o f  w ild type virus, although not as significantly 
as enJS56A 1 -m ediated block (M ura and Palm arini, unpublished). However, an M -PM V 
double m utant bearing a double m utation (R22W  and R55W ) effectively blocks the 
release o f  M -PM V to sim ilar levels as observed by JLR (M ura and Palmarini, 
unpublished). A possible explanation for this extra requirem ent is that because M -PM V 
can follow  two different m orphogenic strategies, a  dom inant-negative M -PM V Gag 
m ust block both pathw ays to be effective, and therefore a double m utation is necessary. 
A n alternative explanation from  a structural point o f  view  could be based on the fact 
that both R22 and R55 are located in exposed loops o f  M -PM V m atrix (Conte, K likova 
et al. 1997) and hence it is feasible that they cooperate for the specific overall topology 
(or electrostatic charge) required for binding either cellular paitners or m em brane 
phospholipids.
H ow  does JLR occur? Based on the data presented here and other studies perform ed in 
our laboratory, we postulate that JSRV  and enJS56A l Gag m olecules interact in trans at 
a  pre-centrosom al stage, giving rise to chim eric particles or m ultim ers. These 
JSR V /enJS56A l chim eras cannot reach the pericentriolar region and form 
m icroaggregates that are degraded by the proteasom e (see paper by Arnaud, M urcia and 
Palm arini attached to this thesis), failing to complete the retroviral cycle. Because 
addition o f  proteasom e inhibitors does not abrogate JLR but results in the form ation o f  
bona fid e  aggresom es bearing JSRV and enJS56A l Gag, we think that JLR affects 
trafficking o f  Gag rather than targeting proteasom al degradation in an active fashion. 
Although cells transfected w ith enJS56A l alone or w ith enJS56A l and JSRV exhibit 
intracytoplasm ic viral particles w ithout m ajor moi*phologic alterations (M ura 2004), it is
Pablo R Murcia, 2007 Chapter 6, 160
feasible to thinlc that enJS56A l/JSR V  chim eric particles (or m ultim ers) are sensed by 
the cell as aggregates o f  m isfolded protein. W hen the intracellular am ount o f  protein 
aggregates/ m isfolded proteins exceeds the capacity o f  the proteasom e, the cell responds 
by form ing aggresom es (Johnston, W ard et al. 1998).
Since deletion o f  the m ajor hom ology region (M HR) o f  enJS56A l abrogates its ability 
to restrict JSRV , we speculate that proper assem bly betw een JSRV  and enJS56A l is 
required for JLR to occur. M oreover, enJS56A lA N C 2, a construct bearing an in-fram e 
deletion in N C  and a functional protease, was able to co-assem ble into exit-com petent 
chim eric viral particles and com plem ent JSRVAPro, a budding-com petent JSRV that 
lacks the viral protease. W e also evaluated the possibility that differential intracellular 
targeting could provide m eans for JLR-escape variants and hence constructed a HERV- 
K/JSRV chim era that is targeted to the plasm a m em brane. This chim eric virus was able 
to release viral particles in  the presence o f  enJS56A l. How ever, this result should be 
considered cautiously. A lthough it is tem pting to conclude that such “type-C ” chim era 
escapes JLR by bypassing the obligatory centrosom al step, it could simply reflect the 
lack o f  proper interaction/assem bly betw een H ERV -K /JSRV  and enJS56A l Gag 
m olecules required for JL R  that was shown for enJS56A l ANC2.
Is JLR occurring in v ivo l  A lthough the existence o f  OP A  and the circulation o f  JSRV  in 
flocks all around the w orld w ould indicate that JLR  is not taking place in vivo, certain 
aspects about the natural progression o f  the disease should be initially considered. First, 
OP A is a very slow  disease: it has been shown that in a natural setting, only few 
infected sheep develop OP A  during their com m ercial lifespan (Caporale, Centoram e et 
al. 2005). Second, JSRV  is m ore easily detected in peripheral leucocytes and lym phoid 
organs than in the lungs o f  infected anim als. Based on this observations, a m odel on 
disease progression has been proposed in which the form er tissues constitute the 
principal reservoir o f  virus, and infection o f  lung cells is opportunistic (Caporale, 
Centoram e et al. 2005). W hat triggers OP A, as well as the cause o f  the long incubation 
period o f  the disease rem ains to be elucidated, but it is appealing to think that JLR  is 
one possible factor that keeps the spread o f  the virus “on hold” w ithin the infected 
animal. Further in vivo studies are required to address this issue. H ow ever and despite 
these speculations, the natural horizontal transm ission o f  JSRV clearly shows that JLR
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(even if  it occurs in vivo) can be overcom e. A  possible reason for this, as described 
above, could be that enJS56A l (and enJSRV -20) are either expressed at very low  levels 
or not expressed at all in the lungs. Alternatively, it is feasible that transdom inant 
enJSRVs are expressed in the same tissues as JSRV but they could be “diverted” by 
other Gag m olecules derived from  non-interfering, budding-com petent enJSRVs. 
Finally, evidence on the evolution o f  en JSRV -like exogenous variants has been found 
w ith the isolation o f  the aforem entioned enJSRV -26, w hich escapes JLR in 
cotransfections (Arnaud, Caporale et al. 2007).
From  a therapeutic perspective, JLR  can provide insight for the developm ent o f  novel 
antiretroviral strategies. Such strategies w ill include the design o f  OPA-resistant 
transgenic sheep. These anim als w ould harbour a transdom inant gag  as a transgene that 
w ould be selectively expressed in specific cell types, for exam ple C lara cells and type II 
pneum ocytes. This am bitious project is actually being carried out by our laboratory 
together with other groups that include the Roslin Institute. W ith regard to therapeutics, 
new  antiretroviral drugs based on JL R  could target a  distinct stage o f  the viral cycle, 
although it is possible that such drugs could only apply to vim ses closely related to 
JSRV , like M -PM V (see below). At the present tim e, highly active antiretroviral therapy 
(HA ART) is the paradigm  treatm ent for HIV infection. HA ART consists on a cocktail 
o f  individual antiretroviral drugs that block reverse transcription, m aturation, and viral 
fusion (Temesgen, W arnke et al. 2006). Since its introduction in 1996, this com bined 
therapy has provided considerable progress in the treatm ent o f  HIV-patients, the 
sim ultaneous targeting o f  m ultiple stages being crucial for the success o f  this treatm ent. 
Because JLR acts on assem bly, this restriction factor provides another “susceptible” 
stage for retroviral blockade that effectively works in vitro. A lthough at first sight it 
could be argued that sheep Betaretroviruses are not closely related to HIV and hence 
JLR does not constitute a valid m odel for developing novel anti-HIV drugs, distantly 
related viruses share conserved biological requirem ents to com plete their cycle, 
assem bly being one o f  them . The principle o f  a JLR-based antiretroviral could be the 
synthesis o f  Gag-like m olecules that can form  hetero-m ultim ers w ith w ild type 
retroviral Gag that could be fuilher degraded by the proteasom e. As aforem entioned, 
studies perform ed in our laboratory by M anuela M ura have shown that a defective M- 
PM V double m utant is transdom inant over wild type M -PM V. Such dom inant-negative
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m u tant (that has been discussed above) has been designed based on the natural 
substitutions observed in enJS56A l and shows that this strategy could potentially be 
extended to another retrovirus closely related to JSRV.
From  a clinical and epidem iological perspective, therapeutic drugs based on JLR could 
help preventing disease transm ission and progression. In a given retroviral infection, 
once the virus integrated into the host cell, the late phase o f  the cycle starts and 
expression o f  the provirus leads to production o f  viral progeny. Hence, cells bearing 
pro viruses constitute reservoirs o f  infection w ithin the infected individual. I f  such cells 
can escape recognition by the im m une system, persistent infections can be developed. 
The more cells persistently infected, the m ore progeny virus is produced, and thus 
disease progression and transm ission to other individuals is likely to develop faster. 
Because the restriction m echanism  described in this thesis blocks viral exit at a late 
stage o f  the replication cycle, a  JLR-based therapeutic approach could be extrem ely 
valuable to avoid the spread o f  the infection w ithin the infected individual, probably 
delaying or attenuating the course o f  the disease, and avoiding the spread o f  virus to in­
contact individuals.
Unfortunately, there has not been developed a tissue culture system  to grow JSRV yet. 
Therefore, our assays have to be perform ed in transfected rather than in infected cells. 
W e aie aware that transient transfections could provide in some cases m isleading results 
if  proteins are overexpressed. How ever, in our case, JSRV exit is blocked by enJS56A l 
even w hen the form er is overexpressed. Indeed, it has previously been shown that 
enJS56A l can still block JSRV  w hen expression plasm ids driven by the sam e prom oter 
are transfected at a ratio o f  1 (for enJS 56A l) to 15 (for JSRV ) (Mui’a 2004),
The study o f  sheep Betaretroviruses has developed beyond the frontiers o f  veterinary 
m edicine as proved intellectually challenging and scientifically em iching. Different 
lines o f  investigation that have been opened in the last few  years shed light on 
m echanism s o f  cell transform ation, lung cancer, reproductive physiology, evolution o f 
retroviruses, and specifically in this thesis, retroviral restriction. Paradoxically, and 
despite all these achievements, our advice as veterinarians to a  sheep fanner when 
JSRV strikes a  flock is still the same as was 20 years ago: elim inate the diseased
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animals. This double-faced reality clearly reflects the necessity o f  in vivo studies to 
address unknow n aspects o f  OP A  pathogenesis. Hopeflilly, in the near future we will be 
able to devise novel strategies based on JL R  to select for JSRV -resistant anim als either 
by genetic engineering or by breeding flocks w ith the “right” pro viruses. An alternative 
strategy w ould include the treatm ent o f  infected sheep w ith drugs that m im ic enJS56A l 
Gag. Despite the feasibility o f  these strategies, and even i f  they succeeded, we should 
bear in m ind that the dynam ics o f  the interaction betw een virus and host w ill likely 
select for new  variants o f  exogenous, JSRV -related viruses.
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Appendices 
Appendix I. Oligonucleotides used in this project.
Primer Plasmid* Sequence
PP201A G Fw pJSALD201
5 ’CCTCA TA A TA A TA CCTTTG CCG G TG CTCC
G C CTTTTCC TCC C3’
PP201A G R V pJSALD201
5 ’ G G GA GG AAA A G G CG G A G C ACCG GC AA A 
GGTATTATTATG AGG 3 ’
PP207A A Fw pJSALD207
5 ’CTCTG CTC CG CCTTTTG CA G CCG CCTA TA
C TC C TTC 3’
PP207A A Rv pJSALD207
5 ’ GA AG GA GTA TA G G CG G CTG C AA AA GGC 
G G A G CA G A G 3’
Double LD Fw
pJSALD201-7
5 ’CC TCA TA A TA A TA CCTTTG CCG G TG CTCC 
G C CTTTTG C A G CC3’
Double LD Rv pJSALD201-7
5 ’G G CTG CA A A A G G CG G A G CA CCG G CA A A  
GGTATTATTATG AGG 3 ’
xK19E Fw JSK19E
5 ’ AC ATGCTA TCTG TA A TG TTG G A A C A TA G  
AG GG ATT ACTGTTTC3 ’
xK 19E R v JSK19E
5 ’ GAAAC A G T A ATCCCTCTA TG TTCC AAC A 
TTAC AG ATAGC ATGT3 ’
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P r im e r P lasm id* Sequence
XK19/H20E Fw JSK 19E/H 20E
5 ’ GTAC A C CTG CTA TCTG TA A TG TTG G A A G  
A A A G A G G G A TTA CTG TTTCTA A A CCTA A 3 ’
XK19/H20E Rv JSK 19E/H 20E
5 ’TTA G G TTTA G A A A C A G TA A TCC CTC TTTC 
TTCCA AC ATTAC AG ATA G CA TG TG TA C3 ’
xG 22A  Rv JSG 22A
5 ’TA A TTTA G G TTA G A A A C A G TA A TCG TCT 
ATGTTTC AAC ATTA C AGATAG3 ’
xH 20E Fw JSH 20E
5 ’ AC AC A TG CTA TCTG TA A TG TTG A A A G A A  
AG AG G G A TTA CTG TTTCTA A A CC3 ’
xH 20E Rv JSH 20E
5 ’G G TTTA G A A A CA G TA A TCC CTC TTTC TTT 
C AAC ATTAC AG A TA G C ATGTGT3 ’
xR21A  Fw JSR21A
5 ’CA TG CTA TCTG TA A TG TTG A A A C A TG CA  
G G G A TTA CTG TTTCTAAA CCTAA 3 ’
xR 2 1 A R v JSR21A
5 ’TTA G G TTTA G A A A C A G TA A TCC CTG CA T 
GTTTC AAC ATTAC AG A TA G C ATG3 ’
x R 2 1 E F w JSR21E
5 ’C A TG C TA TCTG TA A TG TTG A A A CA TG A A  
G G G A TTA CTG TTTCTA A A CCTA  A3 ’
xR21E Rv JSR21E
5’TTA G G TTTA G A A A C A G TA A TCC CTTC A TG  
TTTC AAC ATTACAGA TA GCA TG3 ’
x R 2 1 K F w JSR21K
5 ’ A TCTG TA A TG TTG A A A C A TA A A G G G A TT 
ACTGTTTCTAAA CC3 ’
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Primer Plasmid* Sequence
xR 21K R v JSR21K
5 ’G G TTTA G A A A CA G TA A TCC CTTTA TG TTT
CA A C A TTA CA G A T3’
enG2A Fw en56G2A
5’G A G A G TA TA A A TA TG G CA CA G A C G C A TA
G T C G 3’
enG 2A  Rv en56G2A
5 ’CG A CTA TG CG TCTG TG C CA TA TTTA TA CT 
C T C 3’
eii56A lM H R  Fw pen J S 5 6 A 1AMHR
5 ’GG TA A G A TA A TG TCA G A TG A A CA G G C TG
G G 3 ’
en 5 6 A lM H R R v pen J S 5 6 A 1 AMHR
5 T T T T G A A  A G A TC CTC TG TCTTA G TA CTG G  
A 3 ’
enp l2stop  Fw penJS56A lA C A -N C
5’TG CTTTTCCTG TC TTTTG A A A A TA CA A C C
A G C G 3’
enp l2stop  Rv pen J S 5 6 A 1ACA-N C
5 ’ CG CTG G TTG TTA TTTTC A A AG AC AG G A A  
A A G C A 3’
enCA stop Fw penJS56A lA N C
5 ’G G CG G C A TTA CA G G G A TA A A A G CA TA A A
AGAAG3
enCAstop Rv penJS56A lA N C
5’CTTCTTTTA TG CTTTTA TCCCTG TA A TG CC
G C C 3’
NotICM V I Fw pC M V 4en56A lxs
5’ATA TG CG G CCG C CG A TG TA CG G G CCA G A
T A 3’
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Primer Plasmid* Sequence
en56A13381 Rv pCM V 4en56A lxs
5 ’CA AA GTCTA G A CA G TCA CG A A TTA G TG T
C C 3’
en56A11030 Fw
penJS56A lH A -M A
penJS56A lFL A G -
M A
5’A A CCG A CA G CA A G G TA TA C A G 3’
en l 827-1848 Rv
pen J S 5 6 A 1H A-M  A
penJS56A lFL A G -
M A
5 ’ AG AA TTCA TA CTG TG TA G G A G G TG G C AC 
A 3’
JS21M A 1-18FW pET24bJSM A
5 ’CG CG CA TA TG A TG G G A CA A A CG CA TA G T
CG TCA G 3’
JS21M A270 Rv pET24bJSM A
5 ’CG CG GA ATTCTCA TCA A TCCA A G CA A TC 
A CG A A TTA 3’
HERV-K Gag 
Fw
pCR U 5-H ERV -K G ag
5’C G CG A A TTCG TG A TA A TG G G G CA A A CTA
A A A G 3’
H ERV -K  Gag 
Rv
pCRU 5-H ERV -K G ag
5 ’ A G G G A A G CTTCTA CTG CTG CA CTG CTG C 
T TG TG G 3’
HK G2A Fw
pCRU5-HERV-
K G 2A
5’AA A TG A A TTCG TG A TA A TG G CG CA A A CT 
AA  AAGTAAAATTA3 ’
H K G 2A  Rv
pCRU 5-H ERV -
KG2A
5 ’TA ATTTTA CTTTTA G TTTG CG CCA TTA TC
A CG A A TTC A TTT3’
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Primer Plasmid* Sequence
H K lO ô lC la lR v pH VKmaJ Scanc
5’G TCG A TCG A TA G G TG G TG CCG TA G G A TT
A A G TC T3’
M PM VG 2A Fw pM -PM V G 2A
5’C G CTCG G A TA TG G CG CA A G A A TTA A G CC
3 ’
M PM V G 2A  Rv pM -PM V G 2A
5 ’ GGCTT A A TTCTTG CG CC A TA TCCG A G CG  
3 ’
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